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Abstract 
 
The work presented in this Thesis describes several new and novel radical 
macrocyclisation-transannulation cascade reactions directed towards the single step 
construction of ring-D aromatic steroid ring systems. 
 
The Introduction introduces the steroid class of natural products, their 
biosynthesis and previous literature strategies towards their construction. The ring-
D aromatic steroids, together with their possible total synthesis via a novel free-
radical cascade strategy, are then discussed. 
 
The Results and Discussion Chapter summarises the radical cascade strategies 
towards ring-D aromatic steroid ring systems that have been investigated. It is 
divided into two sections: 
 
Part 1 describes the evolution of our current radical cascade approaches relating to 
the iododienynone precursors 117a-d (Schemes 26-29). We proposed that 
the precursors 117a-d would lead to the 6,6,6,6 ring-D aromatic steroid ring 
system (such as that found in the natural product nicandrenone 67), via a 
cascade of radical ring-forming reactions. However, the proposed radical 
cascade from the Z-iododienynones 117a,c halted at the macrocyclisation 
stage producing the macrocycles 137a,b, whilst a radical cascade from the 
E-iododienynones 117b,d instead led to the unusual bridged tricyclic 
structures 148a,b and 155 (depending on whether benzene or heptane was 
vii 
used as the solvent), rather than the anticipated linear tetracycles 116a,b. A 
rationale for these outcomes is given. 
 
Part 2 discusses an approach to 6,6,5,6 ring-D aromatic steroids via a 
macrocyclisation-transannulation radical cascade from the vinylcyclopropyl 
seleno ester precursor 193. A synthesis of the radical precursor 193 was 
first examined using a novel aryl-vinylcyclopropane Stille reaction coupling 
protocol (the development of which is discussed), as well as several 
alternative routes. A practical, albeit more lengthy, synthesis of the 
precursor 193, was then developed. The proposed radical cascade from the 
vinylcyclopropyl seleno ester 193 led to the desired ring-D aromatic steroid 
ring system 194a (with the correct trans, anti, trans stereochemistry) 
together with the methyl epimer 194b. Also isolated from the product 
mixture was the macrocycle 232, together with the products of reduction 
and decarbonylation of the acyl radical intermediate 235, i.e. 231 and 230, 
and the dioxolane 233. 
 
The Experimental section describes all the procedures used to synthesise the 
precursor compounds 117a-d and 193 and the products of their radical mediated 
cascade cyclisations. Full NMR, and other spectroscopic data, alongside mass 
spectrometry data are also given. 
 
The Appendices include some relevant X-ray and NMR spectroscopic details. 
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Abbreviations 
 
AIBN   2,2'-Azobis(isobutyronitrile) 
Asp   Aspartic acid 
Cp   Cyclopentyl  
CuTC   Copper (I) thiophene-2-carboxylate 
Cy   Cyclohexyl 
dba   Dibenzylideneacetone 
DCM   Dichloromethane CH2Cl2 
DMAP   4-Dimethylaminopyridine 
DME   Dimethoxyethane 
FPP   Farnesylpyrophosphate 
His   Histidine 
HMDS   bis-(Trimethylsilyl)amide 
HMPA   Hexamethylphosphoramide 
IBX   2-Iodoxybenzoic acid 
Ile   Isoleucine 
Imid   Imidazole 
Leu   Leucine 
NADPH  Nicotinamide adenine dinucleotide phosphate 
NCS   N-Chlorosuccinimide 
Nf   Nonaflate –OSO2CF2CF2CF2CF3 
NPSP   N-(Phenylselenyl)phthalimide 
Phe   Phenylalanine 
PP   Pyrophosphate 
TBAF   Tetra-n-butylammonium fluoride 
ix 
TBDPS  tert-Butyldiphenylsilyl –SiPh2C(CH3)3 
TES   Triethylsilyl –Si(CH2CH3)3 
Tf   Trifluoromethanesulfonyl –SO2CF3 
Tol   Toluene 
Trp   Tryptophan 
TTMSS  Tris(trimethylsilyl)silane 
Tyr   Tyrosine 
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The Total Synthesis of Natural Products 
Natural products have played a major role in the intellectual and experimental 
development of the field of organic chemistry. In the early days of chemical theory 
the field was concerned with structure elucidation together with the interactive and 
creative link between proof of structure and the advancement of the current 
theories. The target-oriented total synthesis of a complex natural product is still 
regarded by most to be the ultimate test of reaction design and application of 
fundamental principles.  
   As more and more remarkable compounds were isolated from plants, bacteria, 
fungi and marine sources, the imaginations of organic chemists were provoked. 
This, together with demands in medicine i.e. between 1981 and 2002, 78% of new 
antibacterial and 74% of new anticancer entities, such as clarithromycin 1 and 
paclitaxel 2, were natural products or were natural product-derived,1 became the 
driving force behind modern organic chemistry. 
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Secondary metabolites have been classified into five broad categories, depending 
on their biosynthetic origins, i.e. fatty acids and polyketides (e.g. prostaglandins 
and macrolides), aromatic amino acids and phenylpropanoids (e.g. lignans and 
flavanoids), terpenoids (e.g. taxanes), alkaloids (e.g. lysergic acid and quinolines) 
and peptide derivatives (e.g. penicillins and amino acids).  
   The terpenoids are a fascinating collection of natural products, which also include 
the steroids, compounds which not only have an extraordinary range of biological 
functions but, through the chemical study of their structures and reactions, have had 
a major impact on the development of organic chemistry. It is the steroid family of 
natural products which has particularly sparked this author’s imagination, and it is 
the steroids which will concern the majority of this thesis. 
 
Steroids 
The steroids (from the Greek word ‘stereos’, meaning solid) are modified 
triterpenes containing a tetracyclic ring system 3, which is exemplified in lanosterol 
4. This remarkably stable (samples of sediment 2.7 billion years old, have been 
found to contain steroids)2 cyclopentaperhydrophenanthrene structure 3, with its 
trans, anti, trans, anti, trans stereochemistry, typifies the fundamental structure of 
the steroids, with modifications to this structure creating a wide-range of 
biologically and therapeutically important compounds. For example, 
corticosteroids in inflammation control,3 19-norsteroids in reproductive regulation,4 
vitamin D metabolites as dermatological agents5 and Na+/K+ pump-inhibiting 
cardiac glycosides from Digitalis spp. (first recognised as a treatment for 
congestive heart failure in 1775),6 to name just a few.  
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Not only are the steroids fascinating structurally, and amazingly diverse 
biologically, they also have a remarkable biosynthesis which has captivated organic 
chemists and biochemists for over half a century.7,8 
 
Steroid Biosynthesis 
Over the last few years there have been many important advancements in our 
understanding of the remarkable cyclisation of oxidosqualene 14 leading to the 
steroids and a brief outline of the basics of steroid biosynthesis together with some 
of the ‘new pieces to the puzzle’ follow here. 
   The squalene cyclases occur in higher eukaryotes, and some micro organisms, 
and catalyse what many regard as being one of the most efficient chemical 
processes to have been revealed from nature. Studies with non-natural and radio-
labelled substrates have established the overall pathways.9 
   2,3-Oxidosqualene 14 is derived from farnesylpyrophosphate (FPP) 6 via initial 
attack of the 2,3-olefinic bond of FPP 6 into a second farnesyl cation 7. The 
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resulting carbocation 8 next undergoes loss of a proton and concurrent 
cyclopropane ring formation leading to presqualene pyrophosphate 9. Loss of the 
pyrophosphate group from presqualene PP 9 then gives a cyclopropylmethyl 
primary cation 10 which, via a Wagner-Meerwein 1,3-alkyl shift, generates the 
more stable tertiary carbocation species 11. Finally, cleavage of the cyclopropane 
in 11 leads to an allylic carbocation 12 which is quenched by NADPH, to give 
squalene 13. A flavoprotein mono-oxygenation of 13 then gives 2,3-oxidosqualene 
14 (Scheme 1).10  
OPP
OPP
H H
H
H OPP
H
H
H
H
O
H
H(NADPH)
FPP, 6
squalene
FPP, 6
electrophilic loss of
proton/
Presqualene PP, 9
loss of
diphosphate
1,3-alkyl
shift
2,3-Oxidosqualene, 14
Squalene, 13
cyclopropane
cleavage
NADPH
11
synthase
addition
cyclopropane
formation
O2
NADPH
7
8
10
12
 
Scheme 1 The biosynthesis of 2,3-oxidosqualene 14 
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Oxidosqualene 14 binds to the active site of an oxidosqualene cyclase enzyme, 
folding as it enters the ‘pocket’, into a chair-boat-chair-boat conformation. The 
cyclisation is initiated by protonation of the epoxide which allows the first three 
rings in the steroid to be formed, via a 6-exo-tet and two 6-endo-trig cyclisations. 
The resulting tricyclic carbocation 15, however is associated with a five-membered 
ring C, which then undergoes a 1,2-alkyl shift with concomitant ring expansion to 
give the expected six-membered ring tricyclic 16.11,12 A further electrophilic 
addition results in the formation of the five-membered D-ring tetracyclic 
carbocation 17. The final stages in the biosynthesis of lanosterol 4 from 14 involve 
a series of 1,2-hydride and 1,2-methyl shifts to give the familiar steroidal stereo 
pattern (Scheme 2). 
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Scheme 2 The biosynthesis of lanosterol 4 from 2,3-oxidosqualene 14 
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There are many variations of this fascinating process in nature. For example, whilst 
the above process is typical for animals and fungi, in plants H-9 is not lost from 17 
to produce the olefinic B/C ring bridge, but rather the H-19 proton is lost producing 
cycloartenol 18 instead. There are also various “hopene” and “dammarene” 
cyclases producing pentacyclic hopenes 20 and dammarenoids 19 respectively, as 
well as hundreds of other variations which have fashioned nature with thousands 
and thousands of polycyclic triterpenoids which are utilised in a near countless 
number of biological processes (Scheme 3). 
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Scheme 3 The biosynthesis of cycloartenol 18 and the dammarenoids 19 and hopenoids 20. 
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Recent findings, involving crystallographic and structure-based mutagenesis 
studies, have provided two important additional ‘snapshots’ of the aforementioned 
cascade process leading to steroids, and have begun to reveal intimate structural 
details of the catalytic mechanism. Reinert et al. for example, have determined the 
structure of the hopene cyclase active site complexed with a squalene mimic,13 and 
Thoma et al. have determined the structure of human oxidosqualene cyclase 
complexed with lanosterol 4.14 These results are summarised below in Figure 1 
using hopene cyclase as an example.15  
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Figure 1 The active site of squalene-hopene cyclase 
 
Briefly, we now know that an aspartic acid residue (asp 376) polarised by a 
positive histidine residue (his 451) initiates the cascade cyclisations by protonation. 
Asp 447,313 and tyr 495 then reprotonate asp 376 as the cation moves away, along 
the squalene molecule. There then follows a complex series of interactions between 
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the various intermediate cations and the remaining surrounding residues. For 
example, phe 601,365,605, asp 377, trp 489 and tyr 420,612,609 are involved in 
carbocation stabilisation mostly via non-bonding interactions, ile 261 is 
instrumental in stereocontrol, and trp 312,169 and leu 607 control substrate 
binding.16,17 
 
Having such a diverse range of potential pharmaceutical applications it should 
come as no surprise that chemists have tried to emulate nature by synthesising 
various steroids for therapeutic applications. For thirty years, after world war two, 
the study and synthesis of steroids was a major field of research. These studies 
have contributed to our understanding of basic chemical principles, chemo- and 
stereo-selectivity, orbital alignment and the chemistry of polycyclic ring systems. 
They have also furnished us with several new reagents and named reactions. We 
shall now outline some of the main strategies that have been used so far to 
synthesise steroids in vitro.  
 
The Synthesis of Steroids 
The immense structural and bio-diversity found in the steroids (i.e. the sexual 
hormones estrone 21 and testosterone 22, the metabolic growth hormone 
nandrolone 23 and the synthetic anti-inflammatory pro-drug prednisolone 24)18 has 
resulted in a copious number of approaches and strategies towards their synthesis. 
The complex stereochemistry and the well-defined ring structure, together with 
their various physiological activities make the steroids an interesting challenge for 
synthetic chemists.19 A short historical overview and some highlights in steroid 
synthesis are given below. 
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The first total synthesis of a steroid was that of the naphthalene-based equilenin 25 
by Bachmann et al. in 1939.20 This was followed by the milestone synthesis of 
estrone 21 in 1948 by Anner and Miescher.21 Since then several novel and powerful 
strategies have been developed to combat the multifaceted structure found in the 
steroidal core.  
   Early strategies were mostly based on the Robinson-annulation reaction which 
became more applicable with the discovery of the enantioselective Hajos-Parrish 
reaction allowing access to a building block for the C/D rings (Scheme 4).22 
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Scheme 4 The Robinson-annulation strategy towards steroids 
 
In 1971 Johnson et al. published their pioneering biomimetic synthesis of 
progesterone 26.23 This ‘classic’ synthesis involves the construction of the steroid 
framework 33 in one step, from a linear squalene inspired precursor 30, via a Lewis 
acid catalysed polyolefinic cyclisation (Scheme 5). 
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Scheme 5 Johnson’s biomimetic synthesis of progesterone 26 
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The cascading 6/5-endo-trig cyclisations gave a 5:1 selectivity for the desired 
isomer of 33 according to the Stork-Eschenmoser hypothesis.24 Enantioselective 
versions of this strategy were later developed.25,26 
 
Cascade reactions exploiting transition metal mediated cyclisations have also been 
utilised as an approach to synthesising the steroids. For example, the total synthesis 
of estrone 21 by Tietze et al. involves a double Heck cyclisation of the dibromide 
35 and the olefin 34 (derived from the Hajos-Parrish ketone 28) as the key step 
(Scheme 6).27 
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Scheme 6 A total synthesis of estrone 21 by Tietze et al. 
 
A palladium catalysed polyene cyclisation cascade of the iodide 38 by Negishi et 
al., delivers the steroidal-like polycycle 39 in a single step,28 and the recent gold 
catalysed cascade of the aldehyde 40, by Dyker et al.,29 to give the steroidal 
framework 41, are also good examples of the use of transition metal mediated 
reactions in the creation of steroids (Scheme 7). 
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Scheme 7 Transition metal mediated cyclisation strategies  
 
The Diels-Alder reaction,30 a powerful technique for the construction of six 
membered rings with the concurrent formation of two new carbon-carbon bonds 
and up to four new stereocenters in a single step has, unsurprisingly, been exploited 
in the synthesis of steroids.  
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Scheme 8 Woodward’s synthesis of cortisone 45 via a Diels-Alder strategy. 
 
In 1952, Woodward et al. constructed the A/B rings via an intermolecular Diels-
Alder reaction in a total synthesis of cortisone 45 (Scheme 8).31  
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The intramolecular Diels-Alder reaction has been exploited to the utmost in 
polycycle synthesis by Deslongchamps et al. The example shown below 
demonstrates that the crucial trans stereochemistry of the steroids cannot be 
accessed directly via this strategy, but that this can be solved by a subsequent 
epimerisation of the Diels-Alder product 47 (Scheme 9).32,33  
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Scheme 9 Deslongchamps’ steroid synthesis via a transannular Diels-Alder strategy. 
 
Of special interest is the ‘classic’ synthesis of estrone 21 by Vollhardt et al.34 In 
this novel strategy Vollhardt generates the intramolecular Diels-Alder o-
quinodimethane precursor 5235 via a thermolytic opening of benzocyclobutene 51 
(prepared by a cobalt catalysed cyclotrimerisation of dialkyne 50 and alkyne 49). 
This single step reaction generates the B- and C-rings of 53 with the correct relative 
stereochemistry. A further two steps lead to estrone 21 (Scheme 10).36  
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Scheme 10 A total synthesis of estrone 21 by Vollhardt et al. 
 
The Pattenden group has had a particular interest in cascade radical chemistry from 
polyenes leading to steroids for a number of years, and we shall now introduce this 
strategy for synthesising the steroids. 
 
A Free Radical Cascade Approach to the Steroids 
The current approach to steroids via cascade radical cyclisation has been developed 
over the last twenty years by our group in Nottingham, and others, and it has 
become a powerful method for the construction of polycyclic systems. A cascade 
reaction (sometimes referred to as a ‘domino’ reaction) is a multistep ‘one-pot’ 
sequence whereby the first step creates the functionality for the second step, the 
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second for the third, and so on. This is exactly what occurs in a correctly setup 
polyolefinic system when a suitable carbon radical centre is generated.37 
   Radical chemistry, compared to anionic and cationic chemistry is, relatively 
speaking, still in its infancy having had a lengthy gestation period. Since the first 
carbon centred radical was discovered in 1900 by Gomberg,38 radical reactions 
have mostly been perceived as difficult to control, very unselective, and only of use 
in a few polymerisation reactions. However, we know today that radical chemistry 
can be a powerful tool in organic synthesis and that the radical cascade especially, 
could arguably be described as a highly efficient, mild, clean, and yet functionally 
tolerant reaction. Indeed, due to the large amount of rate constant data collected on 
radical reactions,39 radical-molecule reactions can have a higher level of 
predictability in complex settings than most other types of reaction. Radicals are 
now highly valued synthetic intermediates, often used for transformations that are 
difficult to accomplish by other means (i.e. the kinds of functional group 
protections so often required for ionic reactions are rarely required in radical 
mediated reactions).40 
   There are numerous books and reviews on the use of radicals in organic synthesis 
and several of these are found in ref.41. 
    
The evolution of the current radical cascade strategy to steroids will be discussed in 
the following sections. First however, we shall introduce the fascinating sub-class 
of steroids that have an aromatic ring replacing the more normal cyclopentane D-
ring i.e. ring-D aromatic steroids. 
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Ring-D Aromatic Steroids 
There are two different types of ring-D aromatic steroid, which arise from two 
different biosynthetic modifications of the typical 6,6,6,5 steroid skeleton. The first 
type are the 6,6,5,6 ring-D aromatic steroids. These have a five membered ring-C 
as well as the 6-membered aromatic ring-D, and arise via the simultaneous ring 
expansion of the D ring and contraction of the C ring.  
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Scheme 11 A proposed biosynthetic route to the 6,6,5,6 ring-D aromatic steroids 
 
The current understanding of this biosynthetic process is that it initiates with the 
addition of a leaving group at C-12, most probably a protonated hydroxyl group. A 
1,2-alkyl shift, on cation 55, then gives the 6-membered ring-D tertiary carbocation 
56. Elimination of a proton results in the alkene 57 commonly found in the 
veratrum alkaloids, such as jervine and cyclopamine, and further oxidation of the 
same ring leads to the aromatic D-ring 58 (Scheme 11).42,6 
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Two prominent examples of 6,6,5,6 ring-D aromatic steroids are nakiterpiosinone 
59 and veratramine 60. 
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Nakiterpiosinone 59 is a cytotoxic ring-D aromatic steroid isolated in 2004 by 
Uemura et al., from the marine sponge Terpios hoshinota, off the coast of the 
Ryukyu Islands.43 This was the first ring-D aromatic steroid to be isolated from a 
marine source. Veratramine 60 was isolated from the white hellebore (Veratrum 
grandiflorum) by Saito et al. in 1940.44 This steroidal alkaloid is biologically active 
as an anti-accelerator of the heart,45 an antagonist to the cardiovascular action of 
epinephrine46 and as an excitor of the central nervous system.47 There is also 
evidence to suggest that veratramine 60 is a potent non-teratogenic toxin48 (the only 
non-teratogenic veratrum alkaloid to be isolated). 
   The second type of ring-D aromatic steroid, which we shall discuss has a 6,6,6,6 
steroidal carbon skeleton i.e. they retain the six-membered C-ring whilst expanding 
and aromatising the D-ring. Nicandrenone 67 is the most prominent example of this 
class of ring-D aromatic steroid. The steroid was first isolated from the Peruvian 
‘shoofly’ plant Nicandra physaloides in 1951 by Gizycki and Kotitschke,49 but it 
was not until Yamamato et al. made a separate study in 196450 that the two groups 
from the UK51 and US52 became interested in the potent anti-feedant properties of 
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this steroid. Whilst precise details of the biosynthesis of these steroids are 
unknown, it seems plausible that at some point the angular C-18 methyl in a 
‘regular’ steroid becomes incorporated into the D-ring. Whiting et al. carried out 
numerous studies on the nicandrenoids and proposed a free-radical biosynthetic 
mechanism for the expansion and aromatisation of the D-ring.53 These authors 
proposed that if a radical is generated at C-18 this could attack an oxidised ring-D 
to give a bridged D-ring intermediate 62. This intermediate 62 could then fragment 
in two different ways resulting in a 6,6,6,6 ring-D aromatic steroid with two 
different methyl substitution patterns 65/66 (Scheme 12).54 
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Scheme 12 Whiting’s proposed biosynthetic route to the 6,6,6,6 ring-D aromatic steroids 
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This Thesis details our efforts to synthesis the core 6,6,6,6 and 6,6,5,6 ring systems 
in aromatic D-ring steroids, such as nicandrenone 67 and veratramine 60, via a free 
radical cascade strategy. These studies are described in the Results and Discussion 
sections, which now follow. 
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Results and Discussion 
 
Part 1 
A Cascade Radical-Mediated Approach 
towards Nicandrenone 
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The family of insect antifeedant compounds known as the nicandrenones (or NICs), 
e.g. nicandrenone or NIC-1 (67), isolated from the Peruvian “shoofly” plant 
Nicandra physaloides,49,50 are probably the best-known group of naturally 
occurring ring-D aromatic steroids.51,55 Although some detailed studies have been 
conducted to determine the possible origin of the aromatic D-ring in these 
compounds (see pages 18-20), relatively little attention has been given to their total 
synthesis.  
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Scheme 13 Corey’s total synthesis of nicandrenone 67 
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Until 2000 no member of either the nicandrenones (or the structurally related 
withanolides), had been completed by total synthesis. Corey et al. describe the only 
total synthesis of nicandrenone56 utilising as the key step, a Diels-Alder reaction 
which constructed the B-ring in the key intermediate 70. This highly unusual exo-
selective Diels-Alder reaction57 was followed by a further sixteen steps which 
elaborated the complex pattern of functionality found in the A- and B-rings of 
nicandrenone 67. The side chain in the natural product was then coupled with the 
intermediate nonaflate 71 in a Stille reaction, and a further eleven steps were then 
required to expand the functionality of the side-chain and complete the synthesis of 
nicandrenone 67 (Scheme 13). 
 
Our strategy for synthesising a ring-D aromatic steroid such as nicandrenone 67, 
involved a free-radical cascade as the key step, and we shall now discuss the 
development of this strategy to its current state. 
 
The Development of a Radical Cascade Strategy towards Ring-D 
Aromatic Steroids 
In general, there are two different approaches towards constructing a polycycle via 
a radical cascade: i) a sequential ring closing cascade based on 73→74, and ii) a 
macrocyclisation followed by a series of transannulation reactions e.g. 75→77 
(Scheme 14). 
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Scheme 14 Approaches for the construction of polycycles via radical cascades. 
 
A unique and powerful example of the sequential approach has been developed by 
our research group. Judicious forward planning allowed the polyene 78, when 
subjected to the radical generating conditions of tributyltin hydride and AIBN, to 
undergo seven consecutive cascading 6-endo-trig cyclisations, creating seven new 
carbon-carbon bonds and fourteen new stereocenters within the product heptacycle 
79.58 This example forms a persuasive argument for the merit of this approach in 
organic synthesis (Scheme 15). 
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Scheme 15 Nottingham’s sequential radical cascade approach to the heptacycle 79. 
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Our research group has also demonstrated that the consecutive radical cascade 
approach can also be used to synthesise the steroid ring core in high yield. For 
example, when the acyl radical 81 was generated from the phenylseleno ester 80, 
the tetracycle 82 was produced, in 85% yield (Scheme 16).59 
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Scheme 16 A Synthesis of the steroid ring core via a sequential radical cascade. 
 
The majority of the work contained within this thesis however utilizes the second 
approach (the macrocyclisation-transannulation cascade) and we shall now 
concentrate on how this strategy developed before and during the period of my 
studies.  
   The first significant work in this area was published by Porter et al. who 
determined that for an efficient macrocyclisation of an alkyl radical to take place, 
the unsaturation undergoing attack would need to be electron deficient (to improve 
SOMO-LUMO overlap). Furthermore, alkyl iodides should be used as the radical 
precursors, and the radical cascade should be carried out under high dilution 
conditions (so as to minimize bimolecular radical reactions) and the enone system 
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should be used as the radical acceptor (electrophore).60 Restricting the 
conformation of the macrocycle (and therefore lowering the steric repulsion and 
entropy of the transition state) was also found to significantly promote radical 
macrocyclisation.61 For example, the 14-endo-trig radical macrocyclisation of the 
iodide 83 studied by Porter et al. was optimized according to the above guidelines 
and the reaction occurred in good yield.62 The Pattenden group subsequently 
exploited the radical macrocyclisation to good effect in a total synthesis of mukalol 
87, a macrocyclic terpene natural product ideally suited for this method (Scheme 
17).63   
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Scheme 17 Some Radical macrocyclisations in organic synthesis. 
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More recently, catalytic and enantioselective variants of the radical 
macrocyclisation have been developed. Baldwin et al. developed a catalytic radical 
macrocyclisation using an alkyl selenide as the precursor and an allylic stannane as 
the electrophore. For example the selenide 90, when treated with catalytic amounts 
of stannyl radical resulted in the alkyl radical 89 which then underwent radical 
macrocyclisation to give the macrocycle 88.64 Interestingly, the possibility for 
direct reduction (possibly the foremost potential problem that must be considered 
when planning a radical reaction) was almost eliminated in this type of system due 
to the in situ generation of the stannyl radical in catalytic amounts. 
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Scheme 18 Catalytic and enantioselective variants of the radical macrocyclisation. 
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An enantioselective radical macrocyclisation has been developed by Porter et al., 
via the use of a chiral auxiliary attached to the electrophore. This was utilised in a 
synthesis of R-muscone 93. Thus, when the olefin 91 (bearing a 
dimethylpyrrolidine amide) was treated with tributyltin hydride and AIBN, the 
major product formed was the macrocycle 92. This system produced a 14:1 
diastereomeric ratio in favour of the desired product 92 which was subsequently 
converted into R-muscone 93 (Scheme 18).65 
 
A Radical-Mediated Macrocyclisation-Transannulation Cascade 
Combining a radical macrocyclisation with the potential for subsequent cascading 
transannulations provides the opportunity for the elaboration of a complex 
polycyclic structure in a single step. 
   Some relatively straightforward examples from the laboratories of Porter 
demonstrate the delicate nature of these cascades. In the first example the iodide 94 
underwent a 14-endo-trig radical macrocyclisation in the presence of tributyltin 
hydride and AIBN, in toluene at 80oC. The resulting stabilized radical then 
underwent a 5-exo-trig transannulation leading to the bicycle 97. In the second 
example the iodide 95 underwent a similar macrocyclisation-transannulation 
reaction sequence but 95 also has an extra olefin, positioned so that the bicyclic 
radical could undergo a second 5-exo-trig transannulation. However, this cascade 
did not continue further. Neither did the alkyl iodide 96, in the third example, 
undergo the expected 5-exo-trig transannulation into the Z-alkene bond in 96.66 
These examples serve to illustrate the subtle effects which can alter the outcome of 
these macrocyclisation-transannulation processes, and i) why careful prior planning 
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is required,67 and ii) why more research is required in this area so that the processes 
can be more accurately predicted and controlled (Scheme 19). 
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Scheme 19 Subtle conformational effects during a radical macrocyclisation-transannulation 
 
Our own group in Nottingham has successfully demonstrated the elegance of this 
cascade strategy, converting various linear polyenes into polycyclic structures with 
a much higher level of complexity. I have chosen two examples from our early 
work which demonstrate this escalation in complexity during the radical cascade. 
In the first example the iodide 100 was smoothly converted into the tricycle 102 in 
55% yield (its stereochemistry having been rationalized by MM2 molecular 
modeling studies).68 The second example with the iodide 103, successfully 
modeled the construction of the ABC rings of a ring-A aromatic steroid, such as 
estrone 21 (Scheme 20).69 
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Scheme 20 Nottingham’s early successes with radical macrocyclisation-transannulation cascades. 
 
Our research group has also published some interesting results from attempted 
radical cascades which did not follow the desired plan but which provided exciting 
outcomes nonetheless and were worthy of note. For example, an attempt to 
synthesise the model steroid 108 from the simple iodoenynone 106, instead resulted 
in the tetracyclic structure 109. This was thought to be due to the intermediate 
radical 107 adding into the opposite side of the furan to that desired, which was 
then followed by an unexpected fragmentation. Such unexpected results underline 
the need for the careful consideration of all potential reactions of intermediate 
radicals and the subtle changes which can lead to such unexpected but interesting 
structures (Scheme 21).70 
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Scheme 21 Reagents and conditions i) Bu3SnH, AIBN, benzene, 80oC, 2.5h, 40%. 
 
The development of the strategy led our group to investigate approaches to the 
construction of the steroid skeleton via a radical macrocyclisation-transannulation 
cascade and the ring-A aromatic steroid estrone 21 was chosen as a suitably 
ambitious target. Initially two model systems were devised by our group to 
investigate a possible route towards estrone 21. Thus, the Z- and E-iododienynones 
110 and 112 were subjected separately to the radical generating conditions of 
tributyltin hydride and AIBN, and both underwent the expected 13-endo-dig radical 
macrocyclisation followed by the intended double transannulations. However, 
whilst these results were remarkable and justified continued studies, the desired 
steroidal stereochemistry was not achieved (Scheme 22).71 
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Scheme 22 Nottingham’s model radical cascades towards estrone 21. 
 
These results, and others, led our group to take a different approach in the synthesis 
of estrone 21 via a radical cascade strategy, and instead to use a vinylcyclopropane 
as the electrophore. The successful total synthesis of estrone 21 was completed 
using the iodovinylcyclopropane precursor 114.  
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Scheme 23 A total synthesis of estrone 21 by a radical cascade. 
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The vinylcyclopropane 114 underwent the desired 13-endo-trig radical 
macrocyclisation and subsequent transannulations, to yield an advanced tetracyclic 
intermediate, this time with the correct steroidal stereochemistry. A further two 
steps (oxidation and deprotection of the phenol) led to an impressive cascade 
synthesis of estrone 21 (Scheme 23).72 
 
Having successfully completed a total synthesis of estrone 21, our group decided to 
test the aforementioned radical macrocyclisation-transannulation strategy on a yet 
more challenging target, i.e. the nicandrenones. 
 
A Ring-D Aromatic Model System 
It is at this point in time that the author joined the laboratories in Nottingham and to 
examine a radical cascade approach to the ring-D aromatic steroids. A model 
system would almost certainly be required initially and we decided upon a scheme 
which would use a strategy similar to that used for the related iodides 110/112. 
However, the problem of the steroid stereochemistry still needed to be addressed 
and, after careful consideration, we decided upon the addition of an angular methyl 
group at the 10-position (the 14-position on 110/112). Whilst this introduced a new 
risk, in that it set up three new protons susceptible to 1,5-hydrogen abstraction,73 
we believed it would also enforce the desired transition state and result in the 
desired trans, anti, trans steroid stereochemistry. Hence, synthetic routes to the 
model radical precursors 117a-d were devised (Scheme 24). 
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Scheme 24 Model system for the construction of a 6,6,6,6 ring-D aromatic steroid. 
 
Upon generating the alkyl radical intermediate 119 we hoped that instead of the 
feared 1,5-hydrogen abstraction, the radical centre would undergo the desired 14-
endo-trig radical macrocyclisation leading to the new vinyl radical 118. This 
radical should then be held close enough to the remaining unsaturation in the 
macrocyclic trienone that the subsequent transannulations would occur smoothly 
resulting in the tetracycle 116 (Scheme 24). 
   We decided to synthesise the four different radical precursors (117a-d) i.e. E/Z 
analogues about the trisubstituted olefin (so as to test the stereochemical effect of 
this olefin on the stereochemistry of the final tetracycle) and also the methoxy and 
des-methoxy variants about the aromatic ring (this was to determine the effect on 
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the efficiency of the radical cascade of a methoxy substituent on the aromatic ring, 
which could also be used as a handle for attaching a side chain to the steroid at a 
later stage in the real system).  
   Firstly, we needed to synthesise 117a-d as quickly, efficiently and as simply as 
possible. We therefore proceeded by disconnecting the lower ynone chain in 117 
via a Grignard reaction,74 (and three functional group interconversions) to provide 
us with the ester 120.  
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Scheme 25 A retrosynthetic analysis of the radical cascade precursors 117a-d 
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The upper iodo alkenyl chain in 117 could then be disconnected back to a protected 
alcohol (via a Finkelstein reaction75 and deprotection) leading to the protected 
alcohol 120. Having simplified the radical precursor 117 to the ester 120, we next 
decided to make the synthesis more convergent and disconnect the trisubstituted 
olefin in 120 by means of a (Sylvestre) Julia olefination.76,77 This we surmised, 
would allow access to both E- and Z-olefin isomers, and would lead us back to the 
known aldehydes 121a,b72 and the fairly straightforward looking sulfone 122. The 
aldehydes 121a,b would come from the 2-iodobenzaldehydes 124a,b, of which 
both methoxy- and des-methoxy- variants are easily accessed, and the sulfone 122 
could be synthesised from the widely available γ-valerolactone 123 in four 
relatively straightforward steps (Scheme 25). 
 
This retrosynthesis was appealing for several reasons. Thus, the Julia disconnection 
ensured a convergent synthesis and allowed us to start from the known aldehydes 
121a,b,72 and the remainder of the proposed reactions seemed uncomplicated and 
should be high yielding so as to ensure we achieved our goal as quickly as possible. 
   The first task was to synthesise the olefination coupling partners i.e. the sulfone 
122 and the methoxy and des-methoxy aldehydes 121a,b. 
 
Syntheses of the Sulfone 122 and the Aldehydes 121a,b 
The first step in the synthesis of the sulfone 122 was the selective protection of the 
primary alcohol group in 1,4-pentanediol 125. However, whilst the diol 125 was 
available commercially, the quantity of compound required for the synthesis made 
the purchase of 1,4-pentanediol 125 commercially unviable. We therefore 
synthesized the diol 125 in large quantities from the available and inexpensive γ-
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valerolactone 123, via a lithium aluminium hydride reduction, in good yield.78 
Having obtained a sufficient quantity of the diol 125 we then selectively protected 
the primary alcohol group. We chose the tert-butyldiphenylsilyl (TBDPS) 
protecting group, and this performed well (initial test reactions with the less 
expensive tert-butyldimethylsilyl (TBS) protecting group demonstrated that this led 
to the compound becoming unstable during the later sulphide oxidation step), and 
proceeded in high yield with the trace amounts of bis-protected material being 
easily separated.  
   A Mitsunobu coupling79 of the alcohol 126 was then chosen to introduce the 
aromatic sulphide component required for the Julia olefination. Past experience 
within our group had shown the benzothiazole to be superior to the Kocienski-
modified Julia tetrazole, when used with a small secondary alcohol.  
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Scheme 26 Reagents and conditions i) LiAlH4, THF, 0oC→r.t, 2h, 97%; ii) TBDPSCl, NaH, THF, 
0oC, 2h, 98%; iii) 2-Mercaptobenzothiazole, PPh3, DEAD, THF, 0oC→r.t, 24h, 99%; iv) m-CPBA, 
NaHCO3, DCM, -40oC→0oC, 12h, 93%. 
 
Utilising 2-mercaptobenzothiazole, the coupling reaction proceeded in high yield 
(when the DEAD reagent was used) and the employment of 3-chloroperbenzoic 
acid in the subsequent oxidation step also ensured a good yield on both test and 
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larger scales. This completed a simple and efficient large scale synthesis of the 
sulfone 122 (Scheme 26). 
 
The two substituted aldehydes 121a,b, required for the Julia coupling with the 
sulfone 122, were known compounds from earlier work within our research group. 
However, Scheme 27 shows the yields and the conditions used by us in large scale 
syntheses of these key intermediates. 
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Scheme 27 Reagents and conditions i) MnO2, DCM, r.t, 24h, 94%; ii) a) tBuLi, Et2O, -78oC→r.t, 
3h, b) I2, -78oC→r.t, 84%; iii) Triethylphosphono acetate, NaH, THF, 0oC→r.t, 24h, R=H: 81%, 
R=OMe: 87%; iv) Pd(OAc)2, Allyl alcohol, Bu4NCl, NaHCO3, DMF, 40oC, 5h, R=H: 84%, 
R=OMe: 95%. 
 
Having prepared sufficient quantities of the coupling partners 121a,b and 122, we 
now examined the planned Julia olefination reactions, and the completion of the 
syntheses of the radical precursors 117a-d. 
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Syntheses of the Iododienynones 117a-d 
Our initial attempts at coupling the aldehydes 121a-b with the sulfone 122 were 
successful, but they gave lower yields than expected. Since this was a key step in 
our synthesis we decided to conduct an extensive optimisation study. However, our 
attempts to improve the yield by trying different bases (NaHMDS, LiHMDS, 
KHMDS), altering the amount of base (1.1eq, 1.2eq, 1.5eq), changing the solvent 
(THF, DME), temperature of addition (-78oC, -50oC), and type/order of addition 
failed to improve the yields significantly (i.e. optimised yields of 38-55%). We 
postulated that the lower than expected yield in this coupling were perhaps due to a 
low nucleophilicity of the sulfone anion.  
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Scheme 28 Reagents and conditions i) NaHMDS, THF, -78oC, 14h, R=H: 38%, R=OMe: 55%; ii) 
TBAF, THF, 0oC→r.t, 3h, R=H(Z): 25%, R=H(E): 52%, R=OMe(Z): 32%, R=OMe(E): 37%. 
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The olefination reactions led to inseparable mixtures of olefin isomers 120a,b, in 
3:2 ratios in favour of the E-trisubstituted double bond. Taking, separately, both the 
methoxy and des-methoxy mixtures, we next deprotected the tert-
butyldiphenylsilyl groups using TBAF reagent at 0oC. These deprotections 
proceeded in high yields, and allowed us (with the aid of careful flash column 
chromatography) to separate each of the Z and E-isomers of the resulting alcohols 
thereby allowing us to continue the syntheses with pure Z- 131a,c and pure E-
alkenes 131b,d (the alkene stereochemistry was confirmed by n.o.e) (Scheme 28). 
 
We now proceeded to convert each alcohol into the iododienynones 117a-d. We 
first chlorinated the alcohols using freshly recrystallised N-chlorosuccinimide and 
triphenylphosphine yielding the chlorides 132a-d in good yield.  
   In order to prepare the enynone portions in the targets, we first reduced the ethyl 
esters 132a-d to the corresponding alcohols 133a-d using diisobutylaluminium 
hydride which were then oxidised to the aldehydes 134a-d using manganese (IV) 
oxide. This procedure went smoothly and in excellent overall yield. Addition of 
ethynylmagnesium bromide to the aldehydes 134a-d next led to the allylic alcohols 
135a-d which were oxidised to the corresponding ketones 136a-d using manganese 
(IV) oxide. These oxidations proved to be problematic and clean ynones were only 
obtained in very low yield, until vigorous and successive washings of the filter cake 
with dichloromethane and hot ethyl acetate were performed. We postulated that the 
‘triply’ enynones were strongly ‘adhering’ to the active sites of the manganese (IV) 
oxide. The chloroenynones 136a-d were stable, and could be stored easily until the 
much less stable iododienynones 117a-d were needed. These were prepared by a 
simple Finkelstein reaction with sodium iodide in good yield (Scheme 29). 
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Scheme 29 Reagents and conditions i) NCS, PPh3, K2CO3, DCM, 0oC→r.t, 1h, R=H(Z): 96%, 
R=H(E): 98%, R=OMe(Z): 90%, R=OMe(E): 91%; ii) DIBAL-H, DCM, -78oC, 3h, R=H(Z): 86%, 
R=H(E): 85%, R=OMe(Z): 92%, R=OMe(E): 87%; iii) MnO2, DCM, r.t, 21h, R=H(Z): 89%, 
R=H(E): 87%, R=OMe(Z): 81%, R=OMe(E): 81%; iv) Ethynylmagnesium bromide, THF, -
78oC→r.t, 20h, R=H(Z): 98%, R=H(E): 98%, R=OMe(Z): 99%, R=OMe(E): 93%; v) MnO2, DCM, 
r.t, 18h, R=H(Z): 81%, R=H(E): 86%, R=OMe(Z): 86%, R=OMe(E): 88%; vi) NaI, K2CO3, 2-
butanone, 80oC, 23h, R=H(Z): 87%, R=H(E): 88%, R=OMe(Z): 92%, R=OMe(E): 95%. 
 
With reasonable quantities of all of the four radical precursors 117a-d in hand, we 
now turned our attention to investigating the radical cascade processes. 
 
The Proposed Radical Cascades from the Precursors 117a-d 
The Radical Cascades from the Z-Iododienynones 117a,c 
Our attempts to produce a 6,6,6,6 ring-D aromatic steroid, by subjecting the Z-
radical precursors 117a and 117c to the standard radical generating protocol of 
tributyltin hydride and AIBN, were initially unsuccessful. Numerous different 
conditions were tried but we shall concentrate here on the exciting results 
eventually obtained from this radical cascade.  
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   Conditions were found which resulted in a single identifiable product from 117a 
and 117c. This particular system was more sensitive than other more standard 
radical precursors that the author has worked on and there were several noteworthy 
modifications required in order to achieve the conversion of the Z-iododienynones 
117a,c into their cascade products 137a,b. Most notable was the need for more 
extensive degassing of the solutions than was normally required, and the need for 
the reagents and substrates to be more rigorously dried than was normal. The single 
product isolated from the cascade mixture (in 36% yield) was analysed and it was 
rapidly discovered that it was not the desired 6,6,6,6 ring-D aromatic steroid 
116a,c.  
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Scheme 30 Reagents and conditions i) Bu3SnH, AIBN, benzene, 80oC, 20h, R=H: 35%, R=OMe: 
36%. 
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Analysis of the proton and carbon NMR spectroscopic data showed that the 
cascade product had retained the aryl enone and trisubstituted olefin units, but had 
lost the alkyne signals to be replaced by two new olefin proton signals. Analysis of 
the 2D NMR spectra demonstrated coupling from the new olefin proton signals 
around a three carbon chain to the trisubstituted olefin. These, and other, 
spectroscopic data, led us to propose the macrocyclic structures 137a,b for the 
radical cascade products of the Z-iododienynones 117a,c. We postulated that these 
structures result from the 14-endo-dig radical macrocyclisation of the alkyl radical 
138 and the subsequent quenching of the intermediate vinyl radical 139 before any 
transannulation reaction could occur (Scheme 30). 
 
That the required 14-endo-dig radical macrocyclisation should have occurred, but 
the subsequent transannulations did not take place seemed strange to us initially, 
especially considering our past experiences with related substances (see 110/112). 
However, upon further consideration we postulate that the fourteen membered 
macrocyclic radical 139 with the Z-trisubstituted olefin is held in a very ‘open’ 
conformation and that the distance between the carbon-centered radical in 139 and 
the trisubstituted olefin (in the lowest energy conformation), is simply too great to 
overcome (calculated as 5.27Å).  
   This result led us to examine some molecular mechanics calculations (with the 
assistance of Prof. B. Lygo) on the radical macrocycles 137a,b. These calculations 
demonstrated that the energy difference between the least energy conformation of 
the Z-macrocycle 142 and the conformation required for the desired transannulation 
bond formation to occur 140 (and by loose inference a general approximation of 
the energy barrier that must be overcome), is approximately four times that 
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required for the E-macrocycle to undergo transannulation. These data gave 
credence to our assigned macrocyclic structure 137 and provided hope that the E-
precursors 117b,d would not suffer the same problem/outcome (Figure 2). 
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Figure 2 Computational energies of the macrocyclic radicals 140 - 143. 
    
Having failed to produce the anticipated tetracycle 116 from the Z-precursors 
117a,c, we decided to attempt to ‘force’ the transannulations in the Z-macrocycles 
137a,b. This endeavor was undertaken by treating the macrocycles 137a,b with 
samarium diiodide. We hoped that this would produce the ketyl radical which 
would subsequently induce the desired transannulations, albeit as a separate 
cascade (Scheme 31). 
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Scheme 31 A proposed conversion of the macrocycle 137 into the tetracycle 144. 
 
Unfortunately, we were unable to isolate any tetracyclic structures 144a-b from the 
reaction. Nevertheless, we were still hopeful that the corresponding E-radical 
precursors 117b,d would undergo transannulation successfully. 
 
The Radical Cascades from the E-Iododienynones 117b,d 
Taking the E-radical precursors 117b,d we subjected them to the radical generating 
conditions of tributyltin hydride and AIBN, in refluxing benzene. A single product 
was isolated as a yellow oil in each case, in a respectable yield of 35%. As before 
the radical cascade was unusually sensitive and we discovered that a greater than 
the usual catalytic amount of AIBN initiator was required in order to produce this 
product (approximately 0.3eq instead of the normal 0.01-0.1eq). Analysis of the 
spectroscopic data for the products revealed the loss of the olefinic signals and the 
appearance of numerous new complex methylene signals in the aliphatic region of 
the proton NMR spectra. The spectroscopic data also revealed that the product was 
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present as a 2:1 mixture of diastereoisomers. Our initial assignments led us to 
believe that the spectra could indeed be produced by our desired tetracyclic ring-D 
aromatic steroid 116a,b. However, there were some anomalous data (an unusually 
high integration of the aromatic protons and some anomalous carbon resonances) 
which cast doubts on our tentative structural assignment. 
   At this stage we decided that more ‘absolute’ evidence would be required to 
prove the structures of the cascade products from 117b,d and thus we attempted to 
obtain a crystalline derivative of the cascade product, suitable for X-ray analysis. 
After careful consideration we decided that deprotecting the methoxy analogue 
117b to a phenoxy compound would be the most promising route to a crystalline 
derivative. Hence, we treated the cascade product 116b? with boron tribromide 
(Scheme 32). 
 
i
R
O
H
H
116b?
OMe
O
I
117b
ii
R=OMe
R=OH 147?
 
Scheme 32 Reagents and conditions i) Bu3SnH, AIBN, benzene, 80oC, 20h, R=H: 35%, R=OMe: 
30%; ii) BBr3, DCM, -78oC, 16h, 48%. 
 
This product was indeed crystalline, and a successful X-ray crystal analysis was 
performed. To our surprise, the X-ray crystal structure (Figure 3) showed that the 
product we had produced was not the desired phenolic tetracycle 147? but instead 
the unusual angular 6,6,6-ring fused substituted aromatic structure 147. The 
structure was found to be the major isomer of 147 which had crystallised out 
separately from the minor isomer. An analysis of the spectroscopic data now 
47 
revealed that this structure was a much better fit for the NMR data obtained than 
the desired tetracycle 147? (the unusually high integration of the aromatic protons 
and anomalous carbon resonances were due to the inclusion of a second aryl ring 
into the cascade product).  
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Figure 3 X-ray crystal structure analysis of the phenol 147 
 
The formation of the unusual bridged tricycles 148a,b requires three intramolecular 
carbon-to-carbon bond forming processes and an intermolecular radical coupling, 
presumably with the solvent benzene.  
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Scheme 33 A proposed mechanism for the synthesis of the bridged tricycle 148 from the E-
iododienynone 117 
 
Having carried out a number of model reactions designed to probe the mechanistic 
possibilities for this unusual product outcome and performed an in-depth literature 
search, we postulate that the bridged tricycles 148a,b are produced from the 
precursors 117b,d by an initial 11-endo-trig cyclisation of the first formed radical 
68, leading firstly to the benzylic radical intermediate 150. Sequential 6-exo-trig (to 
intermediate 151) and 6-exo-dig radical cyclisations next lead to the vinyl radical 
intermediate 152. The vinyl radical 152 is then quenched by the solvent benzene80 
resulting in the major and minor diastereoisomers of the benzylidene substituted 
tricycle 148 (Scheme 33). 
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In order to appreciate the remarkable outcome of these radical cascades we need to 
consider the results in comparison with those of the iododienynones 110/112. 
Scheme 34 shows the radical cascades side by side.  
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Scheme 34 A comparison of the outcomes of the present radical cascades compared to others 
discovered in Nottingham.  
 
By synthesising 117 with an extra methylene in the iodo chain, and a tri- instead of 
di-substituted olefin, we see remarkably different product outcomes. The Z-isomers 
117a,c instead of constructing the tetracycle 116 alternatively halt at the 
macrocyclisation stage (probably due to new methyl group holding the macrocycle 
in a more ‘open’ conformation, as discussed in the preceding section). The E-
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isomers 117b,d instead of constructing the tetracycle 116 alternatively produce the 
unique bridged tricycle 148. 
 
We next set about attempting to resolve the route taken from the precursors 117b,d 
during the radical cascade, which resulted in the bridged tricyclic structures 148a,b. 
Taking β–bromostyrene in benzene, we attempted to ‘replicate’ the addition of a 
vinylic radical to benzene81 under the same radical generating conditions. However, 
only styrene was isolated. An analysis of the literature concerning the aspects of 
these unusual radical cascades and the surprising outcome revealed several 
possibilities. In particular we were interested in the unusual way in which the 
cascade had seemingly terminated, i.e. by quenching of the postulated vinylic 
radical 152 on the solvent benzene and its subsequent rearomatisation to give 
148a,b. The process by which 1,4-cyclohexadienyl radicals aromatise appears to be 
contested in the literature with various and contradictory theories. However several 
papers, most notably those by the Crich82 and Beckwith83 groups, suggest that the 
initiator AIBN can act as the oxidant. We found that it was common in many84,85 
(but not all)86 of the radical reactions involving addition to benzene-like systems, 
that “large amounts of initiator” were required.87 This fits in with the requirement 
for more than the typical amount of initiator being necessary, for the successful 
synthesis of the benzene addition products 148a,b. We postulate that the ‘extra’ 
AIBN required, beyond that needed to sustain the catalytic tin radical cycle, is used 
to oxidise/rearomatise the cyclodienyl radical and produce the bridged tricycle 148.  
   In an attempt to prove this hypothesis we attempted to trap this postulated 1,4-
cyclohexadienyl radical by utilising diphenyl diselenide to produce phenyl selenol 
in situ. This would provide the cyclohexadienyl radical with another source from 
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which to quench. We therefore treated the iodide 117d under the same radical 
generating conditions that led to the formation of the benzene addition product 
148b with the following modifications: i) 0.2eq of diphenyl diselenide was added 
and ii) only 0.1eq of AIBN was added. We hoped this would result in formation of 
the 1,4-cyclohexadiene product 154. Unfortunately, only starting iodide was 
recovered (Scheme 35). 
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Scheme 35 Reagents and conditions i) Bu3SnH, AIBN, (PhSe)2, benzene, 80oC, 20h. 
 
Numerous attempts were made, following these interesting results, to produce the 
desired tetracycle 116 by modifying the radical cascade reaction conditions. For 
example, the unusual postulated quenching by the solvent benzene, could suggest 
that the concentration of the tributyltin hydride is so low that the final 1,4-
cyclohexadienyl radical intermediate quenches on benzene instead. We therefore 
increased the amount of tributyltin hydride hoping that the vinylic radical 152 
would quench via hydrogen abstraction (or possibly the entire reaction pathway 
could be altered). However, a threefold increase in the concentration of tributyltin 
hydride had no effect, the only isolated product being the bridged tricycle 148. 
Shortening the addition period of the tributyltin hydride to one hour unfortunately 
also yielded the same result. We also carried out the radical cascade of 117 using 
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TTMSS, as an alternative radical generator. This however, gave the same product 
and in a comparable yield.  
   In a parallel attempt to alter the quenching process and lend some credence to our 
proposed mechanism, we carried out the radical cascade of 117d under the same 
tributyltin hydride radical generating conditions, but the reaction was carried out in 
n-heptane. We reasoned that without the benzene to react with/quench on, the 
postulated vinylic radical 152 would have to seek out another source or 
alternatively alter the reaction pathway. From this reaction mixture we isolated a 
subtly different product. The proton NMR showed this new product to be similar in 
many regards to the bridged tricycle 148b. However there were less aromatic 
signals and two new signals at δ6.23ppm (1H, d, J 1.5Hz) and δ5.43ppm (1H, d, J 
1.5Hz). These data suggested that the new product is the result of hydrogen 
quenching and is the methylidene substituted tricycle 155 (Scheme 36). 
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Scheme 36 Reagents and conditions i) Bu3SnH, AIBN, heptane, 90oC, 20h, 18%. 
 
These results, whilst interesting in themselves, become even more so when 
compared to the results of the radical cascades of the iododienynones 110 and 112 
(see Scheme 34). Whilst the extra methylene and substitution on the alkyl olefin 
could feasibly alter the conformation of the Z-macrocyclic radical 139, to the extent 
that it is unfavourable for it to transannulate as the iododienynone 110 does, we 
find it fascinating that these two subtle modifications can have such a dramatic 
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effect on the outcome of the E-radical precursors 117b,d, completely altering the 
site of initial attack (cinnamyl vs ynone) and producing a structure which finds it 
more favourable to ‘quench’ on the solvent benzene, than the tributyltin hydride. 
We can only postulate that the extra methylene has allowed the upper alkenyl chain 
the length and conformational freedom, to reach the cinnamyl electrophore and so 
pursue a reaction route which was unavailable to the shorter iododienynone 112. 
 
In conclusion, we have evaluated the scope for a radical cascade reaction of an 
ynone electrophore towards synthesising a 6,6,6,6 ring-D aromatic steroid. 
Treatment of the Z-iododienynones 117a,c with tributyltin hydride and AIBN led to 
the macrocycles 137a,b, whilst treatment of the E-iododienynones 117b,d gave the 
novel bridged tricycles 148a,b and 94 (depending on whether benzene or heptane 
was used as the solvent), instead of the desired ring-D tetracycle 116. Not for the 
first time these studies have demonstrated how interesting and yet how subtly 
unpredictable some radical reactions can be. This appears to be even more so when 
the radical intermediates are presented with numerous possibilities within a 
conformationally constrained environment, and yet these reactions have produced 
novel and interesting structures not available by more conventional synthetic 
methods.   
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Results and Discussion 
 
Part 2 
A Cascade Radical-Mediated Approach 
towards Veratramine 
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One of the better known natural products containing a 6,6,5,6 ring-D aromatic 
steroid ring system is the alkaloid veratramine 60, and this compound was selected 
as a synthetic target for our research. Veratramine 60 was isolated from the white 
hellebore (Veratrum grandiflorum) by Saito et al. in 194044 and it exhibits 
interesting and potentially useful biological activity (see page 21).45-48 There have 
been only two total syntheses of this interesting alkaloid. Kutney et al. published a 
synthesis of veratramine (and the structurally related 6,6,5,6 ring-D aromatic 
steroid known as verarine) in 1975,88 following a total synthesis of veratramine 60 
by Johnson et al. in 1967.89 
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W. S. Johnson and co-workers designed an annulation strategy towards 60, 
constructing the steroid ring system one ring at a time, before attaching and 
modifying the alkaloidal side-chain. Thus, starting with Hagemann’s ester 156, 
Johnson et al. first used an annulation sequence involving an alkylation with β-
ethoxy-γ-bromocrotonate followed by hydrolysis and cyclisation of the resulting β-
keto ester, then reduction using palladium on carbon90 leading to the indanane 157. 
A second annulation sequence, this time using ethyl vinyl ketone and phosphoric 
acid, next resulted in the tricyclic ester 158. By reacting the unsaturated ketone 158 
with methyl vinyl ketone in the presence of sodium ethoxide, the final A-ring was 
completed. The ring-D aromatic ester 159 was next resolved leading to the 
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enantiomerically pure material 159. Reduction of the enone group in 159 finally 
gave the intermediate ketone 160 (Scheme 37). 
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Scheme 37 Reagents and conditions i) KOt-Bu, ethyl β–ethoxy-γ-bromocrotonate; ii) a) HCl, EtOH, 
b) piperidine, AcOH; iii) 10% Pd/C, p-cymene, reflux; iv) a) pyrrolidine, b) ethyl vinyl ketone, 
dioxane, c) AcOH, NaOAc; v) 85% H3PO4; vi) methyl vinyl ketone, NaOEt, EtOH; vii) ethylene 
glycol, HCl; viii) HCl, H2O; ix) a) NaH, glyme, b) K, NH3(l); x) diazomethane; xi) DDQ, benzene; 
xii) resolution; xiii) a) NaOH, H2O, b) HCl, H2O, xiv) a) NaH, glyme, b) K, NH3(l); xv) 
diazomethane; xvi) DDQ, benzene. 
 
The intermediate 160 was then converted into veratramine 60 in a further nineteen 
steps which synthesised the alkaloidal side-chain and completed the manipulation 
of the polycycle. 
 
Our attention was drawn to this synthesis of veratramine 60 as we recognised that 
the tetracyclic, intermediate ketone 160 could be a potential target for a radical 
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cascade strategy. The ring-D aromatic steroidal intermediate 160 did not have a 
great deal of functionality and a radical cascade approach to 160 would constitute a 
formal synthesis of veratramine 60. After some deliberation the ketone 160 was 
chosen as a target for our research and we began the process of synthesising an 
appropriate precursor for its synthesis via a radical cascade. 
 
A Ring-D Aromatic Model System 
We decided to take a slightly different approach to our earlier study of cascade 
radical reactions (see page 36) in producing the ketone 160. Instead of utilising an 
alkyl radical precursor adding into an enone electrophore, we decided to use a new 
macrocyclisation-transannulation radical cascade strategy which took advantage of 
the presence of the C-3 ketone in the target molecule 160. We envisaged that this 
ketone could be derived from the acyl radical intermediate 162, by adding into a 
vinylcyclopropyl electrophore via a 12-endo-trig radical macrocyclisation, leading 
first to the benzylic radical 163. This new radical centre could then undergo 
transannulation via a 5-exo-trig cyclisation leading to the bicyclic 164 intermediate 
incorporating a tertiary radical centre. Finally, a 6-exo/endo-trig transannulation 
from 164 followed by a H-atom quench would give the desired 6,6,5,6 ring-D 
aromatic steroidal tetracycle 160 (Scheme 38). 
 
The acyl radical centre 162 could be generated by various different means.91 
However, our research group has already made excellent use of seleno esters92 in 
producing acyl radicals for the cascade syntheses and we were attracted to this 
particular strategy. After careful consideration and comparing the various different 
methods, we decided that the seleno ester would be the most suitable method for 
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generating the acyl radical 162. Hence, our radical cascade precursor target became 
the vinylcyclopropyl seleno ester 161. 
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Scheme 38 A proposed radical cascade from the vinylcyclopropane 161 leading to the tetracycle 
160. 
 
   The proposed radical cascade approach to the tetracycle 160 from 161 had many 
attractions. Not least, if successful this would be the first reaction of its type 
whereby an acyl radical cascade into a vinylcyclopropyl electrophore had been 
demonstrated. We were also intrigued by the presence of the five-membered C-ring 
in 160 and how its presence would affect the cascade, having not found anything 
similar in the literature.  
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   Using a vinylcyclopropyl, instead of an en- or ynone electrophore in synthesis is 
not without precedent. This strategy has already been used to good effect in our 
group’s total synthesis of estrone 21 (see page 32),72 and in elaborating the 
steroidal tetracycle 166 from the alkyl iodide 165.93 
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We now considered an appropriate synthesis of the seleno ester intermediate 161. 
The vinylcyclopropane portion in 161 could be synthesised via a linear sequence, 
i.e. constructing the cyclopropane and olefin separately step by step, but we were 
interested in a more convergent synthetic approach involving coupling the entire 
vinylcyclopropane unit to the aryl ring via palladium catalysis (Scheme 39). 
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Scheme 39 A retrosynthetic analysis of the radical precursor 161 
 
A Model Stille Coupling Reaction using Vinylcyclopropyl Stannanes 
The Stille coupling reaction94 between a vinylcyclopropyl stannane 168 and an aryl 
halide/triflate 170 is unprecedented, to our knowledge. Whilst this proposal has 
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numerous advantages over a linear construction, it was also inherently risky for two 
main reasons: i) palladium(II) catalysed ring openings of vinylcyclopropanes are 
facile, and well known, 170→172 and ii) divinyl cyclopropane products can 
undergo thermal ‘Cope’ rearrangement in situ 171→173.95 A search of the 
literature revealed only two examples of organometallic coupling reactions 
involving vinylcyclopropanes. The first involved a Suzuki coupling of the boronate 
17596 and the second a Negishi coupling reaction using the organozinc species 177 
(Scheme 40).97 
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We decided first to model our proposed coupling reaction using the 
vinylcyclopropyl stannane 18497 and phenol triflate 169 under a range of 
conditions. Thus, propargyl alcohol 180 was first treated with tributyltin hydride 
and AIBN, which led to a mixture of E and Z isomers of the corresponding vinyl 
stannanes from which the desired E-vinyl stannane 181 was separated in 89% 
yield. 
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Scheme 40 Palladium catalysed coupling reactions involving vinylcyclopropanes, and potential side 
reactions. 
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Scheme 41 Reagents and conditions i) Bu3SnH, AIBN, 100oC, 5h, 89%; ii) Et2Zn, CH2I2, DCM, -
50oC→-20oC, 48h, 74%; iii) IBX, DMSO, r.t, 20h, 96%; iv) MePPh3Br, NaHMDS, THF, -
78oC→r.t, 12h, 97%. 
 
Subjecting the vinyl stannane 181 to a carefully temperature controlled Simmons-
Smith reaction98 next gave the cyclopropyl stannane 182. The hydroxyl group in 
182 was then oxidised using IBX99 (which was found to be superior to Dess-Martin 
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or Swern oxidations), and the resulting aldehyde 183 was quickly converted into 
the target vinylcyclopropyl stannane 168, using a Wittig reaction (Scheme 41).100  
 
We were now in a position to attempt our model Stille coupling reaction between 
the vinylcyclopropyl stannane 168 and phenol triflate 169. Unfortunately, and in 
spite of considerable effort, the initial attempts led to failure (Table 1). 
   Numerous different catalysts, solvents, additives and temperatures were utilised 
in our attempts to successfully couple the vinylcyclopropyl stannane 168 with 
phenol triflate 169, including the use of the organocopper catalyst CuTC developed 
by Liebeskind et al.101 This organocopper catalyst was seen as a possible way 
around the palladium catalysed side-reactions. However, both these and all the 
other attempts involving the vinylcyclopropyl stannane 168 were unsuccessful, 
either resulting in an unidentifiable mixture of non-products or returning starting 
materials unaffected by the reaction conditions. 
   Eventually we did uncover conditions which yielded some of the desired aryl 
vinylcyclopropane 184 from coupling between 168 and phenol triflate 169. This 
was during an attempted coupling utilising a large excess of the Liebeskind copper 
catalyst (at 80oC with lithium chloride) when the vinylcyclopropane 184 was 
detected in approximately 5% yield. However, our attempts to improve the yield of 
this copper catalysed coupling by varying additives, temperatures and reaction 
times, failed to improve upon this yield. Fortunately, more success was had when 
using the more traditional palladium acetate catalyst, under some less conventional 
conditions! 
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Stannane Catalyst Solvent Additives Temp./ Time Result 
SnBu3
HO
 
Pd(PPh3)4 Dioxane LiCl 100
oC/ 
15h 94% 
SnBu3
HO
 
Pd(OAc)2 DMF LiCl, CuI, AsPh3 
80oC/ 
15h 67% 
SnBu3
 
Pd(PPh3)4 Dioxane LiCl 100
oC/ 
15h 
No 
Product 
  NMP CuI, CsF r.t/ 24h 
No 
Product 
    
80oC/ 
12h 
No 
Product 
 Pd2(dba)3 NMP CuI, AsPh3 40
oC/ 
5h 
No 
Product 
   CuTC, AsPh3  
No 
Product 
 
 
 
DMF AsPh3  Rec. S.M 
 PdCl2 NMP PCy3, CuI, CsF 
r.t/ 
12h Rec. S.M 
    
80oC/ 
12h 
No 
Product 
 Pd(OAc)2 DMF LiCl(3eq), CuI AsPh3 
80oC/ 
15h 
No 
Product 
   
LiCl(6eq), CuI, 
AsPh3 
 
No 
Product 
  NMP CsF, AsPh3, LiCl, CuI 
r.t→80oC/ 
24h 
No 
Product 
 CuTC NMP LiCl r.t/ 24h Rec. S.M 
   CsF 40
oC/ 
15h 
Rec. 
Phenol 
   LiCl, CsF r.t/ 12h Rec. S.M 
    
80oC/ 
12h 
No 
Product 
Table 1 Reagents and conditions for the reactions between 169 and the stannanes shown. 
 
We surmised that possibly the presence of uncomplexed nucleophilic palladium 
was attacking the vinylcyclopropyl unit (both in the starting stannane 168 and any 
potential aryl vinylcyclopropane 184 product) and inhibiting the process. We 
therefore attempted to eliminate, or at least minimise, the level of nucleophilic 
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palladium. Whilst complexed palladium is required for the Stille reaction, we 
proposed that there will always be some quantity of free palladium in solution 
unless there is a large excess of ligand present. Several attempts at the coupling 
were therefore made, using three times the usual ligand to palladium ratio. Whilst 
this could slow down the rate of the coupling considerably, we hoped that it would 
also allow the product/starting vinylcyclopropanes to survive the coupling 
conditions. A significant pre-mixing period for the ligand and palladium catalyst 
was also introduced, to ensure that the palladium was all complexed before 
introducing the vinylcyclopropane 168. Much to our satisfaction, using these 
modifications, an approximately 70% yield of the desired aryl vinylcyclopropane 
184 was achieved (Scheme 42). 
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Scheme 42 Successful model coupling reactions between the vinylcyclopropyl stannane 168 and 
phenol triflate 169. 
 
Having now successfully modelled what we believe to be the first Stille coupling 
reaction between a vinylcyclopropyl stannane and a phenol triflate, we turned our 
attention to a synthesis of the upper chain aryl unit 167 required for our projected 
synthesis of veratramine 60 (see page 61).  
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Retrosynthetic Analysis of the Precursor 161 
The substituted aromatic ester 190 could be synthesised via conventional aromatic 
substitution chemistry from an appropriate precursor. However, a brief analysis 
revealed numerous selectivity issues together with a potentially long reaction 
sequence for this relativity simple building block. Therefore, we planned to utilise a 
Diels-Alder102 approach to 190 using the 1,3-diene 191 and methyl propiolate 188. 
Whilst this may seem to be a sterically demanding Diels-Alder reaction, there is 
precedent from earlier studies of Pulido et al.103 The 1,3-diene 191 could be 
derived from the 1,3-diketone 192 using a procedure similar to that devised by 
Rutledge et al (Scheme 43).104 Although initial forays into the synthesis of the 1,3-
diene 191 were successful, we decided that it would be prudent to simplify the 
system further for the purpose of modelling the planned radical cascade we 
therefore planned to first synthesise the seleno ester 193 with no substituents in the 
aryl ring (Scheme 44). 
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Scheme 43 The proposed synthesis of the aryl building block 190. 
 
66 
O
O
TMSO
OTMSTMSCl, NEt3,
(5g scale)
95%
HO
OMe
OOMeO
TMSO
OTMS 120oC, sealed tube,
(1.5g scale)
87%
185 186
187 188 189
 
 
O SePh
193
E
Stille
O SePh
X
SnBu3
195
168X=I,Br,OTf
Bu3SnH
AIBN
O H
H
H
194
+
 
Scheme 44 The model radical precursor 193. 
 
Synthetic Routes to the Radical Precursor 193 
Analysis of the C-6 alkenyl chain in the target radical seleno ester 193 presented us 
with the possibility of using a derivative of geraniol as a basis for its synthesis, and 
this prompted us to disconnect the alkenyl chain to the C-6 allylic bromide 198.  
   
The synthesis of 198 was based upon a combined and modified version of similar 
syntheses described by Plé et al.105 and by Canonica et al.106 Thus, geranyl acetate 
was first oxidised selectively using 3-chloroperbenzoic acid and the resulting 
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vicinol diol was then cleaved with periodic acid, leading to the aldehyde 196. 
Oxidation of 196 to the corresponding carboxylic acid using Jones reagent 
followed by esterification and cleavage of the acetate protecting group using acidic 
methanol next gave the hydroxyl ester 197. Several methods were examined for the 
conversion of the alcohol 197 into the bromide 198, and phosphorus tribromide in 
hexane at -40oC was found to be the most effective (Scheme 45). 
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Scheme 45 Reagents and conditions i) m-CPBA, DCM, 0oC, 12h; ii) H5IO6, THF/H2O, 0oC, 2h, 
66% (over 2 steps); iii) Jones reagent, acetone, 0oC, 93%; iv) MeOH, H2SO4, r.t, 12h, 79%; v) PBr3, 
hexane, -40oC, 1.5h, 94%.   
 
Our next synthetic step was to couple the bromide 198 to an appropriate aryl unit. 
Several different methods for this coupling reaction were attempted. Unfortunately, 
after extensive investigations, the best method using an organocopper intermediate, 
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whilst resulting in the desired product, also led to an undesired and inseparable by-
product. For example, a coupling reaction between the aryl bromide 199 and the 
allyl bromide 198 resulted in a 95% yield of an 8:5 mixture of the trisubstituted 
olefin 200 and the undesired isomer 201, resulting from SN2’ attack on 198. 
Unfortunately we were not able to separate these isomers and attempts to reduce 
the amount of the unwanted olefin 201 were unsuccessful; this route was therefore 
abandoned. 
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A change of tactic prompted us to attempt a similar synthesis of the C-6 alkenyl 
chain in 193 by performing a coupling reaction first followed by manipulating the 
geranyl chain whilst it was attached to the aryl unit. Thus, by utilising a similar 
organometallic coupling reaction we united an aryl iodide to geranyl bromide in 
excellent yield, and with no evidence for the co-formation of unwanted isomers. 
Unfortunately, however, whilst the epoxidation of the product proceeded smoothly, 
yields for the subsequent cleavage step etc were very low yielding and were 
accompanied by significant side-products.  
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After this disappointing start to our synthetic approach to 193, we decided to alter 
our strategy to the C-6 alkenyl chain in 195. Thus, the seleno ester 195 could be 
constructed from the carboxylic acid 20291 which itself could be derived from the 
acetate 203 via an Ireland-Claisen rearrangement.107 In turn, the acetate 203 should 
be easily accessible from the aldehyde 204 using a conventional Grignard 
reaction74 using isopropenylmagnesium bromide, followed by treatment with acetic 
anhydride. The aldehyde 204 could be synthesised from the known alkene 205 
(Scheme 46). 
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Scheme 46 A new retrosynthetic analysis of the radical precursor 193. 
 
Thus, following some literature precedent,108 phenol 206 was first converted into 
the corresponding allyl ether 207, which then underwent Claisen rearrangement at 
190oC leading to the corresponding allylphenol 205a. Protection of 205a as the 
tert-butyldimethylsilyl ether 205b followed by oxidative cleavage using potassium 
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permanganate and periodic acid next gave the aldehyde 204 in excellent yield on a 
large scale. The Grignard reaction between 204 and isopropenylmagnesium 
bromide performed poorly, giving the isopropenyl alcohol 208 in a disappointing 
35% yield. This, together with the low yield achieved in the subsequent Ireland-
Claisen reaction, led us to eventually abandon this route to 195 (Scheme 47). 
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Scheme 47 Reagents and conditions i) Allyl bromide, K2CO3, DMF, r.t, 12h, 98%; ii) 190oC, neat, 
5 days, 96%; iii) TBSCl, Imid, DMF, r.t, 3h, 69%; iv) a) KMnO4, H2O/IPA, r.t, ~10mins, b) H5IO6, 
H2O, r.t, ~15mins, 88%; v) Isopropenylmagnesium bromide, BF3.OEt2, THF, -78oC, 2h, 45%; vi) a) 
Ac2O, py, DMAP, r.t, 12h, b) LDA, TMSCl, THF/HMPA, -78oC→r.t, 12h, 12%. 
 
Synthesis of the Radical Cascade Precursor 193 
In light of the low yields achieved for the isopropenyl Grignard reaction with the 
aldehyde 204 and the subsequent Ireland-Claisen rearrangement, a new synthetic 
plan was devised based on a Johnson ortho-ester rearrangement.109 Our synthesis of 
71 
the aldehyde 204 was also modified in order to allow for a change in the leaving 
group for the subsequent Stille reaction and to improve overall yields.  
   Thus, our new retrosynthetic analysis began from the aryl iodide 210 which we 
planned to produce from the allylic alcohol 211 via an E-selective Johnson ortho-
ester rearrangement. The allylic alcohol 211 in turn, would be produced from the 
aldehyde 212 derived in three known110 straightforward steps from 2-iodobenzyl 
alcohol 213 (Scheme 48). 
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Scheme 48 A revised retrosynthetic analysis of the radical cascade precursor 193. 
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Scheme 49 Reagents and conditions i) MnO2, DCM, r.t, 24h, 94%; ii) Ph3PBrCH2OMe, KOtBu, 
THF, r.t, 12h, 92%; iii) Formic acid, DCM, r.t, 4.5 days, 88%.  
 
A Wittig reaction between the aldehyde 212 and isopropyltriphenylphosphonium 
iodide next gave the trisubstituted alkene 216 in good yield. Epoxidation of 216 
followed by Lewis acid catalysed rearrangement111 of the resulting epoxide in the 
presence of aluminium isopropoxide led to the allylic alcohol 211 in equally good 
yield, on large scale.  
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Scheme 50 Reagents and conditions i) Isopropyltriphenylphosphonium iodide, BuLi, THF, 0oC, 3h, 
82%; ii) m-CPBA, DCM, 0oC→r.t, 24h, 84%; iii) Al(Oi-Pr)3, tol, reflux, 12h, 83%; iv) Propionic 
acid, triethyl orthoacetate, 100oC, Dean-Stark, 4 days, 91%.   
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The key rearrangement of the ortho ester derived from the allylic alcohol 211, in 
the presence of freshly distilled propionic acid and triethylorthoacetate at 100oC, 
then gave the desired E-trisubstituted olefin ethyl ester 210 in 91% overall yield 
(Scheme 50). 
 
We were now in a position to examine the key Stille coupling reaction between the 
aryl iodide 210 and the vinylcyclopropyl stannane 168. Using the previously 
developed reaction conditions (notably the large excess of arsine ligand and an 
extended premixing period) we coupled 210 with 168 and gratifyingly isolated the 
desired coupling product 209. However, the required product 209 was accompanied 
by the arylbutane 218 as a by-product which we were unable to separate from the 
vinylcyclopropane 209. 
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We postulated that this aryl butane by-product 218 arose from the Stille cross-
coupling of one of the three butyl groups attached to the tin centre in the stannane 
168 instead of the vinylcyclopropane group. Since this outcome was not observed 
in the model system it was an interesting and surprising result. Indeed, whilst the 
Stille coupling between an aryl unit and a butyl stannane unit is precedented, this 
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has only been reported using a tetrabutyl tin reagent. The situation whereby the sp3 
butyl group in the vinylcyclopropyl stannane 168 migrates in competition with the 
anticipated (sp2/sp3) cyclopropane group is surprising and we suggest that steric 
factors are the most likely cause of this unusual outcome. Indeed, when we went 
back to the model system (see page 66) and modified the substrate to include an 
ortho substituent to the triflate unit, a similar by-product i.e. 218, resulting from 
butyl migration was detected (see below). 
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To our frustration we were unable to separate the aryl butane 218 from the aryl 
vinylcyclopropane 209 and continue with the synthesis of the radical cascade 
precursor 193 from the intermediate.  
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We ultimately decided to synthesise the seleno ester 193 from the aryl iodide 210 
first performing a Stille coupling reaction with (E)-3-(tributylstannyl)prop-2-en-1-
ol 225 leading to 226. This seemingly straightforward reaction unexpectedly 
resulted in a mixture of E/Z alkene isomers with the Z-alkene dominating. 
Fortunately we were able to isomerise the Z-isomer to the more stable E-isomer by 
adding a catalytic amount of iodine adsorbed on silica to a solution of the two 
isomers in benzene and leaving the solution in daylight for twelve hours.  
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Scheme 51 Reagents and conditions i) a) PdCl2(PPh3)2, LiI, LiCl, DMF, 80oC, 16h, b) Iodine on 
silica, hυ, benzene, r.t, 12h, 60%; ii) Et2Zn, CH2I2, DCM, r.t, 48h, 82%; iii) IBX, DMSO, r.t, 12h, 
70%; iv) MePPh3Br, NaHMDS, THF, -78oC→r.t, 12h, 93%; v) LiOH, H2O/MeCN, r.t, 24h, 96%; 
vi) NPSP, Bu3P, benzene, r.t, 24h, 55%.  
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A Simmons-Smith cyclopropanation reaction with the E-alkene 226 next gave the 
cyclopropane 227. Oxidation of 227 using IBX, followed by a Wittig reaction 
between the resulting aldehyde 228 and methyltriphenylphosphonium bromide then 
gave the vinylcyclopropane 209. Saponification of the ester group in 209, using 
lithium hydroxide then gave the carboxylic acid 229. However, we encountered 
several problems when attempting to convert the acid into the corresponding seleno 
ester 193 using N-(phenylseleno) phthalimide and tributylphosphine in 
dichloromethane. Attempts to form the seleno ester 193 under the same conditions 
we had used with an earlier model compound resulted in decomposition of the 
vinylcyclopropane unit in 193. Postulating that this was most likely due to 
nucleophilic attack by benzeneselenyl anion into the vinylcyclopropane unit in 193 
we changed the solvent from dichloromethane to the less polar benzene and this 
simple modification gave the seleno ester 193 in good yield (Scheme 51). 
    
With a reasonable quantity of the seleno ester 193 in hand, we now turned our 
attention to investigating the long-awaited radical cascade sequence shown in 
Scheme 38. 
 
The Macrocyclisation-Transannulation Radical Cascade from the 
Seleno Ester 193 
Treatment of the seleno ester 193 with tributyltin hydride and AIBN in refluxing 
benzene resulted in the formation of two major (~22% each) and three minor 
products (1-8% yield), all of which could be separated by column chromatography. 
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The structure of the first major product (~22% yield) was shown to be the 
macrocyclic dienone 232. The structure followed from examination of its proton 
and carbon NMR spectroscopic data, alongside a 2D NMR analysis; a COSY 
analysis led to the proton coupling data around the macrocycle shown below, 
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and allowed the assignment of E-stereochemistry to both of the alkene bonds in the 
macrocyclic dienone. The isolation of 232 provided evidence for the addition of the 
first-formed acyl radical 235, produced from the seleno ester 193, into the 
vinylcyclopropane electrophore with concomitant cyclopropane ring cleavage, 
leading to the benzylic radical intermediate 243 (Scheme 52). Presumably a 
proportion of this stabilised radical centre is then quenched by a H-atom source 
leading to the observed product. Any benzylic radical centres which are not 
quenched at this stage, undergo two consecutive transannular cyclisations 
producing the second major product of the reaction i.e. the tetracyclic ketone 194. 
78 
O
193
SePh O
Bu3SnH, AIBN,
benzene, reflux,
20h 232
22%
O O
radical
formation
12-endo-trig
H-atom
quench
235 243
 
Scheme 52 Formation of the macrocycle 232 from the seleno ester 193. 
 
The second major product isolated from the reaction mixture showed proton, 
carbon and mass spectral data consistent with a tetracyclic compound, derived from 
a “completed” radical-mediated macrocyclisation-transannulation cascade. The 
spectra, together with analytical HPLC data, demonstrated that the compound was 
present as a 1:1 mixture of diastereoisomers. Reverse phase HPLC 
(acetonitrile/water gradient elution) allowed separation of the diastereoisomers, one 
of which was obtained pure, whilst the second was contaminated with ca 15% of 
the other diastereoisomer. 
   Analysis of the carbon-13 NMR spectrum of the pure diastereoisomer showed 
eighteen resonances (6 aromatic, 11 aliphatic and a C=O resonance). A DEPT 
analysis confirmed four aromatic and three aliphatic methine, six aliphatic 
methylene and a single methyl signal, leaving one aliphatic quaternary and two 
aromatic quaternary carbons. 
   The proton NMR spectrum of this diastereoisomer showed seven distinct regions 
of overlapping proton signals between δ1.3 and δ1.9ppm, and one double doublet 
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(J = 7.0 and 2.0Hz) and a multiplet in the aromatic region. From an HMQC 
experiment all of the proton signals could be correlated with their carbon centres. 
To establish the carbon connectivity both COSY and HMBC experiments were 
then performed. Starting from the readily assigned benzylic proton signals, strong 
correlations were observed around the tetracycle.  
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Figure 4 Pertinent J values for the diastereoisomer 194b. 
 
As Figure 4 illustrates, the vicinal coupling of the B/C ring junction in this 
diastereoisomer was 12.0Hz which was compatible with a trans-ring fusion. The 
dihedral angles for the B-ring protons demonstrate that this ring adopts a chair 
conformation. However, the C-4/C-5 relationship shows no diaxial coupling (6.5 
and 2.5Hz) demonstrating that the A/B ring junction cannot be trans. This evidence 
together with the high carbon-13 shift of the methyl carbon (δ24.8ppm) also led us 
to propose a syn relationship between the C-18 methyl and the H-9 proton. 
Comparison of the observed J-values with those calculated from all possible 
configurations/conformations also supported these observations. Indeed, such 
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NMR coupling patterns established the cis, syn, trans stereochemical pattern, 
shown in Figure 4 for this diastereoisomer. 
 
Carbon-13 and DEPT NMR experiments on the other diastereoisomer established 
the same carbon environments as determined for 194b, and COSY, HMQC and 
HMBC experiments confirmed a similar skeletal pattern. However, whilst the B/C 
ring junction showed a similar trans coupling (12.5Hz), and the diaxial couplings 
of the B-ring strongly suggested that it too was held in the chair conformation, the 
remaining J-values differed from those found in 194b. 
   Significantly the C-4/C-5 relationship demonstrated a trans diaxial coupling 
(13.5Hz). This strongly inferred a trans relationship for the A/B ring junction. A 
comparison of the observed J-values for 194a with those calculated from all 
possible configurations/conformations also supported this observation, and the 
methyl carbon-13 resonance at δ11.6ppm together with these comparisons 
supported a trans, anti, trans stereochemical pattern (Figure 5). 
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Figure 5 Pertinent J values for diastereoisomer 194a. 
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Bhattacharyya et al.112 have reported the tetracycle 194 previously, but 
unfortunately only a melting point was recorded, with no NMR spectroscopic 
details or stereochemical information. However, all our spectroscopic data support 
the assignment of 194 as the desired 6,6,5,6 ring-D aromatic steroid. Unfortunately, 
we were not able to grow a suitable crystal for X-ray crystallographic analysis.  
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NMR spectroscopic analysis of the least polar of the minor products (<1%) 
revealed that it had retained the vinylcyclopropane unit in the starting material, but 
that the selenyl ester group was missing. Further analysis of all the spectroscopic 
data, identified this product as that resulting from radical decarbonylation of the 
first formed acyl radical intermediate, i.e. 230 
   The second minor product (4% yield) was also found to have retained the 
vinylcyclopropane unit in the starting material, but its NMR spectroscopic data also 
showed the presence of a saturated aldehyde group. Further analysis established 
that the aldehyde resulted from H-atom quenching of the acyl radical precursor, i.e. 
231 (Scheme 53). 
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Scheme 53 Formation of the products 230 and 231 from 193. 
 
The most polar minor product, isolated in 8% yield, had an M + O2 molecular ion 
in its mass spectrum, and NMR spectroscopic analysis showed that it had retained 
all the proton signals associated with the C-6 alkenyl chain, including those of the 
seleno ester group. However, the resonances in the proton NMR spectrum 
associated with the cyclopropane ring in the starting material were shifted 
downfield in this product. We ultimately assigned the structure of the compound as 
the dioxolane 233 resulting from phenylselenyl radical-catalysed addition of 
oxygen across the cyclopropane ring in the starting material (Scheme 54). This 
outcome was unexpected, especially in view of the fact that the radical reaction was 
conducted under argon, with oxygen strenuously eliminated from the system before 
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and during the reaction. We presume that 233 was produced when the reaction had 
been cooled, and the flask opened to the atmosphere. Any remaining starting 
material 193 and diphenyl diselenide (a product which was also isolated from the 
reaction) could then mix with residual AIBN and catalyse the addition of oxygen 
across the cyclopropane ring in 193. Indeed, this type of reaction is not unknown, 
and Feldman et al.113 have produced the dioxolane 240 from the aryl 
vinylcyclopropane under comparable conditions.  
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Scheme 54 Formation of the dioxolane 233 from the vinylcyclopropane 193. 
 
To provide further evidence for this hypothesis, we treated a sample of the 
vinylcyclopropane 241 with very small quantities of diphenyl diselenide and 
AIBN, and found that it was entirely converted into the corresponding dioxolane 
242 within five minutes. 
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In conclusion, we have succeeded in developing a new approach to the 6,6,5,6 ring-
D aromatic steroid 194 from the vinylcyclopropyl seleno ester 193, via a novel free 
radical macrocyclisation-transannulation cascade reaction. Treatment of the seleno 
ester 193 with tributyltin hydride and AIBN was shown to lead a 1:1 mixture of 
diastereoisomers of 194, identified as the trans, anti, trans isomer 194a and its 
methyl epimer 194b. Also isolated from the cascade as a major product, was the 
macrocycle 232. Small amounts of the products of direct reduction of 193, i.e. 231, 
the decarbonylated material 230, and the dioxolane 233 were also isolated. These 
studies, once again, have demonstrated that with careful planning radical cascade 
reactions can lead to complex products, with the desired stereochemistry, from 
simple precursors, in a single step. 
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General Details 
Proton magnetic resonance chemical shifts (δH) were recorded in parts per million 
(ppm), are referenced to the residual solvent peak (CHCl3 = 7.26ppm), and are 
recorded to two decimal places. Coupling constants (J), are reported to the nearest 
0.5Hz. The multiplicity of each signal is designated by the following abbreviations: 
s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), app (apparent) and br 
(broad). Proton magnetic resonance spectra were recorded on a Brüker DRX360 
(360.1MHz), Brüker AV400 (400.1MHz) or Brüker DRX500 (500.1MHz) 
spectrometer, at ambient temperature, unless otherwise stated. All assignments are 
confirmed by 1H–1H COSY, 1H–13C HMQC and/or NOE correlations, where 
necessary. 
      
Carbon magnetic resonance chemical shifts (δC), were recorded in parts per million 
(ppm), referenced to the residual solvent peak (CDCl3 = 77.1ppm) and are recorded 
to one decimal place. The multiplicity of each signal was determined by DEPT 
analysis and was designated by the following abbreviations: s (singlet, quaternary), 
d (doublet, CH), t (triplet, CH2), q (quartet CH3). Carbon magnetic resonance 
spectra were recorded on a Brüker DRX360 (90.0MHz), Brüker AV400 
(100.0MHz) or Brüker DRX500 (500.1MHz) spectrometer, at ambient temperature, 
unless otherwise stated. All assignments were confirmed by 1H–13C HMQC and/or 
DEPT analysis. 
 
The assignments of proton and carbon resonances shown in this Experimental 
followed from the aforementioned NMR experiments. Whilst the author is 
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reasonably confident that all the assignments are correct, some caution should be 
taken when two assignments are close in chemical shift. 
 
Mass spectra were recorded on a VG Autospec MM-701CF or Micromass LCT 
spectrometer (CI+ and EI+). Only molecular ions and other significant 
peaks/fragments are reported. These instruments have a tolerance of ±10ppm and 
only formulae within ±10ppm are quoted. The required formulae are calculated 
using the most abundant isotopes of each element (i.e. 12C, 1H, 16O, 14N, 23Na, all 
others as stated). All mass spectrometry data are high resolution and are quoted to 4 
decimal places. 
      
Microanalyses were performed by the Analytical Services Department in 
Nottingham. Results are quoted as percentages of the total mass and to the nearest 
0.05%. Only data within 0.3% are quoted. 
 
Infrared spectra were recorded on a Perkin-Elmer 1600 FT-IR spectrometer, as 
liquid films or as dilute solutions, in spectroscopic grade chloroform. Absorption 
maxima (νmax) of major, significant peaks are reported in wavenumbers (cm-1), 
quoted to the nearest integral wavenumber. The assignment of weak, medium, 
strong or broad is purely qualitative, based relative to the strongest C-H absorption 
peak. 
 
Melting points were measured on a Kofler Hot-Stage or Bibby™ Stuart Scientific 
SMP3 melting point apparatus. The melting points are reported to the nearest oC 
and are uncorrected. 
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Thin Layer Chromatography (TLC) was carried out using Merck aluminium foil 
backed plates, pre-coated with Silica gel 60 F254 (1.05554.0001). Visualisation was 
effected via U.V fluorescence quenching (λmax=254nm), using an iodine on silica 
dip, or staining with phosphomolybdic acid solution (12g phosphomolybdic acid in 
250ml ethanol) or vanillin (12g 3-hydroxy-4-methoxybenzaldehyde, 2ml conc. 
sulphuric acid in 400ml ethanol), followed by heating. Flash column 
chromatography was performed using ICN Silica 32-63, 60Å employing the 
method of Still and co-workers.114 
 
Anhydrous THF was obtained by distillation from sodium/benzophenone, under 
dry nitrogen, or via filtration through a nitrogen pressurised, basic, activated, 58Å 
aluminium oxide column. Anhydrous DCM was obtained by distillation from 
calcium hydride, under dry nitrogen. Anhydrous diethyl ether was obtained via 
filtration through a dry nitrogen pressurised, basic, activated, 58Å aluminium oxide 
column. Anhydrous benzene was obtained by distillation from 
sodium/benzophenone, under dry argon. Petrol refers to the fraction of light 
petroleum ether boiling between 40 and 60oC. Evaporation of solvents was 
achieved using a Büchi rotavapor R-200.  
 
Unless stated otherwise, reactions requiring anhydrous conditions were conducted 
in an inert atmosphere of dry nitrogen in flame-dried or oven-dried apparatus. 
Combined solvent extracts were dried over MgSO4 prior to evaporation, unless 
stated otherwise. Lithium aluminium hydride reactions were quenched according to 
the method of Fieser and Fieser.115 Triphenylphosphine was purified by 
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recrystallisation from hexane. IBX (2-iodoxybenzoic acid) was prepared according 
to the procedure of Santagostino.116 The concentrations of basic alkylation reagents 
were determined by titration against 1,3-diphenylacetone p-tosylhydrazone. All 
other reagents used were purified according to C. L. L. Chai and W. L. F. 
Armarego “Purification of Laboratory Chemicals” Elsevier Science Plc, fifth 
edition, 2003, or used as they were supplied from commercial sources. 
 
Experimental Details 
(±)-5-(tert-Butyl-diphenyl-silanyloxy)-pentan-2-ol 126 
1
HO
O Si5
6
9
10
11
   126 
A solution of 1,4-pentanediol 125 (1.10g, 10.6mmol) in tetrahydrofuran (25ml) was 
added dropwise over 10 min, to a stirred suspension of sodium hydride (60% in 
mineral oil, 0.39g, 9.8mmol) (previously washed with pentane (3 x 25ml)) in 
tetrahydrofuran (50ml) at 0oC, under a nitrogen atmosphere. The mixture was 
stirred at room temperature for 30 min, and then tert-butyldiphenylsilyl chloride 
(2.50ml, 9.61mmol) was added dropwise, over 5 min at 0oC. The mixture was 
stirred at room temperature for 2 h, and then diethyl ether (20ml) and water (20ml) 
were added. The separated aqueous phase was extracted with diethyl ether (3 x 
20ml) and the combined organic extracts were dried over sodium sulphate and then 
concentrated in vacuo. The residue was purified by flash column chromatography 
(30% Et2O, 70% petrol) on silica gel, to give the silyl ether 126 (3.60g, 98%) as a 
colourless oil; νmax(sol CHCl3)/cm-1, 3617 (s), 3418 (br s), 1067 (s); δH (400MHz, 
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CDCl3), 1.07 (9H, s, SiC(CH3)3, H-11), 1.20 (3H, d, J 6.0Hz, CH(OH)CH3, H-1), 
1.27 (1H, br s, OH), 1.48-1.70 (4H, m, CH2CH2, H-3,4), 3.70 (2H, t, J 6.0Hz, 
SiOCH2, H-5), 3.84 (1H, tq, J 7.0 and 6.0Hz, HOCH, H-2), 7.40-7.46 (6H, m, 6 x 
ArH, H-8,9), 7.70-7.72 (4H, m, 4 x ArH, H-7); δC (100MHz, CDCl3), 19.1 (s, C-
10), 23.4 (q, C-1), 26.8 (q, C-11), 28.9 (t, C-4), 36.2 (t, C-3), 64.2 (t, C-5), 67.8 (d, 
C-2), 127.6 (d, C-8), 129.6 (d, C-9), 133.6 (s, C-6), 135.6 (d, C-7); m/z  (ES) 
365.1945 (M + Na+, C21H30O228SiNa requires 365.1913). 
 
 (±)-2-[4-(tert-Butyl-diphenyl-silanyloxy)-1-methyl-butylsulfanyl]-benzothiazole 
127 
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2-Mercaptobenzothiazole (0.74g, 4.4mmol) and triphenylphosphine (1.23g, 
4.7mmol) were added sequentially, to a stirred solution of the alcohol 126 (1.0g, 
2.9mmol) in tetrahydrofuran (33ml) at 0oC, under a nitrogen atmosphere. The 
mixture was stirred at 0oC for 5 min, and then diethyl azodicarboxylate (0.80ml, 
4.4mmol) was added dropwise over 15 min. The yellow mixture was stirred at 
room temperature for 24h and then diethyl ether (6ml), water (6ml) and saturated 
aqueous brine (8ml) were added. The separated aqueous phase was extracted with 
diethyl ether (3 x 50ml) and the combined organic extracts were dried over sodium 
sulphate and then concentrated in vacuo. The residue was purified by flash column 
chromatography (5% Et2O, 95% petrol) on silica gel, to give the sulphide 127 
(1.44g, 99%) as a colourless oil; νmax(sol CHCl3)/cm-1, 1111 (s); δH (400MHz, 
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CDCl3), 1.04 (9H, s, SiC(CH3)3, H-18), 1.51 (3H, d, J 7.0Hz, SCHCH3, H-8), 1.73-
1.79 (2H, m, SiOCH2CH2, H-11), 1.83-1.91 (2H, m, SCHCH2, H-10), 3.71 (2H, t, J 
5.5Hz, SiOCH2, H-12), 4.00 (1H, tq, J 7.0 and 6.5Hz, SCH, H-9), 7.28-7.44 (8H, 
m, 8 x ArH, H-4,5,15,16), 7.66 (4H, dd, J 7.5 and 1.5Hz, 4 x ArH, H-14), 7.75 (1H, 
dd, J 8.0 and 0.5Hz, ArH, H-6), 7.86 (1H, app d, J 8.0Hz, ArH, H-3); δC (100MHz, 
CDCl3), 19.2 (s, C-17), 21.5 (q, C-8), 26.9 (q, C-18), 29.9 (t, C-11), 33.2 (t, C-10), 
44.4 (d, C-9), 63.5 (t, C-12), 120.9 (d, C-6), 121.5 (d, C-3), 124.2 (d, C-4), 126.0 
(d, C-5), 127.7 (d, C-15), 129.6 (d, C-16), 135.6 (d, C-14), 135.3, 137.2 (2 x s, C-
7,13), 153.4 (s, C-2), 166.6 (s, C-1); m/z  (ES) 492.1840 (M + H+, 
C29H33NO32S228Si requires 492.1851). 
 
(±)-2-[5-(tert-Butyl-diphenyl-silanyloxy)-pentane-2-sulfonyl]-benzothiazole 122 
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Saturated aqueous brine (20ml) was added to a solution of 3-chloroperoxybenzoic 
acid (70-75% in H2O, 34.0g, 138mmol) in dichloromethane (50ml) at room 
temperature. The separated organic phase was then added dropwise, over 10 min, 
to a stirred solution of the sulphide 127 (30g, 60mmol) and sodium hydrogen 
carbonate (24.0g, 290mmol) in dichloromethane (150ml), at -40oC. The stirred 
mixture was allowed to warm to room temperature over 12 h, and then 
dichloromethane (100ml) and saturated aqueous sodium thiosulphate solution 
(200ml) were added. The separated aqueous phase was extracted with 
dichloromethane (3 x 50ml) and the combined organic extracts were then washed 
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with water (5 x 200ml) and brine (5 x 100ml), dried and concentrated in vacuo. The 
residue was purified by flash column chromatography (20% Et2O, 80% petrol) on 
silica gel, to give the sulfone 122 (29.9g, 93%) as a colourless oil; νmax(sol 
CHCl3)/cm-1, 1147 (m), 1112 (s); δH (400MHz, CDCl3), 0.96 (9H, s, SiC(CH3)3, H-
18), 1.45 (3H, d, J 7.0Hz, CHCH3, H-8), 1.44-1.64 (2H, m, CH2CH2OTBDPS, H-
11), 1.68-1.78 (2H, m, CH2CH2CH2OTBDPS, H-10), 3.65 (2H, t, J 6.0Hz, 
CH2OTBDPS, H-12), 3.66 (1H, app t, J 7.0Hz, CHCH3, H-9), 7.33-7.43 (6H, m, 6 
x ArH, H-15,16), 7.57-7.65 (6H, m, 6 x ArH, H-4,5,14), 8.01 (1H, ddd, J 7.5, 1.0, 
and 0.5Hz, ArH, H-6), 8.21 (1H, ddd, J 8.0, 1.0, 0.5Hz, ArH, H-3); δC (100MHz, 
CDCl3), 12.8 (q, C-8), 19.0 (s, C-17), 25.9 (t, C-10), 26.7 (q, C-18), 29.2 (t, C-11), 
59.6 (d, C-9), 63.0 (t, C-12), 122.2 (d, C-3), 125.5 (d, C-6), 127.5 (d, C-4), 127.7 
(d, C-15), 129.9 (d, C-5), 129.6 (d, C-16), 133.5, 136.9 (2 x s, C-7,13), 135.5 (d, C-
14), 153.0 (s, C-2), 165.1 (s, C-1); m/z  (ES) 546.1571 (M + Na+, 
C28H33NO332S228SiNa requires 546.1569). 
 
(2E)-Ethyl 3-(2-(7-(tert-Butyl-diphenyl-silanyloxy)-4-methylhept-3-
enyl)phenyl)acrylate 120a 
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Sodium hexamethyldisilazane (2.0M in THF, 1.7ml, 3.4mmol) was added dropwise 
over 10 min, to a stirred solution of the sulfone 122 (1.6g, 3.0mmol) in 
tetrahydrofuran (24ml) at -78oC, under a nitrogen atmosphere. The yellow solution 
was stirred at -78oC for 45 min and then a solution of the aldehyde 121a (0.62g, 
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2.7mmol)71 in tetrahydrofuran, (12ml) was added dropwise over 30 min. The 
mixture was stirred at -78oC for 2h and then allowed to warm to room temperature 
over 12h. Saturated aqueous ammonium chloride solution (10ml) was added, and 
the separated aqueous phase was then extracted with diethyl ether (3 x 50ml). The 
combined organic extracts were dried and concentrated in vacuo. The residue was 
purified by flash column chromatography (5% EtOAc, 95% petrol) on silica gel, to 
give a 2:3 mixture of Z and E isomers of the alkene 120a (0.42g, 38%) as a 
colourless oil; νmax(sol CHCl3)/cm-1, 1703 (s), 1634 (s); δH (400MHz, CDCl3), 1.05 
(9H, 2 x s, SiC(CH3)3, H-25), 1.33 (3H, m, OCH2CH3, H-1), 1.44 (3H, s, 
CH=CCH3, H-16), 1.47-1.67 (2H, m, CH2CH2OTBDPS, H-18), 1.98-2.10 (2H, m, 
CH2CH2CH2OTBDPS, H-17), 2.18-2.34 (2H, m, ArCH2CH2, H-13), 2.71-2.82 
(2H, m, ArCH2, H-12), 3.57-3.67 (2H, m, CH2OTBDPS, H-19), 4.25 (2H, 2 x q, J 
7.0Hz, OCH2CH3, H-2), 5.16 (1H, 2 x t, J 7.0Hz, CH=CCH3, H-14), 6.35 (1H, 2 x 
d, J 16.0Hz, ArCH=CH, H-4), 7.13-7.30 (3H, m, 3 x ArH, H-8,9,10), 7.32-7.45 
(6H, m, 6 x ArH, H-22,23), 7.54 (1H, 2 x dd, J 7.0 and 1.0Hz, ArH, H-7), 7.62-7.70 
(4H, m, 4 x ArH, H-21), 8.01 (1H, 2 x d, J 16.0Hz, ArH, H-5); δC (100MHz, 
CDCl3), 14.3 (q, C-1), 15.8 (s, C-24), 19.1, 19.2 (2 x q, C-16), 26.8, 26.9 (2 x q, C-
25), 29.7, 30.0 (2 x t, C-13), 30.3, 30.8 (2 x t, C-12), 33.4, 33.5 (2 x t, C-18), 34.4, 
35.7 (2 x t, C-17), 60.4, 60.5 (2 x t, C-2), 63.3, 63.6 (2 x t, C-19), 119.2, 119.3 (2 x 
d, C-4), 122.9 (d, C-14), 126.4, 126.5 (2 x d, C-8), 127.5 (2C d, C-22), 129.5 (d, C-
23), 129.9, 130.1, 130.9 (3 x d, C-8,9,10), 132.9, 133.0 (2 x s, C-20), 134.0, 134.1 
(2 x s, C-6), 135.5, 135.6 (2 x 2C d, C-21), 136.0, 136.1 (2 x s, C-11), 138.0, 138.1 
(2 x s, C-15), 141.9, 142.1 (2 x d, C-5), 167.0 (s, C-3); m/z  (ES) 483.2349 (M+ -
tBu, C31H35O328Si requires 483.2355). 
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(2E)-Ethyl 3-(2-((Z)-7-hydroxy-4-methylhept-3-enyl)phenyl)acrylate 131a and 
(2E)-ethyl 3-(2-((E)-7-hydroxy-4-methylhept-3-enyl)phenyl)acrylate 131b 
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A solution of tetra-n-butylammonium fluoride (0.16g, 0.5mmol) in 
tetrahydrofuran (1ml) was added dropwise over 10 min, to a stirred solution of 
the silyl ether 120a (0.12g, 0.3mmol) in tetrahydrofuran (2ml) at 0oC, under a 
nitrogen atmosphere. The pink solution was allowed to warm to room 
temperature over 3 h and then diethyl ether (2ml) and water (2ml) were added 
dropwise. The separated aqueous phase was extracted with diethyl ether (3 x 
30ml) and the combined organic extracts were then dried and concentrated in 
vacuo. The residue was purified by flash column chromatography (30% Et2O, 
70% petrol) on silica gel, to give: i) the Z-isomer of the alcohol 131a (0.021g, 
25%) (eluted first) as a colourless oil; (Found  C, 71.2; H, 7.9%. C19H25ClO2 
requires C, 71.1; H, 7.9%); νmax(sol CHCl3)/cm-1, 3623 (br m), 1706 (s), 1633 
(s); δH (400MHz, CDCl3), 1.26 (3H, t, J 7.0Hz, OCH2CH3, H-1), 1.53 (2H, tt, J 
7.5 and 6.5Hz, CH2CH2OH, H-18), 1.62 (3H, s, CH=CCH3, H-16), 1.90 (1H, br 
s, OH), 2.00 (2H, t, J 7.5Hz, CH2CH2CH2OH, H-17), 2.20 (2H, dt, J 8.0 and 
7.5Hz, ArCH2CH2, H-13), 2.70 (2H, td, J 8.0 and 1.0Hz, ArCH2, H-12), 3.52 
(2H, t, J 6.5Hz, CH2OH, H-19), 4.19 (2H, q, J 7.0Hz, OCH2CH3, H-2), 5.16 
(1H, app t, J 7.5Hz, CH=CCH3, H-14), 6.30 (1H, d, J 16.0Hz, ArCH=CH, H-4), 
7.19 (3H, m, 3 x ArH, H-8,9,10), 7.50 (1H, dd, J 7.0 and 2.0Hz, ArH, H-7), 
7.99 (1H, d, J 16.0Hz, ArCH=CH, H-5); nOe enhancement between H-13 and 
H-17 of 3%; δC (100MHz, CDCl3), 14.3 (q, C-1), 23.3 (q, C-16), 28.0 (t, C-13), 
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30.4 (t, C-12), 31.0 (t, C-18), 34.0 (t, C-17), 60.7 (t, C-2), 62.4 (t, C-19), 119.1 
(d, C-4), 124.3 (d, C-14), 126.4 (d, C-8), 129.0 (d, C-7), 130.1, 130.3 (2 x d, C-
9,10), 132.9 (s, C-6), 136.0 (s, C-11), 142.1 (s, C-15), 142.5 (d, C-5), 167.2 (s, 
C-3); m/z  (ES) 325.1793 (M + Na+, C19H26O3Na requires 325.1779); and ii) the 
E-isomer of the alcohol 131b (0.045g, 52%) (eluted second) as a colourless oil; 
νmax(sol CHCl3)/cm-1, 3623 (br w), 1706 (s), 1633 (s); δH (400MHz, CDCl3), 
1.34 (3H, t, J 7.0Hz, OCH2CH3, H-1), 1.52 (4H, br s, CH=CCH3 + OH, H-16), 
1.64 (2H, tt, J 7.5 and 6.5Hz, CH2CH2OH, H-18), 2.03 (2H, t, J 7.5Hz, 
CH2CH2CH2OH, H-17), 2.27 (2H, dt, J 7.5 and 7.0Hz, ArCH2CH2, H-13), 2.78 
(2H, t, J
  
7.5Hz, ArCH2, H-12), 3.60 (2H, t, J 6.5Hz, CH2OH, H-19), 4.27 (2H, 
q, J 7.0Hz, OCH2CH3, H-2), 5.21 (1H, t, J 7.0Hz, CH=CCH3, H-14), 6.36 (1H, 
d, J 16.0Hz, ArCH=CH, H-4), 7.18-7.32 (3H, m, 3 x ArH, H-8,9,10), 7.56 (1H, 
app d, J 7.5Hz, ArH, H-7), 8.02 (1H, d, J 16.0Hz, ArCH=CH, H-5); nOe 
enhancement between H-13 and H-16 of 2%; δC (100MHz, CDCl3), 14.3 (q, C-
1), 15.8 (q, C-16), 29.9 (t, C-13), 30.7 (t, C-12), 33.3 (t, C-18), 35.8 (t, C-17), 
60.5 (t, C-2), 62.7 (t, C-19), 119.3 (d, C-4), 123.3 (d, C-14), 126.4, 126.5 (2 x d, 
C-7,8), 129.9, 130.2 (2 x d, C-9,10), 133.0 (s, C-6), 136.0 (s, C-11), 141.8 (s, C-
15), 142.3 (d, C-5), 167.1 (s, C-3); m/z  (ES) 325.1764 (M + Na+, C19H26O3Na 
requires 325.1779). 
 
 (2E)-Ethyl 3-(2-((Z)-7-chloro-4-methylhept-3-enyl)phenyl)acrylate 132a 
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N-Chlorosuccinimide (69mg, 0.52mmol) was added in one portion, to a stirred 
solution of the Z-alcohol 131a (105mg, 0.35mmol), triphenylphosphine (120mg, 
0.47mmol) and potassium carbonate (19mg, 0.14mmol) in dichloromethane 
(10ml) at 0oC, under a nitrogen atmosphere. The mixture was stirred at room 
temperature for 1 h and then concentrated in vacuo. The residue was purified by 
flash column chromatography (10% Et2O, 90% petrol) on silica gel, to give the 
chloride 132a (110mg, 96%) as a colourless oil; νmax(sol CHCl3)/cm-1, 1706 (s), 
1633 (s); δH (400MHz, CDCl3), 1.28 (3H, t, J 7.0Hz, OCH2CH3, H-1), 1.59 (3H, 
d, J 1.0Hz, CH=CCH3, H-16), 1.64 (2H, tt, J 7.0 and 6.5Hz, CH2CH2Cl, H-18), 
2.01 (2H, t, J 7.0Hz, CH2CH2CH2Cl, H-17), 2.20 (2H, dt, J 7.5 and 7.0Hz, 
ArCH2CH2, H-13), 2.72 (2H, t, J 7.0Hz, ArCH2, H-12), 3.36 (2H, t, J 6.5Hz, 
CH2Cl, H-19), 4.20 (2H, q, J 7.0Hz, OCH2CH3, H-2), 5.17 (1H, app t, J 7.5Hz, 
CH=CCH3, H-14), 6.29 (1H, d, J 16.0Hz, ArCH=CH, H-4), 7.20-7.35 (3H, m, 3 
x ArH, H-8,9,10), 7.48 (1H, dd, J 7.5 and 1.0Hz, ArH, H-7), 7.94 (1H, d, J 
16.0Hz, ArCH=CH, H-5); δC (100MHz, CDCl3), 11.6 (q, C-1), 14.4 (q, C-16), 
30.2, 30.8 (2 x t, C-13,18), 35.0 (t, C-12), 38.2 (t, C-17), 44.4 (t, C-19), 60.6 (t, 
C-2), 120.2 (d, C-4), 125.2 (d, C-14), 126.8, 127.0 (2 x d, C-7,8), 130.1, 130.3 
(2 x d, C-9,10), 133.1 (s, C-6), 137.5 (s, C-11), 140.1 (s, C-15), 141.5 (d, C-5), 
166.8 (s, C-3); m/z  (ES) 321.1598 (M + H+, C19H2635ClO2 requires 321.1621). 
 
 (2E)-3-(2-((Z)-7-Chloro-4-methylhept-3-enyl)phenyl)prop-2-en-1-ol 133a 
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Diisobutylaluminium hydride (1.0M in hexanes, 6.3ml, 6.3mmol) was added 
dropwise over 10 min, to a stirred solution of the Z-ester 132a (0.96g, 3.0mmol) in 
dichloromethane (50ml) at -78oC under a nitrogen atmosphere. The mixture was 
stirred at -78oC for 4h and then saturated aqueous Rochelle’s salt (50ml) was added 
at 0oC. The separated aqueous phase was extracted with dichloromethane (3 x 
100ml) and the combined organic extracts were dried and then concentrated in 
vacuo. The residue was purified by flash column chromatography (30% Et2O, 70% 
petrol) on silica gel to give the Z-alcohol 133a (0.72g, 86%) as a colourless oil; 
νmax(sol CHCl3)/cm-1, 3611 (br m), 1600 (w); δH (400MHz, CDCl3), 1.69 (3H, s, 
CH=CCH3, H-14), 1.77 (2H, m, CH2CH2Cl, H-16), 2.12 (2H, t, J 7.5Hz, 
CH2CH2CH2Cl, H-15), 2.30 (2H, dt, J 8.0 and 7.0Hz, ArCH2CH2, H-11), 2.73 (2H, 
t, J 8.0Hz, ArCH2, H-10), 3.47 (2H, t, J 7.0Hz, CH2Cl, H-17), 4.35 (2H, dd, J 6.0 
and 1.0Hz, CH2OH, H-1), 5.28 (1H, t, J 7.0Hz, CH=CCH3, H-12), 6.28 (1H, dt, J 
16.0 and 6.0Hz, ArCH=CH, H-2), 6.90 (1H, app d, J 16.0Hz, ArCH=CH, H-3), 
7.14-7.25 (3H, m, 3 x ArH, H-6,7,8), 7.47 (1H, dd, J 6.0 and 2.5Hz, ArH, H-5); δC 
(100MHz, CDCl3), 23.2 (q, C-14), 28.9 (t, C-11), 29.4 (t, C-10), 30.8 (t, C-16), 
33.6 (t, C-15), 44.8 (t, C-17), 63.9 (t, C-1), 125.6, 126.2, 126.3, 127.7, 128.7, 
129.7, 130.2 (7 x d, C-2,3,5,6,7,8,12), 134.3 (s, C-4), 135.4 (s, C-9), 139.6 (s, C-
13); m/z  (ES) 301.1342 (M + Na+, C17H2335ClONa requires 301.1335). 
 
 (2E)-3-(2-((Z)-7-Chloro-4-methylhept-3-enyl)phenyl)acrylaldehyde 134a 
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Activated manganese (IV) oxide (4.34g, 50.5mmol) was added portionwise over 5 
mins, to a stirred solution of the Z-alcohol 133a (0.70g, 2.5mmol) in 
dichloromethane (50ml) at room temperature, under a nitrogen atmosphere. The 
mixture was stirred at room temperature for 21h, then filtered through celite with 
ethyl acetate (200ml) and concentrated in vacuo. The residue was purified by flash 
column chromatography (30% Et2O, 70% petrol) on silica gel, to give the Z-
aldehyde 134a (0.62g, 89%) as a colourless oil; νmax(sol CHCl3)/cm-1, 1673 (s), 
1622 (m); δH (400MHz, CDCl3), 1.68 (3H, d, J 1.0Hz, CH=CCH3, H-14), 1.74 (2H, 
m, CH2CH2Cl, H-16), 2.10 (2H, t, J 7.5Hz, CH2CH2CH2Cl, H-15), 2.36 (2H, dt, J 
7.5 and 7.0Hz, ArCH2CH2, H-11), 2.86 (2H, t, J 7.5Hz, ArCH2, H-10), 3.45 (2H, t, 
J 6.5Hz, CH2Cl, H-17), 5.26 (1H, app t, J 7.0Hz, CH=CCH3, H-12), 6.70 (1H, dd, J 
16.0 and 7.5Hz, ArCH=CH, H-2), 7.25-7.33 (2H, m, 2 x ArH, H-6,8), 7.39 (1H, 
ddd, J 7.5, 7.0 and 1.0Hz, ArH, H-7), 7.62 (1H, dd, J 8.0 and 1.0Hz, ArH, H-5), 
7.85 (1H, d, J 16.0Hz, ArCH=CH, H-3), 9.76 (1H, d, J 7.5Hz, C(O)H, H-1); δC 
(100MHz, CDCl3), 23.2 (q, C-14), 28.7 (t, C-11), 30.0 (t, C-10), 30.6 (t, C-16), 
33.5 (t, C-15), 44.6 (t, C-17), 124.9 (d, C-12), 126.8, 126.9 (2 x d, C-5,6), 129.6 (d, 
C-7), 130.5 (d, C-8), 131.1 (d, C-2), 132.4 (s, C-4), 134.9 (s, C-9), 142.1 (s, C-13), 
150.1 (d, C-3), 193.8 (d, C-1); m/z (ES) 277.1335 (M + H+, C17H2235ClO requires 
277.1359). 
 
 (±)-(1E)-1-(2-((Z)-7-Chloro-4-methylhept-3-enyl)phenyl)pent-1-en-4-yn-3-ol 
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Ethynylmagnesium bromide (0.5M in THF, 0.64ml, 0.32mmol) was added 
dropwise over 5 min, to a stirred solution of the Z-aldehyde 134a (59mg, 
0.21mmol) in tetrahydrofuran (5ml) at -78oC under a nitrogen atmosphere. The 
mixture was allowed to warm to room temperature over 22h, and then diethyl ether 
(5ml) and saturated aqueous ammonium chloride (5ml) were added. The separated 
aqueous phase was extracted with diethyl ether (3 x 25ml) and the combined 
organic extracts were then washed with brine (20ml), dried and concentrated in 
vacuo. The residue was purified by flash column chromatography (20% Et2O, 80% 
petrol) on silica gel, to give the Z-propargylic alcohol 135a (64mg, 98%) as a 
colourless oil; νmax(sol CHCl3)/cm-1, 3594 (m), 3305 (s), 1601 (w); δH (400MHz, 
CDCl3), 1.44 (3H, s, CH=CCH3, H-16), 1.79 (2H, tt, J 7.5 and 7.0Hz, CH2CH2Cl, 
H-18), 1.94 (1H, d, J 6.0Hz, OH), 2.04 (2H, t, J 7.5Hz, CH2CH2CH2Cl, H-17), 2.19 
(2H, dt, J 7.5 and 7.0Hz, ArCH2CH2, H-13), 2.58 (1H, t, J 2.0Hz, ≡C-H, H-1), 2.66 
(2H, t, J 7.5Hz, ArCH2, H-12), 3.41 (2H, t, J 7.0Hz, CH2Cl, H-19), 4.99-5.05 (1H, 
m, CHOH, H-3), 5.15 (1H, t, J 7.0Hz, CH=CCH3, H-14), 6.13 (1H, dd, J 15.5 and 
6.0Hz, ArCH=CH, H-4), 7.02-7.20 (4H, m, ArCH=CH + 3 x ArH, H-5,8,9,10), 
7.38 (1H, dd, J 7.0 and 1.5Hz, ArH, H-7); δC (100MHz, CDCl3), 23.2 (q, C-16), 
28.9 (t, C-13), 29.5 (t, C-12), 30.7 (t, C-18), 33.6 (t, C-17), 44.8 (t, C-19), 63.0 (d, 
C-3), 74.6 (d, C-1), 83.2 (s, C-2), 125.5, 126.2, 126.4, 128.1, 129.0, 129.8, 130.0 (7 
x d, C-4,5,7,8,9,10,14), 134.3, 134.5 (2 x s, C-6,11), 140.0 (s, C-15); m/z (ES) 
325.1355 (M + Na+, C19H2335ClONa requires 325.1335). 
 
 (1E)-1-(2-((Z)-7-Chloro-4-methylhept-3-enyl)phenyl)pent-1-en-4-yn-3-one 136a 
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Activated manganese (IV) oxide (290mg, 3.3mmol) was added portionwise over 5 
mins, to a stirred solution of the Z-secondary alcohol 135a (50mg, 0.2mmol) in 
dichloromethane (5ml) at room temperature under a nitrogen atmosphere. The 
mixture was stirred at room temperature for 18h, then filtered through celite with 
dichloromethane (50ml) and warm ethyl acetate (50ml), and concentrated in vacuo. 
The residue was purified by flash column chromatography (20% Et2O, 80% petrol) 
on silica gel, to give the Z-acetylenic ketone 136a (40mg, 81%) as a colourless oil; 
νmax(sol CHCl3)/cm-1, 3297 (m), 2101 (m), 1635 (s), 1598 (m); δH (400MHz, 
CDCl3), 1.65 (3H, d, J 1.0Hz, CH=CCH3, H-16), 1.70 (2H, tt, J 7.5 and 6.5Hz, 
CH2CH2Cl, H-18), 2.04 (2H, t, J 7.5Hz, CH2CH2CH2Cl, H-17), 2.32 (2H, dt, J 7.5 
and 7.0Hz, ArCH2CH2, H-13), 2.83 (2H, t, J 7.5Hz, ArCH2, H-12), 3.34 (1H, s, 
≡C-H, H-1), 3.40 (2H, t, J 6.5Hz, CH2Cl, H-19), 5.23 (1H, app t, J 7.0Hz, 
CH=CCH3, H-14), 6.75 (1H, d, J 16.0Hz, ArCH=CH, H-4), 7.21-7.32 (2H, m, 2 x 
ArH, H-8,10), 7.37 (1H, ddd, J 7.5,
 
7.0 and 1.5Hz, ArH, H-9), 7.60 (1H, dd, J 7.5 
and
 
1.5Hz, ArH, H-7), 8.26 (1H, d, J 16.0Hz, ArCH=CH, H-5); δC (100MHz, 
CDCl3), 23.2 (q, C-16), 28.8 (t, C-12), 30.1 (t, C-13), 30.6 (t, C-18), 33.5 (t, C-17), 
44.6 (t, C-19), 79.1 (d, C-1), 80.1 (s, C-2), 124.7 (d, C-14), 126.7 (d, C-8), 128.6 
(d, C-7), 130.2, 130.5, 131.2 (3 x d, C-4,9,10), 132.3 (s, C-6), 135.0 (s, C-11), 
142.6 (s, C-15), 147.2 (d, C-5), 177.6 (s, C-3); m/z (ES) 301.1367 (M + H+, 
C19H2235ClO requires 301.1359). 
 
 (1E)-1-(2-((Z)-7-Iodo-4-methylhept-3-enyl)phenyl)pent-1-en-4-yn-3-one 117a 
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Sodium iodide (220mg, 1.5mmol) was added in one portion, to a stirred solution of 
the Z- chloride 136a (115mg, 0.4mmol) and potassium carbonate (2mg, 0.01mmol) 
in 2-butanone (6ml) at room temperature under a nitrogen atmosphere. The mixture 
was heated under reflux for 24h, then cooled to room temperature and concentrated 
in vacuo. The residue was purified by flash column chromatography (10% Et2O, 
90% petrol) on silica gel to give the iodide 117a (129mg, 87%) as a yellow oil; 
νmax(sol CHCl3)/cm-1, 3297 (s), 2102 (s), 1635 (s), 1598 (s); δH (400MHz, CDCl3), 
1.64 (3H, s, CH=CCH3, H-16), 1.74 (2H, tt, J 7.5 and 7.0Hz, CH2CH2I, H-18), 1.97 
(2H, t, J 7.5Hz, CH2CH2CH2I, H-17), 2.33 (2H, dt, J 7.5 and 7.5Hz, ArCH2CH2, H-
13), 2.84 (2H, t, J 7.5Hz, ArCH2, H-12), 3.04 (2H, t, J 7.0Hz, CH2I, H-19), 3.34 
(1H, s, ≡C-H, H-1), 5.22 (1H, t, J 7.5Hz, CH=CCH3, H-14), 6.75 (1H, d, J 16.0Hz, 
ArCH=CH, H-4), 7.22-7.29 (2H, m, 2 x ArH, H-8,10), 7.37 (1H, ddd, J 7.5, 7.0 
and 1.5Hz, ArH, H-9), 7.60 (1H, dd, J 7.5 and 1.5Hz, ArH, H-7), 8.26 (1H, d, J 
16.0Hz, ArCH=CH, H-5); δC (100MHz, CDCl3), 6.5 (t, C-19), 23.3 (q, C-16), 30.2, 
(t, C-13), 31.7 (t, C-18), 32.4 (t, C-12), 33.6 (t, C-17), 79.2 (d, C-1), 80.2 (s, C-2), 
124.8 (d, C-14), 126.8, 126.9 (2 x d, C-7,8), 128.7 (d, C-4), 130.6 (d, C-10), 131.2 
(d, C-9), 132.3 (s, C-6), 134.9 (s, C-11), 142.6 (s, C-15), 147.3 (d, C-5), 177.7 (s, 
C-3); m/z  (ES) 393.0742 (M + H+, C19H22127IO requires 393.0715). 
 
 (5E,8E,13Z)-11,12,15,16-Tetrahydro-13-methylbenzo[14]annulen-7(10H)-one 
137a 
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A solution of tri-n-butyltin hydride (110l, 0.41mmol) and 2,2'-
azobis(isobutyronitrile) (32mg, 0.19mmol) in degassed benzene (13ml) was added 
dropwise, over 8 h, via syringe pump to a stirred solution of the iodide 117a 
(127mg, 0.32mmol) and 2,2'-azobis(isobutyronitrile) (16mg, 0.10mmol) in 
degassed benzene (130ml) at 80oC under an argon atmosphere. The mixture was 
heated under reflux for a further 12h, then cooled to room temperature and 
concentrated in vacuo. The residue was purified by flash column chromatography 
(5–10% Et2O, 95-90% petrol) on silica gel to leave the macrocycle 137a (30mg, 
35%) as a colourless oil; νmax(sol CHCl3)/cm-1, 1644 (s), 1623 (s); δH (400MHz, 
CDCl3), 1.63-1.76 (2H, m, CH=CHCH2CH2, H-18), 1.76 (3H, s, CH=CCH3, H-16), 
2.12-2.20 (4H, m, ArCH2CH2 + CH=CHCH2CH2CH2, H-13,17), 2.37 (2H, dtd, J 
7.0, 4.5 and 1.5Hz, CH=CHCH2, H-19), 2.66 (1H, app dd, J 5.0 and 4.0Hz, 
ArCHaHb, H-12a), 2.67 (1H, app d, J 12.0Hz, ArCHaHb, H-12b), 5.37 (1H, t, J 
8.0Hz, CH=CCH3, H-14), 6.21 (1H, dt, J 16.0 and 1.5Hz, O=CCH=CH, H-2), 6.58 
(1H, dt, J 16.0 and 4.5Hz, O=CCH=CH, H-1), 6.73 (1H, d, J 16.5Hz, ArCH=CH, 
H-4), 6.97-7.34 (3H, m, 3 x ArH, H-8,9,10), 7.70 (1H, dd, J 7.5 and 1.5Hz, ArH, 
H-7), 7.86 (1H, d, J 16.5Hz, ArCH=CH, H-5); δC (100MHz, CDCl3), 23.2 (q, C-
16), 28.1 (t, C-18), 30.1, 31.3 (2 x t, C-13,17), 32.1 (t, C-19), 35.3 (t, C-12), 123.4 
(d, C-14), 125.7 (d, C-8), 126.9 (d, C-7), 127.7 (d, C-10), 130.5, 130.6, 130.7 (3 x 
d, C-2,4,9), 132.3 (s, C-15), 137.7 (s, C-6), 142.2 (s, C-11), 142.7 (d, C-5), 147.7 
(d, C-1), 197.0 (s, C-3); m/z (ES) 289.1566 (M + Na+, C19H22ONa requires 
289.1568). 
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(2E)-Ethyl 3-(2-((E)-7-chloro-4-methylhept-3-enyl)phenyl)acrylate 132b 
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N-Chlorosuccinimide (0.067g, 0.50mmol) was added in one portion, to a stirred 
solution of the alcohol 131b (0.115g, 0.38mmol), triphenylphosphine (0.117g, 
0.45mmol) and potassium carbonate (12mg, 0.15mmol) in dichloromethane (5ml) 
at 0oC, under a nitrogen atmosphere. The mixture was stirred at room temperature 
for 1h and then concentrated in vacuo. The residue was purified by flash column 
chromatography (10% Et2O, 90% petrol) on silica gel, to leave the chloride 132b 
(0.119g, 98%) as a colourless oil; νmax(sol CHCl3)/cm-1, 1706 (s), 1633 (s); δH 
(400MHz, CDCl3), 1.35 (3H, t, J 7.0Hz, OCH2CH3, H-1), 1.50 (3H, app s, 
CH=CCH3, H-16), 1.83 (2H, tt, J 7.5 and 6.5Hz, CH2CH2Cl, H-18), 2.09 (2H, t, J 
7.5Hz, CH2CH2CH2Cl, H-17), 2.27 (2H, dt, J 7.5 and 7.0Hz, ArCH2CH2, H-13), 
2.79 (2H, t, J 7.0Hz, ArCH2, H-12), 3.46 (2H, t, J 6.5Hz, CH2Cl, H-19), 4.27 (2H, 
q, J 7.0Hz, OCH2CH3, H-2), 5.22 (1H, tq, J 7.5 and 1.0Hz, CH=CCH3, H-14), 6.37 
(1H, d, J 16.0Hz, ArCH=CH, H-4), 7.16-7.36 (3H, m, 3 x ArH, H-8,9,10), 7.56 
(1H, app d, J 7.5Hz, ArH, H-7), 8.02 (1H, d, J 16.0Hz, ArCH=CH, H-5); δC 
(100MHz, CDCl3), 14.3 (q, C-1), 15.7 (q, C-16), 29.9 (t, C-13), 30.6 (t, C-18), 33.3 
(t, C-12), 36.6 (t, C-17), 44.6 (t, C-19), 60.5 (t, C-2), 119.3 (d, C-4), 124.1 (d, C-
14), 126.5, 126.6 (2 x d, C-7,8), 129.9, 130.2 (2 x d, C-9,10), 133.0 (s, C-6), 134.6 
(s, C-11), 141.7 (s, C-15), 142.1 (d, C-5), 167.0 (s, C-3); m/z  (ES) 343.1430 (M + 
Na+, C19H2535ClO2Na requires 343.1435). 
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Diisobutylaluminium hydride (1.0M in hexanes, 8.25ml, 8.25mmol) was added 
dropwise over 10 min, to a stirred solution of the ester 132b (1.26g, 3.93mmol) in 
dichloromethane (50ml) at -78oC, under a nitrogen atmosphere. The solution was 
stirred at -78oC for 4h and then a saturated aqueous solution of Rochelle’s salt 
(50ml) was added at 0oC. The aqueous phase was extracted with dichloromethane 
(3 x 100ml) and then the combined organic extracts were dried and concentrated in 
vacuo. The residue was purified by flash column chromatography (30% Et2O, 70% 
petrol) on silica gel, to leave the alcohol 133b (0.93g, 85%) as a colourless oil; 
νmax(sol CHCl3)/cm-1, 3609 (br s), 1601 (w); δH (400MHz, CDCl3), 1.52 (3H, app s, 
CH=CCH3, H-14), 1.84 (2H, tt, J 7.5 and 7.0Hz, CH2CH2Cl, H-16), 2.10 (2H, t, J 
7.5Hz, CH2CH2CH2Cl, H-15), 2.26 (2H, dt, J 8.0 and 7.5Hz, ArCH2CH2, H-11), 
2.70 (2H, t, J 8.0Hz, ArCH2CH2, H-10), 3.47 (2H, t, J 7.0Hz, CH2Cl, H-17), 4.36 
(2H, dd, J 5.5 and 1.5Hz, ≡C-H, H-1), 5.23 (1H, tq, J 7.5 and 1.0Hz, CH=CCH3, H-
12), 6.27 (1H, dt, J 15.5 and 5.5Hz, ArCH=CH, H-2), 6.70 (1H, dt, J 15.5 and 
1.5Hz, ArCH=CH, H-3), 7.11-7.23 (3H, m, 3 x ArH, H-6,7,8), 7.46 (1H, dd, J 7.5 
and 2.0Hz, ArH, H-5); δC (100MHz, CDCl3), 15.8 (q, C-14), 28.7 (t, C-10), 29.6 (t, 
C-11), 32.3 (t, C-16), 36.6 (t, C-15), 44.7 (t, C-17), 63.9 (t, C-1), 124.7, 126.3, 
126.4, 127.6, 129.7, 130.3, 130.9 (7 x d, C-2,3,5,6,7,8,12), 134.3 (s, C-4), 135.4 (s, 
C-9), 139.6 (s, C-13); m/z (ES) 301.1330 (M + Na+, C17H2335ClONa requires 
301.1335). 
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 (2E)-3-(2-((E)-7-Chloro-4-methylhept-3-enyl)phenyl)acrylaldehyde 134b 
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Activated manganese (IV) oxide (1.21g, 13.9mmol) was added portionwise, to a 
stirred solution of the alcohol 133b (0.18g, 0.6mmol) in dichloromethane (20ml) at 
room temperature, under a nitrogen atmosphere. The solution was stirred at room 
temperature for 22h and then filtered through celite with dichloromethane (50ml), 
and concentrated in vacuo. The residue was purified by flash column 
chromatography (20% Et2O, 80% petrol) on silica gel, to leave the aldehyde 134b 
(0.15g, 87%) as a colourless oil; νmax(sol CHCl3)/cm-1, 1674 (s), 1621 (m); δH 
(400MHz, CDCl3), 1.49 (3H, d, J 0.5Hz, CH=CCH3, H-14), 1.83 (2H, tt, J 7.5 and 
6.5Hz, CH2CH2Cl, H-16), 2.10 (2H, t, J 7.5Hz, CH2CH2CH2Cl, H-15), 2.30 (2H, 
dt, J 7.5 and 7.0Hz, ArCH2CH2, H-11), 2.83 (2H, t, J 7.0Hz, ArCH2, H-10), 3.46 
(2H, t, J 6.5Hz, CH2Cl, H-17), 5.22 (1H, tq, J 7.5 and 0.5Hz, CH=CCH3, H-12), 
6.69 (1H, dd, J 15.5 and 7.5Hz, ArCH=CH, H-2),  7.22-7.30 (2H, m, 2 x ArH, H-
6,8), 7.37 (1H, ddd, J 7.5, 7.0 and 1.5Hz, ArH, H-7), 7.61 (1H, dd, J 7.5 and 1.5Hz, 
ArH, H-5), 7.82 (1H, d, J 15.5Hz, ArCH=CH, H-3), 9.74 (1H, d, J 7.5Hz, C(O)H, 
H-1); δC (100MHz, CDCl3), 15.8 (q, C-14), 30.0 (t, C-11), 30.6 (t, C-16), 33.3 (t, 
C-10), 36.6 (t, C-15), 44.5 (t, C-17), 123.9 (d, C-12), 126.8, 126.9 (2 x d, C-5,6), 
129.7 (d, C-7), 130.5 (d, C-8), 131.0 (d, C-2), 132.4 (s, C-4), 135.0 (s, C-9), 142.1 
(s, C-13), 150.1 (d, C-3), 193.8 (d, C-1); m/z (ES) 299.1195 (M + Na+, 
C17H2135ClONa requires 299.1173). 
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 (±)-(1E)-1-(2-((E)-7-Chloro-4-methylhept-3-enyl)phenyl)pent-1-en-4-yn-3-ol 
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Ethynylmagnesium bromide (0.5M in THF, 1.64ml, 0.82mmol) was added 
dropwise over 5 min, to a stirred solution of the aldehyde 134b (0.15g, 
0.55mmol) in tetrahydrofuran (10ml) at -78oC, under a nitrogen atmosphere. 
The solution was slowly warmed to room temperature over 22h and then diethyl 
ether (10ml) and a saturated aqueous ammonium chloride solution (10ml) were 
added. The aqueous phase was extracted with diethyl ether (3 x 25ml) and the 
combined organic extracts washed with brine (20ml), dried and concentrated in 
vacuo. The residue was purified by flash column chromatography (20% Et2O, 
80% petrol) on silica gel, to leave the alkyne 135a (0.16g, 98%) as a colourless 
oil; νmax(sol CHCl3)/cm-1, 3594 (m), 3305 (s), 1648 (w); δH (400MHz, CDCl3), 
1.51 (3H, app s, CH=CCH3, H-16), 1.59 (1H, br s, OH), 1.83 (2H, tt, J 7.5 and 
6.5Hz, CH2CH2Cl, H-18), 2.10 (2H, t, J 7.5Hz, CH2CH2CH2Cl, H-17), 2.26 
(2H, dt, J 7.5 and 7.0Hz, ArCH2CH2, H-13), 2.65 (1H, d, J 2.0Hz, ≡C-H, H-1), 
2.71 (2H, t, J 7.5Hz, ArCH2, H-12), 3.46 (2H, t, J 6.5Hz, CH2Cl, H-19), 5.06-
5.12 (1H, m, CHOH, H-3), 5.23 (1H, tq, J 7.0 and 1.0Hz, CH=CCH3, H-14), 
6.21 (1H, dd, J 15.5 and 6.0Hz, ArCH=CH, H-4), 7.07-7.25 (4H, m, ArCH=CH 
+ 3 x ArH, H-5,8,9,10), 7.47 (1H, dd, J 7.0 and 2.0Hz, ArH, H-7); δC (100MHz, 
CDCl3), 15.8 (q, C-16), 29.5 (t, C-13), 30.6 (t, C-12), 33.3 (t, C-18), 36.6 (t, C-
17), 44.6 (t, C-19), 62.9 (d, C-3), 74.6 (d, C-1), 84.5 (s, C-2), 124.5, 126.2, 
107 
126.3, 128.1, 128.9, 129.7, 130.0 (7 x d, C-4,5,7,8,9,10,14), 134.3 134.6 (2 x s, 
C-6,11), 140.0 (s, C-15). 
 
 (1E)-1-(2-((E)-7-Chloro-4-methylhept-3-enyl)phenyl)pent-1-en-4-yn-3-one 136b 
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Activated manganese (IV) oxide (0.95g, 10.9mmol) was added portionwise, to a 
stirred solution of the alcohol 135b (0.14g, 0.5mmol) in dichloromethane (20ml) at 
room temperature, under a nitrogen atmosphere. The solution was stirred at room 
temperature for 60h, filtered through celite with dichloromethane (50ml) and warm 
ethyl acetate (50ml), and concentrated in vacuo. The residue was purified by flash 
column chromatography (20% Et2O, 80% petrol) on silica gel, to leave the ketone 
136b (0.12g, 86%) as a colourless oil; νmax(sol CHCl3)/cm-1, 3297 (m), 2101 (m), 
1635 (s), 1598 (m); δH (400MHz, CDCl3), 1.51 (3H, app s, CH=CCH3, H-16), 1.83 
(2H, m, CH2CH2Cl, H-18), 2.12 (2H, t, J 7.5Hz, CH2CH2CH2Cl, H-17), 2.32 (2H, 
dt, J
 
7.5 and 7.0Hz, ArCH2CH2, H-13), 2.86 (2H, t, J 7.0Hz, ArCH2, H-12), 3.35 
(1H, s, ≡C-H, H-1), 3.47 (2H, t, J 6.5Hz, CH2Cl, H-19), 5.24 (1H, tq, J 7.5 and 
1.0Hz, CH=CCH3, H-14), 6.77 (1H, d, J 16.0Hz, ArCH=CH, H-4), 7.21-7.31 (2H, 
m, 2 x ArH, H-8,10), 7.39 (1H, ddd, J 7.5,
 
7.0 and 1.0Hz, ArH, H-9), 7.62 (1H, dd, 
J 7.5 and
 
1.0Hz, ArH, H-7), 8.28 (1H, d, J 16.0Hz, ArCH=CH, H-5); δC (100MHz, 
CDCl3), 15.8 (q, C-16), 30.2 (t, C-12), 30.6 (t, C-13), 33.4 (t, C-18), 36.6 (t, C-17), 
44.5 (t, C-19), 79.1 (d, C-1), 80.9 (s, C-2), 123.9 (d, C-14), 126.8 (d, C-8), 128.8 
(d, C-7), 130.6, 131.0, 131.2 (3 x d, C-4,9,10), 132.6 (s, C-6), 134.9 (s, C-11), 
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142.3 (s, C-15), 147.2 (d, C-5), 172.9 (s, C-3); m/z (ES) 323.1173 (M + Na+, 
C19H2135ClONa requires 323.1173). 
 
 (1E)-1-(2-((E)-7-Iodo-4-methylhept-3-enyl)phenyl)pent-1-en-4-yn-3-one 117b 
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Sodium iodide (250mg, 1.67mmol) was added in one portion to a stirred 
solution of the chloride 136b (116mg, 0.39mmol) and potassium carbonate 
(2mg, 0.01mmol) in 2-butanone (8ml) at room temperature, under a nitrogen 
atmosphere. The solution was heated under reflux for 32h, cooled to room 
temperature and concentrated in vacuo. The residue was purified by flash 
column chromatography (10% Et2O, 90% petrol) on silica gel, to leave the 
iodide 117b (134mg, 89%) as a yellow oil; (Found C, 58.3; H, 5.3%. C19H21IO 
requires C, 58.2; H, 5.4%); νmax(sol CHCl3)/cm-1, 3297 (m), 2102 (m), 1635 (s), 
1598 (w); δH (400MHz, CDCl3), 1.40 (3H, app s, CH=CCH3, H-16), 1.74-1.83 
(2H, m, CH2CH2I, H-18), 2.00 (2H, t, J 7.5Hz, CH2CH2CH2I, H-17), 2.23 (2H, 
dt, J 7.5 and 7.0Hz, ArCH2CH2, H-13), 2.79 (2H, t, J 7.0Hz, ArCH2, H-12), 
3.02 (2H, t, J 7.0Hz, CH2I, H-19), 3.26 (1H, s, ≡C-H, H-1), 5.15 (1H, tq, J 7.5 
and 1.0Hz, CH=CCH3, H-14), 6.68 (1H, d, J 16.0Hz, ArCH=CH, H-4), 7.15-
7.21 (2H, m, 2 x ArH, H-8,10), 7.29 (1H, ddd, J 7.5, 7.0, 1.0Hz, ArH, H-9), 
7.53 (1H, dd, J 7.5 and 1.0Hz, ArH, H-7), 8.18 (1H, d, J 16.0Hz, ArCH=CH, H-
5); δC (100MHz, CDCl3), 6.6 (t, C-19), 15.8 (q, C-16), 30.2, (t, C-13), 31.4 (t, 
C-18), 33.4 (t, C-12), 40.0 (t, C-17), 79.2 (d, C-1), 80.1 (s, C-2), 124.1 (d, C-
14), 126.7, 126.8 (2 x d, C-7,8), 128.8 (d, C-4), 130.5 (d, C-10), 131.2 (d, C-9), 
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132.2 (s, C-6), 134.6 (s, C-11), 142.6 (s, C-15), 147.2 (d, C-5), 177.7 (s, C-3); 
m/z (ES) 415.0563 (M + Na+, C19H21127IONa requires 415.0537). 
 
(±)-Benzylidene substituted bridged tricycle 148a 
O
HH
H
1
18
4
86
13
15
17
19
23
major
isomer
   148a 
A solution of tri-n-butyltin hydride (107l, 0.40mmol) and 2,2'-
azobis(isobutyronitrile) (32mg, 0.19mmol) in degassed benzene (13ml), was added 
dropwise, over 8h, via syringe pump to a stirred solution of the iodide 117b 
(130mg, 0.33mmol) and 2,2'-azobis(isobutyronitrile)  (16mg, 0.1mmol) in degassed 
benzene (130ml), at 80oC under an argon atmosphere. The mixture was heated 
under reflux for 12h, then cooled to room temperature and concentrated in vacuo. 
The residue was purified by flash column chromatography on silica, (5–10% Et2O, 
95-90% petrol) to give the bridged tricyclic ketone 148a (38mg, 35%) as a 
colorless oil (inseparable mixture of diastereoisomers in a 2:1 ratio); νmax(sol 
CHCl3)/cm-1, 1694 (s), 1614 (m); δH (400MHz, CDCl3), (major diastereoisomer) 
1.40 (3H, s, CH3, H-18), 1.48–1.89 (6H, m), 1.98–2.24 (3H, m)(H-1,2,3,5,6), 2.68 
(1H, app td, J 15.5 and 2.5Hz, ArCHaHb, H-7a), 2.94 (1H, app dt, J 15.5 and 3.5Hz, 
ArCHaHb, H-7b), 3.28 (1H, app dt, J 8.0 and 3.0Hz, O=CCH, H-15), 3.38 (1H, dd, J 
10.0 and 3.0Hz, ArCH, H-14), 6.89 (1H, s, PhCH, H-19), 7.08–7.43 (9H, m, 9 x 
ArH, H-9,10,11,12,21,22,23); (minor diastereoisomer) 1.27 (3H, s, CH3, H-18), 
1.48–1.89 (6H, m), 1.98–2.24 (3H, m)(H-1,2,3,5,6), 2.86 (1H, app d, J
 
10.5 and 
1.5Hz, O=CCH, H-15), 3.02 (2H, m, ArCH2, H-7), 3.34 (1H, dd, J 10.5 and 1.5Hz, 
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ArCH, H-14), 6.71 (1H, s, PhCH, H-19), 7.08–7.43 (9H, m, 9 x ArH, H-
9,10,11,12,21,22,23); δC (100MHz, CDCl3)  (major diastereoisomer) 21.4 (t, C-2), 
24.7 (t, C-6), 25.0 (t, C-1), 27.6 (q, C-18), 30.9 (t, C-7), 36.8 (d, C-14), 37.1 (t, C-
3), 43.5 (s, C-4), 45.7 (d, C-5), 52.4 (d, C-15), 125.7, 126.4 (2 x d, C-10,11), 127.5 
(d, C-9), 127.9 (2C d, C-21), 128.0 (d, C-23), 129.0 (2C d, C-22), 129.1 (d, C-12), 
135.4 (d, C-19), 136.8 (s, C-20), 137.0 (s, C-8), 139.6 (s, C-13), 144.1 (s, C-17), 
205.7 (s, C-16); (minor diastereoisomer) 21.8 (t, C-2), 24.0 (t, C-6), 24.3 (q, C-18), 
25.8 (t, C-1), 28.7 (t, C-7), 40.7 (s, C-4), 43.6 (d, C-14), 46.0 (t, C-3), 46.5 (d, C-5), 
47.2 (d, C-15), 123.3, 125.4 (2 x d, C-10,11), 126.2 (d, C-9), 127.8 (2C d, C-21), 
128.6 (2C d, C-22), 128.9 (d, C-23), 129.1 (d, C-12), 135.1 (d, C-19), 136.6 (s, C-
20), 137.4 (s, C-8), 139.5 (s, C-13), 142.6 (s, C-17), 206.1 (s, C-16); m/z (ES) 
343.2053 (M + H+, C25H27O requires 343.2056). 
 
(2E)-Ethyl 3-(2-(7-(tert-Butyl-diphenyl-silanyloxy)-4-methylhept-3-enyl)-4-
methoxyphenyl)acrylate 120b 
1 O
O
OSi
6
11
14
16
19
23
20
24
25
O
26
   120b 
Sodium hexamethyldisilazane (2.0M in THF, 9.0ml, 18mmol) was added 
dropwise over 10 min, to a stirred solution of the sulfone 122 (8.25g, 16mmol) 
and the aldehyde 121 (3.75g, 14mmol)71 in tetrahydrofuran (50ml) at -78oC, 
under a nitrogen atmosphere. The yellow mixture was stirred at -78oC for 3h 
and then allowed to warm to room temperature over 12h. Saturated aqueous 
ammonium chloride (30ml) was added, and the separated aqueous phase was 
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then extracted with diethyl ether (3 x 50ml). The combined organic extracts 
were dried and concentrated in vacuo. The residue was purified by flash colomn 
chromatography (5% EtOAc, 95% petrol) on silica gel, to give a 2:3 mixture of 
Z and E isomers of the alkene 120b (3.30g, 55%) as a colourless oil; νmax(sol 
CHCl3)/cm-1, 1706 (s), 1631 (s); δH (400MHz, CDCl3), 1.02, 1.07 (9H, 2 x s, 
SiC(CH3)3, H-25), 1.31 (3H, 2 x t, J 7.0Hz, OCH2CH3, H-1), 1.48-1.69 (5H, m, 
CH=CCH3 + CH2CH2OTBDPS, H-16,18), 2.02 (2H, 2 x t, J 6.0Hz, 
CH2CH2CH2OTBDPS, H-17), 2.17-2.29 (2H, m, ArCH2CH2, H-13), 2.72 (2H, 2 
x t, J 7.0Hz, ArCH2, H-12), 3.61 (2H, 2 x t, J 6.5Hz, CH2OTBDPS, H-19), 3.81 
(3H, 2 x s, OCH3, H-26), 4.24 (2H, 2 x q, J 7.0Hz, OCH2CH3, H-2), 5.16 (1H, 2 
x tq, J 7.0 and 1.0Hz, CH=CCH3, H-14), 6.26 (1H, 2 x d, J 16.0Hz, ArCH=CH, 
H-4), 6.73-6.78 (3H, m, 3 x ArH, H-8,9,10), 7.32-7.45 (6H, m, 6 x ArH, H-
22,23), 7.53 (1H, 2 x d, J 8.5Hz, ArH, H-7), 7.62-7.84 (4H, m, 4 x ArH, H-21), 
7.95 (1H, 2 x d, J 16.0Hz, ArCH=CH, H-5); δC (100MHz, CDCl3), 14.4 (q, C-
1), 16.0 (t, C-18), 19.2, 19.3 (2 x s, C-24), 23.4 (q, C-16), 26.8, 26.9 (2 x q, C-
25), 28.1 (t, C-17), 29.7, 30.0 (2 x t, C-13), 31.0 (q, C-16), 33.7 (2 x t, C-12), 
35.8 (t, C-17), 55.3, 55.4 (2 x q, C-26), 60.3, 60.4 (2 x t, C-2), 63.7, 63.8 (2 x t, 
C-19), 112.2, 112.3 (2 x d, C-8), 115.1, 115.2 (2 x d, C-10), 116.7, 116.8 (2 x d, 
C-4), 122.9, 123.9 (2 x d, C-14), 125.5, 125.6 (2 x s, C-6), 127.6, 127.7 (2 x 2C 
d, C-22), 128.0, 128.1 (2 x d, C-7), 129.5, 1297 (2 x d, C-23), 134.1, 134.2 (2 x 
s, C-20), 135.6, 135.7 (2 x 2C d, C-21), 136.2, 136.3 (2 x s, C-15), 141.7, 141.8 
(2 x d, C-5), 144.0, 144.1 (2 x s, C-11), 161.0, 161.1 (2 x s, C-9), 167.4, 167.5 
(2 x s, C-3). 
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 (2E)-Ethyl 3-(2-((Z)-7-hydroxy-4-methylhept-3-enyl)-4-methoxyphenyl)acrylate 
131c and (2E)-ethyl 3-(2-((E)-7-hydroxy-4-methylhept-3-enyl)-4-
methoxyphenyl)acrylate 131d 
1 O
O
6
11
1416 O
20
HO
19
  131c 
1 O
O
HO
6
11
14
16
19 O
20
  131d 
A solution of tetra-n-butylammonium fluoride (90mg, 0.30mmol) in 
tetrahydrofuran (1.5ml) was added dropwise over 10 min, to a stirred solution of 
the silyl ether 120b (130mg, 0.20mmol) in tetrahydrofuran (2ml) at 0oC, under a 
nitrogen atmosphere. The pink solution was allowed to warm to room 
temperature over 3h and then diethyl ether (5ml) and water (5ml) were added at 
0oC. The separated aqueous phase was extracted with diethyl ether (3 x 25ml) 
and the combined organic extracts were then dried and concentrated in vacuo. 
The residue was purified by flash column chromatography (35% Et2O, 65% 
petrol) on silica gel, to give i) the Z-isomer of the alcohol 131c (24mg, 
32%)(eluted first) as a colourless oil; νmax(sol CHCl3)/cm-1, 3623 (w), 3513 (br 
w), 1699 (s), 1629 (s); δH (400MHz, CDCl3), 1.33 (3H, t, J 7.0Hz, OCH2CH3, 
H-1), 1.62 (2H, tt, J 7.5 and 6.5Hz, CH2CH2OH, H-18), 1.70 (3H, s, CH=CCH3, 
H-16), 2.08 (2H, t, J 7.5Hz, CH2CH2CH2OH, H-17), 2.25 (2H, dt, J 8.0 and 
7.0Hz, ArCH2CH2, H-13), 2.74 (2H, t, J 8.0Hz, ArCH2, H-12), 3.59 (2H, t, J 
6.5Hz, CH2OH, H-19), 3.82 (3H, s, OCH3, H-20), 4.25 (2H, q, J 7.0Hz, 
OCH2CH3, H-2), 5.23 (1H, t, J 7.0Hz, CH=CCH3, H-14), 6.28 (1H, d, J 16.0Hz, 
ArCH=CH, H-4), 6.72 (1H, d, J 2.5Hz, CH3OCCHC, H-10), 6.76 (1H, dd, J 8.5 
and 2.5Hz, CH3OCCHCH, H-8), 7.55 (1H, d, J 8.5Hz, CH3OCCHCH, H-7), 
8.00 (1H, d, J 16.0Hz, ArCH=CH, H-5); nOe enhancement between H-13 and 
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H-17 of 3%; δC (100MHz, CDCl3), 14.3 (q, C-1), 23.3 (q, C-16), 27.9 (t, C-17), 
30.4 (t, C-13), 31.0 (t, C-18), 34.2 (t, C-12), 55.3 (q, C-20), 60.5 (t, C-2), 62.5 
(t, C-19), 112.3 (d, C-8), 115.2 (d, C-10), 116.4 (d, C-4), 124.2 (d, C-14), 125.4 
(s, C-6), 127.9 (d, C-7), 136.0 (s, C-15), 142.0 (d, C-5), 144.2 (s, C-11), 161.1 
(s, C-9); m/z (ES) 355.1880 (M + Na+, C20H28O4Na requires 355.1880); and ii) 
the E-isomer of the alcohol 131d (28mg, 37%)(eluted second) as a colourless 
oil; νmax(sol CHCl3)/cm-1, 3621 (br w), 1700 (s), 1630 (m); δH (400MHz, 
CDCl3), 1.33 (3H, t, J 7.0Hz, OCH2CH3, H-1), 1.53 (3H, s, CH=CCH3, H-16), 
1.64 (2H, tt, J 7.5 and 6.5Hz, CH2CH2OH, H-18), 2.03 (2H, t, J 7.5Hz, 
CH2CH2CH2OH, H-17), 2.26 (2H, dt, J 7.5 and 7.0Hz, ArCH2CH2, H-13), 2.76 
(2H, t, J
  
7.5Hz, ArCH2, H-12), 3.59 (2H, t, J 6.5Hz, CH2OH, H-19), 3.82 (3H, 
s, OCH3, H-20), 4.25 (2H, q, J 7.0Hz, OCH2CH3, H-2), 5.21 (1H, t, J 7.0Hz, 
CH=CCH3, H-14), 6.27 (1H, d, J 16.0Hz, ArCH=CH, H-4), 6.71 (1H, d, J 
2.5Hz, CH3OCCHC, H-10), 6.76 (1H, dd, J 9.0 and 2.5Hz, CH3OCCHCH, H-8), 
7.54 (1H, d, J 9.0Hz, CH3OCCHCH, H-7), 7.95 (1H, d, J 16.0Hz, ArCH=CH, 
H-5); nOe enhancement between H-13 and H-16 of 2%; δC (100MHz, CDCl3), 
14.3 (q, C-1), 15.8 (q, C-16), 29.8 (t, C-13), 30.6 (t, C-18), 33.5 (t, C-12), 35.8 
(t, C-17), 55.2 (q, C-20), 60.3 (t, C-2), 62.6 (t, C-19), 112.1 (d, C-8), 115.2 (d, 
C-10), 116.7 (d, C-4), 123.2 (d, C-14), 125.6 (s, C-6), 128.0 (d, C-7), 136.0 (s, 
C-15), 141.7 (d, C-5), 143.9 (s, C-11), 160.9 (s, C-9), 167.4 (s, C-3); m/z (ES) 
355.1880 (M + Na+, C20H28O4Na requires 355.1880). 
 
 (2E)-Ethyl 3-(2-((Z)-7-chloro-4-methylhept-3-enyl)-4-methoxyphenyl)acrylate 
132c 
114 
1 O
O
6
11
1416 O
20
Cl
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   132c 
N-Chlorosuccinimide (0.80g, 6.0mmol) was added in one portion, to a stirred 
solution of the Z-alcohol 131c (1.40g, 4.3mmol), triphenylphosphine (1.45g, 
5.6mmol) and potassium carbonate (0.12g, 0.9mmol) in dichloromethane (50ml) at 
0oC, under a nitrogen atmosphere. The solution was stirred at 0oC for 4h and then 
concentrated in vacuo. The residue was purified by flash column chromatography 
(15% Et2O, 85% petrol) on silica gel, to give the chloride 132c (1.34g, 90%) as a 
colourless oil; νmax(sol CHCl3)/cm-1, 1703 (s), 1630 (s); δH (400MHz, CDCl3), 1.33 
(3H, t, J 7.0Hz, OCH2CH3, H-1), 1.66 (3H, d, J 1.0Hz, CH=CCH3, H-16), 1.73 (2H, 
tt, J 7.5 and 6.5Hz, CH2CH2Cl, H-18), 2.08 (2H, t, J 7.5Hz, CH2CH2CH2Cl, H-17), 
2.27 (2H, dt, J 7.5 and 7.0Hz, ArCH2CH2, H-13), 2.76 (2H, t, J 7.5Hz, ArCH2, H-
12), 3.43 (2H, t, J 6.5Hz, CH2Cl, H-19), 3.82 (3H, s, OCH3, H-20), 4.26 (2H, q, J 
7.0Hz, OCH2CH3, H-2), 5.24 (1H, app t, J 7.0Hz, CH=CCH3, H-14), 6.27 (1H, d, J 
16.0Hz, ArCH=CH, H-4), 6.73 (1H, d, J 2.5Hz, CH3OCCHC, H-10), 6.77 (1H, dd, 
J 8.5 and 2.5Hz, CH3OCCHCH, H-8), 7.54 (1H, d, J 8.5Hz, CH3OCCHCH, H-7), 
7.95 (1H, d, J 16.0Hz, ArCH=CH, H-5); δC (100MHz, CDCl3), 14.4 (q, C-1), 23.2 
(q, C-16), 28.8 (t, C-17),  29.9 (t, C-13), 30.7 (t, C-18), 33.7 (t, C-12), 44.7 (t, C-
19), 55.3 (q, C-20), 60.3 (t, C-2), 112.3 (d, C-8), 115.2 (d, C-10), 116.8 (d, C-4), 
125.1 (d, C-14), 125.9 (s, C-6), 128.1 (d, C-7), 134.7 (s, C-15), 141.6 (d, C-5), 
143.8 (s, C-11), 161.0 (s, C-9), 167.4 (s, C-3); m/z (ES) 351.1713 (M + H+, 
C20H2835ClO3 requires 351.1721). 
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 (2E)-3-(2-((Z)-7-Chloro-4-methylhept-3-enyl)-4-methoxyphenyl)prop-2-en-1-ol 
133c 
OH
4
9
1214 O 18
Cl
17
1
   133c 
Diisobutylaluminium hydride (1.0M in hexanes, 3.5ml, 3.50mmol) was added 
dropwise over 10 min, to a stirred solution of the ester 132c (0.58g, 1.65mmol) in 
dichloromethane (30ml) at -78oC under a nitrogen atmosphere. The mixture was 
stirred at -78oC for 3h and then saturated aqueous Rochelle’s salt (30ml) was added 
at 0oC. The separated aqueous phase was extracted with dichloromethane (3 x 
50ml) and the combined organic extracts were dried and then concentrated in 
vacuo. The residue was purified by flash column chromatography (30% Et2O, 70% 
petrol) on silica gel, to give the alcohol 133c (0.47g, 92%) as a colourless oil; 
νmax(sol CHCl3)/cm-1, 3610 (br m), 1607 (s); δH (400MHz, CDCl3), 1.68 (3H, s, 
CH=CCH3, H-14), 1.76 (2H, tt, J 7.5 and 6.5Hz, CH2CH2Cl, H-16), 2.11 (2H, t, J 
7.5Hz, CH2CH2CH2Cl, H-15), 2.26 (2H, dt, J 8.0 and 7.0Hz, ArCH2CH2, H-11), 
2.67 (2H, t, J 8.0Hz, ArCH2, H-10), 3.45 (2H, t, J 6.5Hz, CH2Cl, H-17), 3.80 (3H, 
s, OCH3, H-18), 4.32 (2H, dd, J 6.0 and 1.5Hz, CH2OH, H-1), 5.25 (1H, app t, J 
7.0Hz, CH=CCH3, H-12), 6.17 (1H, dt, J 15.5 and 6.0Hz, ArCH=CH, H-2), 6.69 
(1H, d, J 2.5Hz, CH3OCCHC, H-8), 6.74 (1H, dd, J 8.0 and 2.5Hz, CH3OCCHCH, 
H-6), 6.80 (1H, app d, J 15.5Hz, ArCH=CH, H-3), 7.41 (1H, d, J 8.0Hz, 
CH3OCCHCH, H-5); δC (100MHz, CDCl3), 23.2 (q, C-14), 28.8 (t, C-11), 29.3 (t, 
C-16), 30.7 (t, C-10), 33.8 (t, C-15), 44.8 (t, C-17), 55.2 (q, C-18), 64.1 (t, C-1), 
111.8 (d, C-6), 114.9 (d, C-8), 125.5 (d, C-12), 127.2 (d, C-2), 128.0 (s, C-4), 128.1 
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(d, C-5), 128.4 (d, C-3), 134.3 (s, C-13), 141.1 (s, C-9), 159.1 (s, C-7); m/z (ES) 
291.1507 (M + - OH, C18H2435ClO requires 291.1510). 
 
 (2E)-3-(2-((Z)-7-Chloro-4-methylhept-3-enyl)-4-methoxyphenyl)acrylaldehyde 
134c 
O
4
9
1214 O
18
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1
   134c 
Activated manganese (IV) oxide (5.80g, 66.70mmol) was added portionwise over 5 
mins, to a stirred solution of the alcohol 133c (1.03g, 3.34mmol) in 
dichloromethane (50ml) at room temperature, under a nitrogen atmosphere. The 
solution was stirred at room temperature for 20h and then filtered through celite 
with ethyl acetate (200ml) and concentrated in vacuo. The residue was purified by 
flash column chromatography (40% Et2O, 60% petrol) on silica gel, to leave the Z-
aldehyde 134c (0.83g, 81%) as a colourless oil; νmax(sol CHCl3)/cm-1, 1671 (s), 
1598 (s); δH (400MHz, CDCl3), 1.67 (3H, s, CH=CCH3, H-14), 1.74 (2H, tt, J 7.5 
and 6.5Hz, CH2CH2Cl, H-16), 2.09 (2H, t, J 7.5Hz, CH2CH2CH2Cl, H-15), 2.31 
(2H, dt, J 7.5 and 7.0Hz, ArCH2CH2, H-11), 2.80 (2H, t, J 7.0Hz, ArCH2, H-10), 
3.43 (2H, t, J 6.5Hz, CH2Cl, H-17), 3.85 (3H, s, OCH3, H-18), 5.24 (1H, app t, J 
7.5Hz, CH=CCH3, H-12), 6.60 (1H, dd, J 16.0 and 8.0Hz, ArCH=CH, H-2), 6.77 
(1H, d, J 2.5Hz, CH3OCCHC, H-8), 6.81 (1H, dd, J 8.0 and 2.5Hz, CH3OCCHCH, 
H-6), 7.60 (1H, d, J 8.0Hz, CH3OCCHCH, H-5), 7.73 (1H, d, J 16.0Hz, 
ArCH=CH, H-3), 9.68 (1H, d, J 8.0Hz, C(O)H, H-1); δC (100MHz, CDCl3), 23.2 
(q, C-14), 28.7 (t, C-15), 29.9 (t, C-11), 30.5 (t, C-16), 33.6 (t, C-10), 44.6 (t, C-
17), 55.4 (q, C-18), 112.6 (d, C-6), 115.5 (d, C-8), 124.8 (d, C-12), 124.9 (s, C-4), 
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127.4 (d, C-2), 128.7 (d, C-5), 135.0 (s, C-13), 144.4 (s, C-9), 149.8 (d, C-3), 161.9 
(s, C-7), 193.8 (s, C-1); m/z (ES) 329.1280 (M  + Na+, C18H2335ClO2Na requires 
329.1279). 
 
 (±)-(1E)-1-(2-((Z)-7-Chloro-4-methylhept-3-enyl)-4-methoxyphenyl)pent-1-en-4-
yn-3-ol 135c 
OH
6
11
1416 O 20
Cl
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   135c 
Ethynylmagnesium bromide (0.5M in THF, 7.8ml, 3.9mmol) was added dropwise 
over 5 min, to a stirred solution of the aldehyde 134c (0.80g, 2.6mmol) in 
tetrahydrofuran (45ml) at -78oC, under a nitrogen atmosphere. The mixture was 
allowed to warm to room temperature over 20h, and then diethyl ether (30ml) and 
saturated aqueous ammonium chloride (50ml) were added at room temperature. 
The separated aqueous phase was extracted with diethyl ether (3 x 80ml) and the 
combined organic extracts were then washed with brine (20ml), dried and 
concentrated in vacuo. The residue was purified by flash column chromatography 
(20% Et2O, 80% petrol) on silica gel, to give the alkyne 135c (0.86g, 99%) as a 
colourless oil; νmax(sol CHCl3)/cm-1, 3593 (br m), 3305 (s), 1606 (s); δH (400MHz, 
CDCl3), 1.68 (3H, d, J 1.0Hz, CH=CCH3, H-16), 1.75 (2H, tt, J 7.5 and 6.5Hz, 
CH2CH2Cl, H-18), 2.00 (1H, d, J 6.5Hz, OH), 2.10 (2H, t, J 7.5Hz, CH2CH2CH2Cl, 
H-17), 2.27 (2H, dt, J 8.0 and 7.5Hz, ArCH2CH2, H-13), 2.64 (1H, d, J 2.0Hz, ≡C-
H, H-1), 2.68 (2H, t, J 8.0Hz, ArCH2, H-12), 3.45 (2H, t, J 6.5Hz, CH2Cl, H-19), 
3.80 (3H, s, OCH3, H-20), 5.04-5.09 (1H, m, HOCH, H-3), 5.25 (1H, app t, J 
7.5Hz, CH=CCH3, H-14), 6.11 (1H, dd, J 15.5 and 6.0Hz, ArCH=CH, H-4), 6.70 
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(1H, d, J 2.5Hz, CH3OCCHC, H-10), 6.74 (1H, dd, J 8.5 and 2.5Hz, 
CH3OCCHCH, H-8), 7.02 (1H, d, J 15.5Hz, ArCH=CH, H-5), 7.42 (1H, d, J 
8.5Hz, CH3OCCHCH, H-7); δC (100MHz, CDCl3), 23.2 (q, C-16), 29.4 (t, C-13), 
30.7 (t, C-18), 33.8 (t, C-12), 35.2 (t, C-17), 44.8 (t, C-19), 55.2 (q, C-20), 63.1 (d, 
C-3), 77.2 (d, C-1), 83.0 (s, C-2), 108.1 (d, C-8), 115.0 (d, C-10), 124.6 (d, C-14), 
126.9 (d, C-7), 127.2 (s, C-6), 127.4 (d, C-4), 129.6 (d, C-5), 134.4 (s, C-15), 145.0 
(s, C-11), 159.5 (s, C-9); m/z (ES) 355.1434 (M  + Na+, C20H2535ClO2Na requires 
355.1441). 
 
 (1E)-1-(2-((Z)-7-Chloro-4-methylhept-3-enyl)-4-methoxyphenyl)pent-1-en-4-yn-
3-one 136c 
O
6
11
1416 O
20
Cl
19
1
    136c 
Activated manganese (IV) oxide (4.34g, 49.9mmol) was added portionwise over 5 
mins, to a stirred solution of the Z-alcohol 135c (0.83g, 2.5mmol) in 
dichloromethane (45ml) at room temperature, under a nitrogen atmosphere. The 
solution was stirred at room temperature for 23h, then filtered through celite with 
dichloromethane (50ml) and warm ethyl acetate, (100ml) and concentrated in 
vacuo. The residue was purified by flash column chromatography (20% Et2O, 80% 
petrol) on silica gel, to give the ketone 136c (0.77g, 86%) as a colourless oil; 
νmax(sol CHCl3)/cm-1, 3297 (m), 2101 (m), 1630 (s), 1596 (s); δH (400MHz, 
CDCl3), 1.66 (3H, d, J 1.0Hz, CH=CCH3, H-16), 1.72 (2H, tt, J 7.5 and 6.5Hz, 
CH2CH2Cl, H-18), 2.06 (2H, t, J 7.5Hz, CH2CH2CH2Cl, H-17), 2.32 (2H, dt, J 7.5 
and 7.0Hz, ArCH2CH2, H-13), 2.81 (2H, t, J 7.0Hz, ArCH2, H-12), 3.30 (1H, s, 
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≡C-H, H-1), 3.42 (2H, t, J 6.5Hz, CH2Cl, H-19), 3.85 (3H, s, OCH3, H-20), 5.24 
(1H, app t, J 7.5Hz, CH=CCH3, H-14), 6.67 (1H, d, J 16.0Hz, ArCH=CH, H-4), 
6.77 (1H, d, J 2.5Hz, CH3OCCHC, H-10), 6.80 (1H, dd, J 8.5 and 2.5Hz, 
CH3OCCHCH, H-8), 7.60 (1H, d, J 8.5Hz, CH3OCCHCH, H-7), 8.20 (1H, d, J 
16.0Hz, ArCH=CH, H-5); δC (100MHz, CDCl3), 23.3 (q, C-16), 28.8, 30.1, 30.7, 
33.8 (4 x t, C-12,13,17,18), 44.7 (t, C-19), 55.4 (q, C-20), 78.7 (d, C-1), 80.3 (s, C-
2), 112.7, 115.6 (2 x d, C-8,10), 124.7 (d, C-14), 124.9 (s, C-6), 126.4 (d, C-7), 
128.6 (d, C-4), 135.0 (s, C-15), 145.1 (s, C-11), 147.0 (d, C-5), 162.1 (s, C-9), 
177.6 (s, C-3); m/z (ES) 331.1433 (M  + H+, C20H2435ClO2 requires 331.1459). 
 
 (1E)-1-(2-((Z)-7-Iodo-4-methylhept-3-enyl)-4-methoxyphenyl)pent-1-en-4-yn-3-
one 117c 
O
6
11
1416 O
20
I
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1
    117c 
Sodium iodide (270mg, 1.81mmol) was added in one portion, to a stirred solution 
of the Z- chloride 136c (115mg, 0.34mmol) and potassium carbonate (3mg, 
0.02mmol) in 2-butanone (6ml) at room temperature under a nitrogen atmosphere. 
The mixture was heated under reflux for 23h, then cooled to room temperature and 
concentrated in vacuo. The residue was purified by flash column chromatography 
(10% Et2O, 90% petrol) on silica gel, to give the iodide 117c (135mg, 92%) as a 
yellow solid; m.p = 80-81oC (petrol); νmax(sol CHCl3)/cm-1, 3297 (m), 2101 (w), 
1631 (s), 1596 (s); δH (400MHz, CDCl3), 1.65 (3H, d, J 1.0Hz, CH=CCH3, H-16), 
1.76 (2H, tt, J 7.5 and
 
7.0Hz, CH2CH2I, H-18), 2.00 (2H, t, J 7.5Hz, CH2CH2CH2I, 
H-17), 2.34 (2H, dt, J 7.5 and 7.0Hz, ArCH2CH2, H-13), 2.82 (2H, t, J 7.0Hz, 
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ArCH2, H-12), 3.05 (2H, t, J 7.0Hz, CH2I, H-19), 3.30 (1H, s, ≡C-H, H-1), 3.85 
(3H, s, OCH3, H-20), 5.23 (1H, app t, J 7.5Hz, CH=CCH3, H-14), 6.68 (1H, d, J 
16.0Hz, ArCH=CH, H-4), 6.78 (1H, d, J 2.5Hz, CH3OCCHC, H-10), 6.81 (1H, dd, 
J 8.5 and 2.5Hz, CH3OCCHCH, H-8), 7.60 (1H, d, J 8.5Hz, CH3OCCHCH, H-7), 
8.20 (1H, d, J 16.0Hz, ArCH=CH, H-5); δC (100MHz, CDCl3), 6.5 (t, C-19), 23.2 
(q, C-16), 30.2, (t, C-13), 31.7 (t, C-18), 32.4 (t, C-17), 33.7 (t, C-12), 55.5 (q, C-
20), 78.8 (d, C-1), 80.3 (s, C-2), 112.7 (d, C-8), 115.7 (d, C-10), 124.8 (d, C-14), 
124.9 (s, C-6), 126.4 (d, C-4), 128.7 (d, C-7), 134.9 (s, C-15), 145.0 (s, C-11), 
147.0 (d, C-5), 162.1 (s, C-9), 180.1 (s, C-3); m/z (ES) 445.0610 (M  + Na+, 
C20H23127IO2Na requires 445.0640). 
 
(5E,8E)-11,12,13,14,15,16-Hexahydro-2-methoxy-13-methylbenzo[14]annulen-
7(10H)-one 137b 
6
11
1416
19
1
O
O 20
   137b 
A solution of tri-n-butyltin hydride (85l, 0.32mmol) and 2,2'-
azobis(isobutyronitrile) (26mg, 0.16mmol) in degassed benzene (11ml) was added 
dropwise, over 8h, via syringe pump to a stirred solution of the iodide 117c 
(110mg, 0.26mmol) and 2,2'-azobis(isobutyronitrile) (13mg, 0.08mmol) in 
degassed benzene (110ml) at 80oC under an argon atmosphere. The mixture was 
heated under reflux for a further 12h, then cooled to room temperature and 
concentrated in vacuo. The residue was purified by flash column chromatography 
(5–10% Et2O, 95-90% pentane) on silica gel to leave the macrocycle 137b (28mg, 
36%) as a yellow oil; νmax(sol CHCl3)/cm-1, 1640 (s), 1602 (s); δH (400MHz, 
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CDCl3), 1.63-1.80 (2H, m, CH=CHCH2CH2, H-18), 1.82 (3H, s, CH=CCH3, H-16), 
2.10-2.19 (4H, m, ArCH2CH2 + CH=CHCH2CH2CH2, H-13,17), 2.39 (2H, dtd, J 
7.0, 4.0 and 1.0Hz, CH=CHCH2, H-19), 2.66 (2H, app t, J 6.0Hz, ArCH2, H-12), 
3.84 (3H, s, OCH3, H-20), 5.38 (1H, t, J 7.5Hz, CH=CCH3, H-14), 6.20 (1H, dt, J 
15.5 and 1.0Hz, O=CCH=CH, H-2), 6.58 (1H, dt, J 15.5 and 4.0Hz, O=CCH=CH, 
H-1), 6.75 (1H, d, J 16.0Hz, ArCH=CH, H-4), 6.79 (1H, d, J 1.5Hz, CH3OCCHC, 
H-10), 6.84 (1H, dd, J 7.0 and 1.5Hz, CH3OCCHCH, H-8), 7.55 (1H, d, J 7.0Hz, 
CH3OCCHCH, H-7), 7.88 (1H, d, J 16.0Hz, ArCH=CH, H-5); δC (100MHz, 
CDCl3), 23.0 (q, C-16), 29.0 (t, C-18), 30.1 (t, C-17), 31.5 (t, C-13), 32.1 (t, C-19), 
35.5 (t, C-12), 55.4 (q, C-20), 123.3 (d, C-14), 125.7 (d, C-8), 127.0 (d, C-7), 127.7 
(d, C-10), 130.4 (d, C-4), 130.3 (d, C-2), 130.8 (d, C-9), 132.3 (s, C-15), 137.9 (s, 
C-6), 142.1 (s, C-11), 142.7 (d, C-5), 147.6 (d, C-1), 198.3 (s, C-3); m/z  (ES) 
297.1864 (M + H+, C20H25O2 requires 297.1854). 
 
(2E)-Ethyl-3-(2-((E)-7-chloro-4-methylhept-3-enyl)-4-methoxyphenyl)acrylate 
132d 
1 O
O
Cl
6
1114
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20
   132d 
N-Chlorosuccinimide (1.1g, 8.3mmol) was added in one portion, to a stirred 
solution of the alcohol 131d (2.0g, 5.9mmol), triphenylphosphine (2.0g, 7.7mmol) 
and potassium carbonate (0.16g, 1.2mmol) in dichloromethane (50ml) at 0oC, 
under a nitrogen atmosphere. The solution was stirred at 0oC for 4h and then 
concentrated in vacuo. The residue was purified by flash column chromatography 
(15% Et2O, 85% petrol) on silica gel, to leave the chloride 132d (1.9g, 91%) as a 
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colourless oil; νmax(sol CHCl3)/cm-1, 1698 (s), 1631 (s); δH (400MHz, CDCl3), 1.33 
(3H, t, J 7.0Hz, OCH2CH3, H-1), 1.52 (3H, d, J 1.0Hz, CH=CCH3, H-16), 1.83 
(2H, tt, J 7.5 and 6.5Hz, CH2CH2Cl, H-18), 2.09 (2H, t, J 7.5Hz, CH2CH2CH2Cl, 
H-17), 2.27 (2H, dt, J 8.0 and 7.5Hz, ArCH2CH2, H-13), 2.76 (2H, t, J 8.0Hz, 
ArCH2, H-12), 3.46 (2H, t, J 6.5Hz, CH2Cl, H-19), 3.82 (3H, s, OCH3, H-20), 4.26 
(2H, q, J 7.0Hz, OCH2CH3, H-2), 5.21 (1H, tq, J 7.5 and 1.0Hz, CH=CCH3, H-14), 
6.27 (1H, d, J 16.0Hz, ArCH=CH, H-4), 6.72 (1H, d, J 2.5Hz, CH3OCCHC, H-10), 
6.77 (1H, dd, J 8.5 and 2.5Hz, CH3OCCHCH, H-8), 7.55 (1H, d, J 8.5Hz, 
CH3OCCHCH, H-7), 7.96 (1H, d, J 16.0Hz, ArCH=CH, H-5); δC (100MHz, 
CDCl3), 14.4 (q, C-1), 15.8 (q, C-16), 29.9 (t, C-13), 30.7 (t, C-18), 33.5 (t, C-12), 
36.6 (t, C-17), 44.6 (t, C-19), 55.3 (q, C-20), 60.3 (t, C-2), 112.2 (d, C-8), 115.3 (d, 
C-10), 116.8 (d, C-4), 124.1 (d, C-14), 125.6 (s, C-6), 128.0 (d, C-7), 134.7 (s, C-
15), 144.6 (d, C-5), 143.8 (s, C-11), 161.0 (s, C-9), 167.4 (s, C-3); m/z (ES) 
351.1720 (M  + H+, C20H2835ClO3 requires 351.1721). 
 
 
(2E)-3-(2-((E)-7-Chloro-4-methylhept-3-enyl)-4-methoxyphenyl)prop-2-en-1-ol 
133d 
OH
Cl
4
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   133d 
Diisobutylaluminium hydride (1.0M in hexanes, 4.50ml, 4.50mmol) was added 
dropwise over 10 min, to a stirred solution of the ester 132d (0.75g, 2.14mmol) in 
dichloromethane (30ml) at -78oC, under a nitrogen atmosphere. The solution was 
stirred at -78oC for 3h and then a saturated aqueous solution of Rochelle’s salt 
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(30ml) was added at 0oC. The aqueous phase was extracted with dichloromethane 
(3 x 50ml) and the combined organic extracts were dried and concentrated in 
vacuo. The residue was purified by flash column chromatography (30% Et2O, 70% 
petrol) on silica gel, to leave the alcohol 133d (0.58g, 87%) as a colourless oil; 
νmax(sol CHCl3)/cm-1, 3610 (br m), 1607 (s); δH (400MHz, CDCl3), 1.53 (3H, app s, 
CH=CCH3, H-14), 1.84 (2H, tt, J 7.5 and 6.5Hz, CH2CH2Cl, H-16), 2.11 (2H, t, J 
7.5Hz, CH2CH2CH2Cl, H-15), 2.26 (2H, dt, J 8.0 and 7.5Hz, ArCH2CH2, H-11), 
2.67 (2H, t, J 8.0Hz, ArCH2, H-10), 3.47 (2H, t, J 6.5Hz, CH2Cl, H-17), 3.80 (3H, 
s, OCH3, H-18), 4.33 (2H, dd, J 6.0 and 1.5Hz, CH2OH, H-1), 5.23 (1H, tq, J 7.5 
and 1.0Hz, CH=CCH3, H-12), 6.17 (1H, dt, J 15.5 and 6.0Hz, ArCH=CH, H-2), 
6.68 (1H, d, J 2.5Hz, CH3OCCHC, H-8), 6.74 (1H, dd, J 8.5 and 2.5Hz, 
CH3OCCHCH, H-6), 6.81 (1H, app d, J 15.5Hz, ArCH=CH, H-3), 7.41 (1H, d, J 
8.5Hz, CH3OCCHCH, H-5); δC (100MHz, CDCl3), 15.8 (q, C-14), 29.3 (t, C-11), 
30.7 (t, C-16), 33.5 (t, C-10), 36.7 (t, C-15), 44.6 (t, C-17), 55.2 (q, C-18), 64.2 (t, 
C-1), 111.7 (d, C-6), 114.9 (d, C-8), 124.6 (d, C-12), 127.2 (d, C-2), 128.0 (d, C-5), 
128.1 (s, C-4), 128.6 (d, C-3), 134.3 (s, C-13), 141.1 (s, C-9), 159.1 (s, C-7); m/z 
(ES) 331.1422 (M  + Na+, C18H2535ClO2Na requires 331.1441). 
 
(2E)-3-(2-((E)-7-Chloro-4-methylhept-3-enyl)-4-methoxyphenyl)acrylaldehyde 
134d 
O
Cl
4
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Activated manganese (IV) oxide (0.56g, 6.4mmol) was added portionwise, to a 
stirred solution of the alcohol 133d (0.10g, 0.3mmol) in dichloromethane (15ml) at 
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room temperature, under a nitrogen atmosphere. The solution was stirred at room 
temperature for 24h, filtered through celite with dichloromethane (100ml) and 
concentrated in vacuo. The residue was purified by flash column chromatography 
(20% Et2O, 80% petrol) on silica gel, to leave the aldehyde 134d (0.08g, 81%) as a 
colourless oil; νmax(sol CHCl3)/cm-1, 1671 (s), 1595 (s); δH (400MHz, CDCl3), 1.51 
(3H, app s, CH=CCH3, H-14), 1.83 (2H, tt, J 7.5 and 6.5Hz, CH2CH2Cl, H-16), 
2.11 (2H, t, J 7.5Hz, CH2CH2CH2Cl, H-15), 2.30 (2H, dt, J 7.5 and 7.0Hz, 
ArCH2CH2, H-11), 2.80 (2H, t, J 7.0Hz, ArCH2, H-10), 3.46 (2H, t, J 6.5Hz, 
CH2Cl, H-17), 3.85 (3H, s, OCH3, H-18), 5.22 (1H, tq, J 7.5 and 1.0Hz, 
CH=CCH3, H-12), 6.61 (1H, dd, J 15.5 and 7.5Hz, ArCH=CH, H-2), 6.76 (1H, d, J 
2.5Hz, CH3OCCHC, H-8), 6.81 (1H, dd, J 8.5 and 2.5Hz, CH3OCCHCH, H-6), 
7.60 (1H, d, J 8.5Hz, CH3OCCHCH, H-5), 7.73 (1H, d, J 15.5Hz, ArCH=CH, H-
3), 9.68 (1H, d, J 7.5Hz, C(O)H, H-1); δC (100MHz, CDCl3), 15.8 (q, C-14), 29.9 
(t, C-11), 30.6 (t, C-16), 33.4 (t, C-10), 36.6 (t, C-15), 44.5 (t, C-17), 55.4 (q, C-
18), 112.4 (d, C-6), 115.6 (d, C-8), 123.9 (d, C-12), 125.0 (s, C-4), 127.4 (d, C-2), 
128.6 (d, C-5), 128.7 (s, C-13), 144.4 (s, C-9), 149.8 (d, C-3), 161.9 (s, C-7), 193.8 
(s, C-1); m/z (ES) 329.1297 (M  + Na+, C18H2335ClO2Na requires 329.1279). 
 
 (±)-(1E)-1-(2-((E)-7-Chloro-4-methylhept-3-enyl)-4-methoxyphenyl)pent-1-en-4-
yn-3-ol 135d 
OH
Cl
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Ethynylmagnesium bromide (0.5M in THF, 12.9ml, 6.50mmol) was added 
dropwise over 5 min, to a stirred solution of the aldehyde 134d (1.32g, 4.30mmol) 
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in  tetrahydrofuran (45ml) at -78oC, under a nitrogen atmosphere. The solution was 
slowly warmed to room temperature over 20 h and then diethyl ether (30ml) and a 
saturated aqueous ammonium chloride solution (50ml) were added. The aqueous 
phase was extracted with diethyl ether (3 x 80ml) and the combined organic 
extracts were washed with brine (20ml), dried and concentrated in vacuo. The 
residue was purified by flash column chromatography (20% Et2O, 80% petrol) on 
silica gel, to leave the alkyne 135d (1.33g, 93%) as a colourless oil; νmax(sol 
CHCl3)/cm-1, 3591 (br m), 3305 (s), 1608 (s); δH (400MHz, CDCl3), 1.53 (3H, app 
s, CH=CCH3, H-16), 1.84 (2H, tt, J 7.5 and 7.0Hz, CH2CH2Cl, H-18), 2.01 (1H, d, 
J 6.5Hz, OH), 2.11 (2H, t, J 7.0Hz, CH2CH2CH2Cl, H-17), 2.27 (2H, dt, J 8.0 and 
7.5Hz, ArCH2CH2, H-13), 2.64 (1H, d, J 2.0Hz, ≡C-H, H-1), 2.69 (2H, t, J 8.0Hz, 
ArCH2, H-12), 3.46 (2H, t, J 7.5Hz, CH2Cl, H-19), 3.80 (3H, s, OCH3, H-20), 5.03-
5.09 (1H, m, CHOH, H-3), 5.22 (1H, tq, J 7.5 and 1.0Hz, CH=CCH3, H-14), 6.11 
(1H, dd, J 15.5 and 6.0Hz, ArCH=CH, H-4), 6.69 (1H, d, J 2.5Hz, CH3OCCHC, H-
10), 6.74 (1H, dd, J 8.5 and 2.5Hz, CH3OCCHCH, H-8), 7.02 (1H, d, J 15.5Hz, 
ArCH=CH, H-5), 7.42 (1H, d, J
 
8.5Hz, CH3OCCHCH, H-7); δC (100MHz, CDCl3), 
15.8 (q, C-16), 29.4 (t, C-13), 30.7 (t, C-18), 33.5 (t, C-12), 36.6 (t, C-17), 44.6 (t, 
C-19), 55.2 (q, C-20), 63.1 (d, C-3), 74.5 (d, C-1), 83.0 (s, C-2), 111.8 (d, C-8), 
115.0 (d, C-10), 124.5 (d, C-14), 126.9 (d, C-7), 127.2 (s, C-6), 127.4 (d, C-4), 
129.6 (d, C-5), 134.3 (s, C-15), 141.6 (s, C-11), 159.5 (s, C-9); m/z (ES) 355.1423 
(M  + Na+, C20H2535ClO2Na requires 355.1441). 
 
 (1E)-1-(2-((E)-7-Chloro-4-methylhept-3-enyl)-4-methoxyphenyl)pent-1-en-4-yn-
3-one 136d 
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Activated manganese (IV) oxide (0.260g, 3.00mmol) was added portionwise, to a 
stirred solution of the alcohol 135d (0.050g, 0.15mmol) in dichloromethane (5ml) 
at room temperature, under a nitrogen atmosphere. The solution was stirred at room 
temperature for 18h, filtered through celite with dichloromethane (50ml) and warm 
ethyl acetate (50ml) and then concentrated in vacuo. The residue was purified by 
flash column chromatography (20% Et2O, 80% petrol) on silica gel, to leave the 
ketone 136d (0.044g, 88%) as a colourless oil; νmax(sol CHCl3)/cm-1, 3297 (m), 
2101 (m), 1631 (s), 1594 (s); δH (400MHz, CDCl3), 1.51 (3H, app s, CH=CCH3, H-
16), 1.83 (2H, tt, J 7.5 and 6.5Hz, CH2CH2Cl, H-18), 2.10 (2H, t, J 7.5Hz, 
CH2CH2CH2Cl, H-17), 2.31 (2H, dt, J 7.5 and 7.0Hz, ArCH2CH2, H-13), 2.81 (2H, 
t, J 7.0Hz, ArCH2, H-12), 3.20 (3H, s, ≡C-H, H-1), 3.45 (2H, t, J 6.5Hz, CH2Cl, H-
19), 3.85 (3H, s, OCH3, H-20), 5.22 (1H, tq, J 7.5 and 1.0Hz, CH=CCH3, H-14), 
6.68 (1H, d, J 15.5Hz, ArCH=CH, H-4), 6.76 (1H, d, J 2.5Hz, CH3OCCHC, H-10), 
6.80 (1H, dd, J 8.5 and 2.5Hz, CH3OCCHCH, H-8), 7.60 (1H, d, J 8.5Hz, 
CH3OCCHCH, H-7), 8.21 (1H, d, J 15.5Hz, ArCH=CH, H-5); δC (100MHz, 
CDCl3), 15.8 (q, C-16), 30.1, 30.6, 33.6, 36.6 (4 x t, C-12,13,17,18), 44.4 (t, C-19), 
55.4 (q, C-20), 78.7 (d, C-1), 80.2 (s, C-2), 112.5, 115.6 (2 x d, C-8,10), 123.9 (d, 
C-14), 124.8 (s, C-6), 126.4 (d, C-7), 128.6 (d, C-4), 134.9 (s, C-15), 145.1 (s, C-
11), 146.9 (d, C-5), 162.1 (s, C-9), 177.6 (s, C-3); m/z (ES) 331.1456 (M  + H+, 
C20H2435ClO2 requires 331.1459). 
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 (1E)-1-(2-((E)-7-Iodo-4-methylhept-3-enyl)-4-methoxyphenyl)pent-1-en-4-yn-3-
one 117d 
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Sodium iodide (310mg, 2.07mmol) was added in one portion, to a stirred solution 
of the chloride 136d (110mg, 0.33mmol) and potassium carbonate (3mg, 
0.02mmol) in 2-butanone (6ml) at room temperature, under a nitrogen atmosphere. 
The mixture was heated under reflux for 24h and then cooled to room temperature 
and concentrated in vacuo. The residue was purified by flash column 
chromatography (10% Et2O, 90% petrol) on silica gel, to leave the iodide 117d 
(133mg, 95%) as a yellow oil; νmax(sol CHCl3)/cm-1, 3297 (s), 2101 (w), 1634 (s), 
1592 (m); δH (400MHz, CDCl3), 1.50 (3H, app s, CH=CCH3, H-16), 1.87 (2H, tt, J 
7.5 and
 
7.0Hz, CH2CH2I, H-18), 2.05 (2H, t, J 7.0Hz, CH2CH2CH2I, H-17), 2.30 
(2H, dt, J 7.5 and 7.0Hz, ArCH2CH2, H-13), 2.81 (2H, t, J 7.0Hz, ArCH2, H-12), 
3.09 (2H, t, J 7.5Hz, CH2I, H-19), 3.30 (1H, s, ≡C-H, H-1), 3.85 (3H, s, OCH3, H-
20), 5.24 (1H, tq, J 7.5 and 1.0Hz, CH=CCH3, H-14), 6.68 (1H, d, J 16.0Hz, 
ArCH=CH, H-4), 6.76 (1H, d, J 2.5Hz, CH3OCCHC, H-10), 6.80 (1H, dd, J 8.5 
and 2.5Hz, CH3OCCHCH, H-8), 7.60 (1H, d, J 8.5Hz, CH3OCCHCH, H-7), 8.20 
(1H, d, J 16.0Hz, ArCH=CH, H-5); δC (100MHz, CDCl3), 6.5 (t, C-19), 15.8 (q, C-
16), 30.1, (t, C-13), 31.4 (t, C-18), 33.5 (t, C-12), 40.0 (t, C-17), 55.4 (q, C-20), 
78.8 (d, C-1), 80.2 (s, C-2), 112.5 (d, C-8), 115.6 (d, C-10), 124.1 (d, C-14), 124.8 
(s, C-6), 126.4 (d, C-4), 128.6 (d, C-7), 134.6 (s, C-15), 145.0 (s, C-11), 146.9 (d, 
C-5), 162.1 (s, C-9), 177.6 (s, C-3); m/z (ES) 445.0629 (M  + Na+, C20H23127IO2Na 
requires 445.0640). 
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 (±)-Benzylidene substituted methoxy bridged tricycle 148b 
O
HH
H
1
18
4
86
13
15
17
19
23
O
24
major
isomer
   148b 
A solution of tri-n-butyltin hydride (170l, 0.61mmol) and 2,2'-
azobis(isobutyronitrile) (25mg, 0.15mmol) in degassed benzene (20ml), was added 
dropwise over 8h via syringe pump, to a stirred solution of the iodide 117d 
(200mg, 0.51mmol) and 2,2'-azobis(isobutyronitrile) (50mg, 0.30mmol) in 
degassed benzene (200ml), at 80oC under an argon atmosphere. The mixture was 
heated under reflux for a further 12h, then allowed to cool to room temperature and 
concentrated in vacuo. The residue was purified by flash column chromatography 
on silica (2–10% Et2O, 98-90% petrol) to give the bridged tricyclic ketone 148b 
(45mg, 30%) as an inseparable mixture of diastereoisomers in a 2:1 ratio, as a 
colourless oil; νmax(sol CHCl3)/cm-1, 1693 (s), 1612 (s); δH (400MHz, CDCl3), 
(major diastereoisomer) 1.39 (3H, s, CH3, H-18), 1.47–1.63 (3H, m), 1.69–1.85 
(3H, m), 2.01–2.19 (3H, m)(H-1,2,3,5,6), 2.67 (1H, app td, J 15.5 and 3.0Hz, 
ArCHaHb, H-7a), 2.89 (1H, app dt, J 15.5 and 3.5Hz, ArCHaHb, H-7b), 3.21 (1H, 
ddd, J 8.0 and 3.0Hz, and 2.5Hz, O=CCH, H-15), 3.32 (1H, dd, J 10.0 and 3.0Hz, 
ArCH, H-14), 3.80 (3H, s, OCH3, H-24), 6.69 (1H, d, J 2.5Hz, CH3OCCHC, H-9), 
6.77 (1H, dd, J 8.5 and 2.5Hz, CH3OCCHCH, H-11), 6.87 (1H, s, PhCH=, H-19), 
7.17 (1H, d, J 8.5Hz, CH3OCCHCH, H-12), 7.26–7.44 (5H, m, 5 x PhH, H-
21,22,23); (minor diastereoisomer) 1.27 (3H, s, CH3, H-18), 1.51–1.82 (6H, m), 
1.96–2.19 (3H,m)(H-1,2,3,5,6), 2.81 (1H, app d, J 8.5Hz, O=CCH, H-15), 3.00 
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(2H, app t, J 8.5Hz, ArCH2, H-7), 3.29 (1H, dd, J 8.5 and 1.5Hz, ArCH, H-14), 
3.79 (3H, s, OCH3, H-24), 6.68 (1H, d, J 3.0Hz, CH3OCCHC, H-9), 6.71 (1H, s, 
PhCH=, H-19), 6.78 (1H, dd, J 8.5 and 3.0Hz, CH3OCCHCH, H-11), 7.00 (1H, d, J 
8.5Hz, CH3OCCHCH, H-12), 7.26–7.38 (5H, m, 5 x PhH, H-21,22,23); δC 
(100MHz, CDCl3), (major diastereoisomer) 21.4 (t, C-2), 24.7 (t, C-6), 24.8 (t, C-
1), 27.6 (q, C-18), 31.2 (t, C-7), 36.1 (d, C-14), 36.9 (t, C-3), 43.4 (s, C-4), 45.7 (d, 
C-5), 52.6 (d, C-15), 55.2 (q, C-24), 112.4 (d, C-11), 113.3 (d, C-9), 127.8 (2C d, 
C-21), 127.9 (d, C-23), 128.5 (d, C-12), 128.7 (s, C-13), 129.0 (2C d, C-22), 135.3 
(d, C-19), 136.9 (s, C-20), 140.7 (s, C-8), 144.0 (s, C-17), 157.4 (s, C-10), 205.8 (s, 
C-16); (minor diastereoisomer) 21.8 (t, C-2), 23.7 (t, C-6), 24.2 (q, C-18), 25.9 (t, 
C-1), 29.1 (t, C-7), 40.7 (s, C-4), 42.9 (d, C-14), 46.0 (t, C-3), 46.7 (d, C-5), 47.3 
(d, C-15), 55.2 (q, C-24), 110.6 (d, C-11), 114.4 (d, C-9), 124.2 (d, C-23), 127.7 
(2C d, C-21), 127.8 (d, C-12), 129.0 (2C d, C-22), 131.6 (s, C-13), 135.0 (d, C-19), 
136.6 (s, C-20), 138.7 (s, C-8), 142.6 (s, C-17), 158.0 (s, C-10), 206.1(s, C-16); m/z 
(ES) 373.2155 (M  + H+, C26H29O2 requires 373.2162). 
 
 
 (±)-Phenolic bridged tricycle 147 
O
HH
H
1
18
4
86
13
15
17
19
23
OH
major
isomer
   147 
Boron tribromide (50l, 0.53mmol) was added dropwise, to a stirred solution of the 
tricycle 148b (50mg, 0.13mmol) in dichloromethane (10ml) at -78oC, under a 
nitrogen atmosphere. The solution was warmed to room temperature slowly over 
130 
13h, and then quenched with water (50ml). The separated aqueous phase was 
extracted with dichloromethane (3 x 50ml) and the combined organic extracts were 
dried and concentrated in vacuo. The residue was purified by flash column 
chromatography, (10% Et2O, 90% petrol) to give a 2:1 mixture of diastereoisomers 
of the phenol 147 (23mg, 48%) as a viscous liquid solid. Crystallisation from 
diethyl ether and pentane gave the major diastereoisomer as colourless crystals; mp 
= 195–196oC; νmax(sol CHCl3)/cm-1, 3597 (br m), 1693 (s), 1608 (s); δH (400MHz, 
CDCl3), (major diastereoisomer) 1.39 (3H, s, CH3, H-18), 1.46–1.62 (3H, m), 1.69–
1.85 (3H, m), 2.01–2.20 (3H, m)(H-1,2,3,5,6), 2.63 (1H, app td, J 15.5 and 3.5Hz, 
ArCHaHb, H-7a), 2.85 (1H, app dt, J 15.5 and 3.0Hz, ArCHaHb, H-7b), 3.19 (1H, 
app d, J 10.0Hz, O=CCH, H-15), 3.31 (1H, dd, J 10.0 and 3.0Hz, ArCH, H-14), 
4.71 (1H, br s, OH), 6.62 (1H, d, J 2.5Hz, HOCCHC, H-9), 6.66 (1H, dd, J 8.5 and 
2.5Hz, HOCCHCH, H-11), 6.89 (1H, s, PhCH=, H-19), 7.11 (1H, d, J 8.5Hz, 
HOCCHCH, H-12), 7.27–7.36 (3H, m, 3 x PhH, H-21,23), 7.42 (2H, app d, J 
7.5Hz, 2 x PhH, H-22); (minor diastereoisomer) 1.26 (3H, s, CH3, H-18), 1.47–1.81 
(6H, m), 1.95–2.13 (3H, m)(H-1,2,3,5,6), 2.79 (1H, app d, J 10.0Hz, O=CCH, H-
15), 2.93–2.99 (2H, m, ArCH2, H-7), 3.30 (1H, dd, J 10.0 and 2.0Hz, ArCH, H-14), 
5.25 (1H, br s, OH), 6.59 (1H, d, J 2.5Hz, HOCCHC, H-9), 6.65 (1H, dd, J 8.5 and
 
2.5Hz, HOCCHCH, H-11), 6.71 (1H, s, PhCH=, H-19), 6.92 (1H, d, J 8.5Hz, 
HOCCHCH, H-12), 7.25–7.39 (5H, m, 5 x PhH, H-21,22,23); δC (100MHz, 
CDCl3), (major diastereoisomer) 21.4 (t, C-2), 24.7 (t, C-6), 24.9 (t, C-1), 27.6 (q, 
C-18), 31.0 (t, C-7), 36.1 (d, C-14), 37.0 (t, C-3), 43.5 (s, C-4), 45.7 (d, C-5), 52.6 
(d, C-15), 113.7 (d, C-11), 114.8 (d, C-9), 127.8 (2C d, C-21), 127.9 (d, C-23), 
128.7 (d, C-12), 128.8 (s, C-13), 129.0 (2C d, C-22), 135.4 (d, C-19), 137.0 (s, C-
20), 141.0 (s, C-8), 144.0 (s, C-17), 153.3 (s, C-10), 205.9 (s, C-16); (minor 
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diastereoisomer) 21.8 (t, C-2), 23.8 (t, C-6), 24.3 (q, C-18), 25.9 (t, C-1), 28.9 (t, C-
7), 40.7 (s, C-4), 43.0 (d, C-14), 46.0 (t, C-3), 46.8 (d, C-5), 47.3 (d, C-15), 112.3 
(d, C-11), 115.7 (d, C-9), 127.7 (s, C-13), 127.8 (2C d, C-21), 128.0 (d, C-23), 
128.7 (d, C-12), 128.9 (2C d, C-22), 135.3 (d, C-19), 138.1 (s, C-20), 139.3 (s, C-
8), 144.5 (s, C-17), 154.1 (s, C-10), 206.7 (s, C-16); m/z (ES) 359.1999 (M  + H+, 
C25H27O2 requires 359.2006). 
 
(±)-Methylidene substituted methoxy bridged tricycle 155 
H O
HH
H
1
18
4
86
13
15
17
19
O
20
major
isomer
   155 
A solution of tri-n-butyltin hydride (107l, 0.40mmol) and 2,2'-
azobis(isobutyronitrile) (6mg, 0.04mmol) in degassed heptane (14ml), was 
added dropwise over 8h via syringe pump, to a stirred solution of the iodide 147 
(140mg, 0.33mmol) and 2,2'-azobis(isobutyronitrile) (35mg, 0.21mmol) in 
degassed heptane (140ml), at 90oC under an argon atmosphere. The mixture was 
heated under reflux for a further 12h, then allowed to cool to room temperature 
and concentrated in vacuo. The residue was purified by flash column 
chromatography on silica (2–10% Et2O, 98-90% petrol) to give the bridged 
tricyclic ketone 155 (18mg, 18%) as an inseparable mixture of diastereoisomers 
in a 2:1 ratio, as a colourless oil; νmax(sol CHCl3)/cm-1, 1695 (s), 1611 (s); δH 
(400MHz, CDCl3), (major diastereoisomer) 1.31 (3H, s, CH3, H-18), 1.50–1.83 
(6H, m), 1.98–2.14 (3H, m)(H-1,2,3,5,6), 2.62 (1H, app td, J 14.5 and 3.0Hz, 
ArCHaHb, H-7a), 2.86 (1H, app dt, J 14.5 and 3.5Hz, ArCHaHb, H-7b), 3.21 (1H, 
app dd, J 9.0 and 3.0Hz, and 2.5Hz, O=CCH, H-15), 3.32 (1H, dd, J 10.5 and 
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3.0Hz, ArCH, H-14), 3.79 (3H, s, OCH3, H-20), 5.43 (1H, d, J 1.0Hz, =CHaHb, 
H-19a), 6.23 (1H, d, J 1.0Hz, =CHaHb, H-19b), 6.69 (1H, d, J 2.5Hz, 
CH3OCCHC, H-9), 6.75 (1H, dd, J 8.5 and 2.5Hz, CH3OCCHCH, H-11), 7.16 
(1H, d, J 8.5Hz, CH3OCCHCH, H-12); (minor diastereoisomer) 1.20 (3H, s, 
CH3, H-18), 1.55–1.95 (6H, m), 1.98–2.18 (3H,m)(H-1,2,3,5,6), 2.52 (1H, app 
d, J 9.0Hz, O=CCH, H-15), 2.95 (2H, app t, J 8.5Hz, ArCH2, H-7), 3.26 (1H, 
dd, J 9.0 and 1.5Hz, ArCH, H-14), 3.78 (3H, s, OCH3, H-20), 5.33 (1H, d, J 
1.0Hz, =CHaHb, H-19a), 6.19 (1H, d, J 1.0Hz, =CHaHb, H-19b), 6.68 (1H, d, J 
3.0Hz, CH3OCCHC, H-9), 6.76 (1H, dd, J 8.0 and 3.0Hz, CH3OCCHCH, H-11), 
6.98 (1H, d, J 8.0Hz, CH3OCCHCH, H-12); δC (100MHz, CDCl3), (major 
diastereoisomer) 21.5 (t, C-2), 23.4 (t, C-6), 24.8 (t, C-1), 27.0 (q, C-18), 31.1 
(t, C-7), 36.2 (d, C-14), 37.0 (t, C-3), 43.4 (s, C-4), 44.3 (d, C-5), 51.2 (d, C-
15), 55.2 (q, C-20), 112.3 (d, C-11), 113.3 (d, C-9), 119.0 (t, C-19), 128.3 (d, C-
12), 128.6 (s, C-13), 140.9 (s, C-8), 148.5 (s, C-17), 157.4 (s, C-10), 205.2 (s, 
C-16); (minor diastereoisomer) 21.8 (t, C-2), 22.3 (t, C-6), 24.4 (q, C-18), 25.9 
(t, C-1), 29.1 (t, C-7), 40.1 (s, C-4), 41.7 (d, C-14), 44.7 (t, C-3), 46.1 (d, C-5), 
46.5 (d, C-15), 55.3 (q, C-20), 110.6 (d, C-11), 114.4 (d, C-9), 119.7 (t, C-19), 
127.8 (d, C-12), 131.6 (s, C-13), 138.7 (s, C-8), 146.2 (s, C-17), 158.0 (s, C-10), 
205.3 (s, C-16); m/z (ES) 319.1669 (M + Na+, C20H24O2Na requires 319.1674). 
 
[2E-(Tributylstannyl)cyclopropyl]methanol 182 
SnBu3
HO
1
4
3
2
   182 
Diethylzinc (1.1M in Tol, 32ml, 35mmol) was added dropwise over 10 min, to a 
stirred solution of (E)-3-(tributylstannyl)prop-2-en-1-ol 181 (6.09g, 18mmol)117 
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and diiodomethane (4.2ml, 52mmol) in  dichloromethane (250ml) at -50oC, 
under a nitrogen atmosphere. The solution was warmed slowly to -20oC over 2h 
and stirred at this temperature for a further 48h, before triethylamine (20ml) was 
added. After warming to room temperature, water (100ml) was added and the 
separated aqueous phase was then extracted with dichloromethane (3 x 100ml). 
The combined organic extracts were washed with brine (20ml), dried over 
sodium sulphate and concentrated in vacuo. The residue was purified by flash 
column chromatography (10% EtOAc, 90% petrol) on silica gel, to give the 
cyclopropane 182 (4.66g, 74%) as a colourless oil; νmax(sol CHCl3)/cm-1, 3611 
(br m), 3029 (m); δH (400MHz, CDCl3), 0.29–0.36 (1H, m, SnCH, H-4), 0.50-
0.55 (2H, m, CHCH2CH, H-3), 0.81 (6H, t, J 8.0Hz, SnCH2, H-5), 0.89 (9H, t, J 
7.5Hz, CH2CH3, H-8), 1.02–1.14 (1H, m, HOCH2CH, H-2), 1.24–1.36 (6H, m, 
CH3CH2, H-7), 1.41–1.56 (6H, m, SnCH2CH2, H-6), 3.39 (1H, dd, J 10 and 
7.5Hz, HOCHaHb, H-1a), 3.55 (1H, dd, J 10 and 6.5Hz, HOCHaHb, H-1b); δC 
(100MHz, CDCl3), -2.6 (d, C-4), 7.4 (t, C-3), 8.7 (t, C-5), 13.7 (q, C-8), 18.1 (d, 
C-2), 27.3 (t, C-7), 29.1 (t, C-6), 69.6 (t, C-1); m/z (ES) 385.1539 (M + Na+, 
C16H34O120SnNa requires 385.1529). This data agrees with that previously 
published for the chiral material.118 
 
2E-(Tributylstannyl)cyclopropanecarbaldehyde 183 
SnBu3
O
1
4
3
2
   183 
2-Iodoxybenzoic acid (5.0g, 17.9mmol) was added portionwise, to a stirred 
solution of the alcohol 182 (4.0g, 11.1mmol) in dimethylsulfoxide (80ml) at 
room temperature, under a nitrogen atmosphere. The solution was stirred at 
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room temperature for 20h, then water (40ml) was added and the resulting 
precipitate was filtered through celite with diethyl ether (50ml). The separated 
aqueous phase was extracted with diethyl ether (3 x 20ml) and the combined 
organic extracts were washed with brine (10ml), dried over sodium sulphate and 
concentrated in vacuo. The residue was purified by flash column 
chromatography (20% Et2O, 80% petrol) on silica gel, to give the aldehyde 183 
(3.8g, 96%) as a colourless oil; νmax(sol CHCl3)/cm-1, 3029 (s), 1696 (s); δH 
(400MHz, CDCl3), 0.58 (1H, ddd, J 11.0, 8.5 and 5.5Hz, SnCH, H-4), 0.88 (6H, 
t, J 8.5Hz, SnCH2, H-5), 0.89 (9H, t, J 7.0Hz, CH2CH3, H-8), 1.04 (1H, ddd, J 
8.5, 7.0 and 4.5Hz, CHCHaHbCH, H-3a), 1.24–1.37 (7H, m, CHCHaHbCH  + 
CH3CH2, H-3b,7), 1.43–1.54 (6H, m, SnCH2CH2, H-6), 1.68-1.76 (1H, m, 
O=CHCH, H-2), 8.52 (1H, d, J 6.5Hz, O=CH, H-1); δC (100MHz, CDCl3), 1.7 
(d, C-4), 9.0 (t, C-5), 11.2 (t, C-3), 13.7 (q, C-8), 26.9 (d, C-2), 27.3 (t, C-7), 
28.9 (t, C-6), 201.6 (d, C-1); m/z (ES) 383.1359 (M + Na+, C16H32O120SnNa 
requires 383.1373). 
 
Tributyl(2-vinyl-E-cyclopropyl)stannane 168 
SnBu3
1
5
3
4
   168 
Tetrahydrofuran (60ml) was added to freshly dried (100oC, 1mmHg, 5h) 
methyltriphenylphosphonium bromide (7.0g, 19.6mmol) at room temperature. 
Sodium hexamethyldisilazane (2.0M in THF, 6.0ml, 12.0mmol) was added 
dropwise over 10 min, to the stirred solution at -78oC, under a nitrogen 
atmosphere. The yellow solution was stirred at -78oC for 30 min and then a 
solution of the aldehyde 183 (3.4g, 9.5mmol) in tetrahydrofuran (30ml) was 
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added dropwise over 5 min. The mixture was stirred at -78oC for 2h and then 
allowed to warm to room temperature over 12h. Saturated aqueous ammonium 
chloride solution (10ml) was added, and the separated aqueous phase was then 
extracted with diethyl ether (3 x 20ml). The combined organic extracts were 
dried over sodium sulphate and concentrated in vacuo. The residue was purified 
by flash column chromatography (100% petrol) on silica gel, to give the alkene 
168 (3.3g, 97%) as a colourless oil; νmax(sol CHCl3)/cm-1, 3083 (w), 1631 (m); 
δH (400MHz, CDCl3), 0.11 (1H, ddd, J 10.5, 8.5 and 5.5Hz, SnCH, H-5), 0.70-
0.76 (2H, m, CHCH2CH, H-4), 0.81 (6H, t, J 8.0Hz, SnCH2, H-6), 0.89 (9H, t, J 
7.5Hz, CH2CH3, H-9), 1.25–1.36 (6H, m, CH3CH2, H-8), 1.36–1.44 (1H, m, 
H2C=CHCH, H-3), 1.44-1.56 (6H, m, SnCH2CH2, H-7), 4.80 (1H, dd, J 10.0 
and 1.5Hz, HaHbC=CH, H-1a), 5.05 (1H, dd, J 17.0 and 1.5Hz, HaHbC=CH, H-
1b), 5.29 (1H, ddd, J 17.0, 10.0 and 9.0Hz, H2C=CH, H-2); δC (100MHz, 
CDCl3), 2.6 (d, C-5), 8.7 (t, C-6), 11.5 (t, C-4), 13.7 (q, C-9), 19.4 (d, C-3), 27.3 
(t, C-8), 29.1 (t, C-7), 110.5 (t, C-1), 144.6 (d, C-2); m/z (EI) 301.0986 (M – 
Bu, C13H25120Sn requires 301.0978). 
 
[2Z-(Tributylstannyl)cyclopropyl)methanol 182Z 
HO
1
4
3
2
Bu3Sn
   182Z 
Diethylzinc (1.0M in hexanes, 5.8ml, 5.8mmol) was added dropwise over 10 
min, to a stirred solution of (Z)-3-(tributylstannyl)prop-2-en-1-ol 181Z (1.0g, 
2.9mmol)119 and diiodomethane (0.9ml, 11.1mmol) in  dichloromethane (100ml) 
at -50oC, under a nitrogen atmosphere. The solution was warmed slowly to -
20oC over 2h and stirred at this temperature for a further 48h, before 
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triethylamine (20ml) was added. After warming to room temperature, water 
(50ml) was added and the separated aqueous phase was then extracted with 
dichloromethane (3 x 20ml). The combined organic extracts were washed with 
brine (20ml), dried over sodium sulphate and concentrated in vacuo. The 
residue was purified by flash column chromatography (10% EtOAc, 90% petrol) 
on silica gel, to give the cyclopropane 182Z (0.8g, 78%) as a colourless oil; 
νmax(sol CHCl3)/cm-1, 3610 (br m), 3053 (w); δH (400MHz, CDCl3), -0.02 (1H, 
ddd, J 9.5, 9.0 and 7.5Hz, CHCHaHbCH, H-3a), 0.20 (1H, ddd, J 7.5, 4.0 and 
3.5Hz, CHCHaHbCH, H-3b), 0.81-0.86 (6H, m, SnCH2, H-5), 0.86-0.93 (10H, 
m, SnCH + CH2CH3, H-4,8), 1.26–1.41 (7H, m, CH3CH2 + HOCH2CH, H-2,7), 
1.44–1.54 (6H, m, SnCH2CH2, H-6), 3.25 (1H, ddd, J 11.0,8.0 and 3.5Hz, 
HOCHaHb, H-1a), 3.56 (1H, app dt, J 11.0 and 5.5Hz, HOCHaHb, H-1b); δC 
(100MHz, CDCl3), -1.3 (d, C-4), 7.2 (t, C-3), 9.8 (t, C-5), 13.7 (q, C-8), 17.5 (d, 
C-2), 27.4 (t, C-7), 29.1 (t, C-6), 68.6 (t, C-1); m/z (ES) 385.1511 (M + Na+, 
C16H34O120SnNa requires 385.1524).  
 
Tributyl(2-vinyl-Z-cyclopropyl)stannane 168Z 
1
4
3
5
Bu3Sn
   168Z 
2-Iodoxybenzoic acid (6.5g, 23.2mmol) was added portionwise, to a stirred 
solution of the alcohol 182Z (5.6g, 15.5mmol) in dimethylsulfoxide (100ml) at 
room temperature, under a nitrogen atmosphere. The solution was stirred at 
room temperature for 12h, then water (50ml) was added and the resulting 
precipitate was filtered through celite with diethyl ether (50ml). The separated 
aqueous phase was extracted with diethyl ether (3 x 20ml) and the combined 
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organic extracts were washed with brine (10ml) and then dried over sodium 
sulphate. The solution was filtered through a short plug of silica and 
concentration in vacuo to leave the aldehyde 183Z (4.4g, 79%) as a colourless 
oil. Due to its poor stability, the aldehyde was taken onto the next reaction 
immediately.  
   Tetrahydrofuran (100ml) was added to freshly dried (100oC, 1mmHg, 5h) 
methyltriphenylphosphonium bromide (9.9g, 27.7mmol) at room temperature. 
Sodium hexamethyldisilazane (2.0M in THF, 8.4ml, 16.8mmol) was added 
dropwise over 10 min, to the stirred solution at -78oC, under a nitrogen 
atmosphere. The yellow solution was stirred at -78oC for 30 min and then a 
solution of the aldehyde 183Z (4.4g, 12.3mmol) in tetrahydrofuran (40ml) was 
added dropwise over 10 min. The mixture was stirred at -78oC for 2h and then 
allowed to warm to room temperature over 12h. Saturated aqueous ammonium 
chloride solution (10ml) was added, and the separated aqueous phase was then 
extracted with petroleum ether (3 x 30ml). The combined organic extracts were 
dried over sodium sulphate and concentrated in vacuo. The residue was purified 
by flash column chromatography (100% petrol) on silica gel, to give the alkene 
168Z (3.0g, 74%) as a colourless oil; νmax(sol CHCl3)/cm-1, 3084 (w), 1633 (m); 
δH (400MHz, CDCl3), 0.22 (1H, ddd, J 13.5, 9.0 and 8.0Hz, SnCH, H-5), 0.44 
(1H, app dt, J 8.0 and 4.0Hz, CHCHaHbCH, H-4a), 0.81 (6H, t, J 8.0Hz, SnCH2, 
H-6), 0.89 (9H, t, J 7.5Hz, CH2CH3, H-9), 1.07 (1H, ddd, J 9.0, 4.5 and 4.0Hz 
CHCHaHbCH, H-4b), 1.25–1.37 (6H, m, CH3CH2, H-8), 1.45-1.55 (6H, m, 
SnCH2CH2, H-7), 1.71 (1H, app dtd, J 13.5, 9.0 and 4.0Hz, H2C=CHCH, H-3), 
4.86 (1H, dd, J 10.0 and 2.0Hz, HaHbC=CH, H-1a), 5.10 (1H, dd, J 17.0 and 
2.0Hz, HaHbC=CH, H-1b), 5.29 (1H, ddd, J 17.0, 10.0 and 9.0Hz, H2C=CH, H-
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2); δC (100MHz, CDCl3), 3.7 (d, C-5), 9.7 (t, C-6), 10.6 (t, C-4), 13.7 (q, C-9), 
18.6 (d, C-3), 27.3 (t, C-8), 29.1 (t, C-7), 112.2 (t, C-1), 143.9 (d, C-2); m/z (EI) 
301.0980 (M – Bu, C13H25120Sn requires 301.0978). 
 
3-(2-(Benzyloxy)ethyl)pentane-2,4-dione 192 
O O
O
1
4
810
   192 
Potassium carbonate (32g, 232mmol) was added in one portion, to a stirred 
solution of pentane-2,4-dione (20g, 200mmol) and 1-((2-iodoethoxy)methyl) 
benzene120 (5g, 19mmol) in freshly distilled acetone (150ml) at room 
temperature, under a nitrogen atmosphere. The mixture was heated under reflux 
for 48h and then cooled to room temperature and concentrated in vacuo. The 
residue was purified by flash column chromatography (10% EtOAc, 90% petrol) 
on silica gel, to give the ketone 192 (3.4g, 64% (98% BRSM)) as a colourless 
oil; νmax(sol CHCl3)/cm-1, 2863 (m), 1695 (s), δH (400MHz, CDCl3), (exists as a 
3:2 mixture of Keto-enol forms) (Keto) 2.16-2.20 (2H, m, OCH2CH2, H-7), 2.19 
(6H, s, O=CCH3, H-10), 3.48 (2H,t, J 5.5Hz, OCH2CH2, H-6), 3.85 (1H, t, J 
7.0Hz, O=CCH, H-8), 4.43 (2H, s, PhCH2, H-5), 7.26-7.36 (5H, m, 5 x PhH, H-
1,2,3); (Enol) 2.16 (6H, s, 2 x CH3, H-10), 2.56 (2H, t, J 7.0Hz, OCH2CH2, H-
7), 3.49 (2H, t, J 7.0Hz, OCH2CH2, H-6), 4.51 (2H, s, PhCH2, H-5), 7.26-7.36 
(5H, m, 5 x PhH, H-1,2,3); δC (100MHz, CDCl3) (Oxo) 28.5 (t, C-7), 29.4 (q, C-
10), 65.8 (d, C-8), 67.7 (t, C-6), 73.1 (t, C-5), 127.7 (2C d, C-3), 127.8 (d, C-1), 
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128.5 (2C d, C-2), 138.0 (s, C-4), 204.2 (s, C-9); (Enol) 23.1 (q, C-10), 28.1 (t, 
C-7), 69.9 (t, C-6), 73.1 (t, C-5), 106.8 (s, C-8), 127.5 (2C d, C-3), 127.7 (d, C-
1), 127.8 (2C d, C-2), 138.2 (s, C-4), 191.8 (s, C-9); m/z (ES) 257.1146 (M  + 
Na+, C14H18O3Na requires 257.1148). 
 
((E/Z)-3-(2-(Benzyloxy)ethyl)penta-2,4-dien-2,4-yloxy)-bis-trimethylsilane 191 
O
O OSi Si
1
4
11
810
9
12
1314
   191 
Freshly distilled trimethylsilyl chloride (1.64ml, 12.8mmol) was added 
dropwise, over 5min, to a stirred solution of anhydrous LiBr (1.49g, 17.1mmol) 
in tetrahydrofuran (5ml) at -20oC, under a nitrogen atmosphere. A solution of 
the 1,3-dione 192 (1g, 4.3mmol) in tetrahydrofuran (2ml), and distilled 
triethylamine (1.8ml, 12.9ml), were then added sucessively, via cannula over 5 
mins, to the stirred mixture at -20oC. The mixture was stirred for 1h at -20oC 
before being warmed to 40oC and stirred for a further 48h. The mixture was 
cooled to 0oC, then cold pentane (10ml) was added and the mixture was poured 
onto a cold solution of saturated sodium hydrogen carbonate (20ml). The 
separated aqueous phase was extracted with cold pentane (3 x 5ml) and the 
combined organic extracts were then dried over sodium sulphate and 
concentrated in vacuo to leave the bis-enol ether 191 (1.59g, 99%) as a slightly 
yellow oil; (the compound was unstable to acid and moisture) δH (400MHz, 
C6D6) (a 2:1 mixture of E:Z isomers) (E) 0.20, 0.26 (18H, 2 x s, 2 x Si(CH3)3, 
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H-13,14), 2.08 (3H, s, C=CCH3, H-10), 2.97 (2H, t, J 7.5Hz, OCH2CH2, H-7), 
3.80 (2H, t, J 7.5Hz, OCH2CH2, H-6), 4.34 (1H, s, C=CHaHb, H-12a), 4.54 (2H, 
s, PhCH2, H-5), 4.57 (1H, s, C=CHaHb, H-12b), 7.13-7.43 (5H, m, 5 x PhH, H-
1,2,3); (Z) 0.24, 0.29 (18H, 2 x s, 2 x Si(CH3)3, H-13,14), 1.85 (3H, s, C=CCH3, 
H-10), 2.70 (2H, t, J 7.5Hz, OCH2CH2, H-7), 3.68 (2H, t, J 7.5Hz, OCH2CH2, 
H-6), 4.49 (2H, s, PhCH2, H-5), 4.64 (1H, s, C=CHaHb, H-12a), 4.80 (1H, s, 
C=CHaHb, H-12b), 7.13-7.43 (5H, m, 5 x PhH, H-1,2,3); δC (100MHz, C6D6) (E) 
0.2, 0.8 (2 x q, C-13,14), 20.7 (q, C-10), 29.0 (t, C-7), 69.4 (t, C-6), 72.9 (t, C-
5), 95.1 (t, C-12), 116.8 (s, C-8), 127.4, 127.9, 128.4 (3 x d, C-1,2,3), 139.7 (s, 
C-4), 147.7 (s, C-9), 157.2 (s, C-11); (Z) 0.3, 0.8 (2 x q, C-13,14), 19.8 (q, C-
10), 30.5 (t, C-7), 70.1 (t, C-6), 73.0 (t, C-5), 95.0 (t, C-12), 114.7 (s, C-8), 
127.3, 128.1, 128.5 (3 x d, C-1,2,3), 139.6 (s, C-4), 146.8 (s, C-9), 154.8 (s, C-
11).  
(±)-2-(2-(tert-Butyldiphenylsilanyloxy)-3-methylbut-3-enyl)phenol 208 
TBSO
HO 4
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A solution of potassium permanganate (0.4g, 2.5mmol) in water (1.5ml) was 
added dropwise over 10min to a stirred solution of (2-allylphenoxy)(tert-
butyl)dimethylsilane (0.25g, 1.1mmol)121 in isopropyl alcohol (3.5ml), (until 
TLC showed no remaining olefin). A solution of periodic acid (0.45g, 2.0mmol) 
in water (0.5ml) was added quickly, in one portion, and the mixture was then 
stirred until TLC showed no remaining diol (approximately 15mins). The 
mixture was poured onto water (10ml) and extracted with ethyl acetate (3 x 
20ml). The combined organic extracts were washed with saturated sodium 
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hydrogen carbonate solution (50ml), dried over sodium sulphate and 
concentrated in vacuo to leave the crude aldehyde 204 an unstable oil which 
was used immediately in the next step without further purification; δH 
(400MHz, CDCl3), 0.25 (6H, s, OSi(CH3)2, H-3), 0.99 (9H, s, OSiC(CH3)3, H-
1), 3.63 (2H, d, J 2.0Hz, ArCH2, H-10), 6.90 (1H, dd, J 8.0 and 1.0Hz, ArH, H-
5), 6.95 (1H, ddd, J 7.5, 7.5 and 1.0Hz, ArH, H-7), 7.15 (1H, dd, J 7.5 and 
1.5Hz, ArH, H-8), 7.19 (1H, ddd, J 8.0, 7.5 and 1.5Hz, ArH, H-6), 9.69 (1H, t, J 
2.0Hz, O=CH, H-11). 
Boron trifluoride etherate (4.4ml, 35mmol) was added dropwise over 2 min, to a 
stirred solution of the crude aldehyde 204 (8g, 34mmol) in tetrahydrofuran 
(200ml) at -78oC, under a nitrogen atmosphere. The mixture was stirred at -
78oC for 10mins and then a solution of isopropylmagnesium bromide (0.5M in 
THF, 82ml, 41mmol) was added dropwise over 20 min, at -78oC. The mixture 
was allowed to warm to room temperature over 2h, and then saturated 
ammonium chloride solution (20ml) and ethyl acetate (20ml) were added. The 
separated aqueous phase was extracted with ethyl acetate (3 x 20ml) and the 
combined organic extracts were then washed with brine (20ml), dried over 
sodium sulphate and concentrated in vacuo. The residue was purified by flash 
column chromatography (4% EtOAc, 96% petrol) on silica gel, to give the 
alcohol 208 (4.45g, 45%) as a colourless oil; νmax(sol CHCl3)/cm-1, 3487 (br m), 
2930 (s), 1453 (m); δH (400MHz, CDCl3), 0.27 (6H, s, OSi(CH3)2, H-3), 1.03 
(9H, s, OSiC(CH3)3, H-1), 1.82 (3H, s, C=CCH3, H-13), 2.13 (1H, d, J 3.0Hz, 
OH), 2.78 (1H, dd, J 13.5 and 9.5Hz, ArCHaHb, H-10a), 2.93 (1H, dd, J 13.5 
and 4.0Hz, ArCHaHb, H-10b), 4.31 (1H, ddd, J 9.5, 4.0 and 3.0Hz, HOCH, H-
11), 4.85 (1H, app t, J 1.5Hz, C=CHaHb, H-14a), 4.94 (1H, app t, J 1.0Hz, 
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C=CHaHb, H-14b), 6.83 (1H, dd, J 8.0 and 1.0Hz, ArH, H-5), 6.92 (1H, ddd, J 
7.5, 7.5 and 1.0Hz, ArH, H-7), 7.12 (1H, ddd, J 8.0, 7.5 and 1.5Hz, ArH, H-6), 
7.18 (1H, dd, J 7.5 and 1.5Hz, ArH, H-8); δC (100MHz, CDCl3), -4.1 (2C q, C-
3), 18.0 (q, C-13), 18.3 (s, C-2), 25.8 (3C q, C-1), 37.4 (t, C-10), 75.7 (d, C-11), 
111.0 (t, C-14), 118.6 (d, C-5), 121.3 (d, C-7), 127.6 (d, C-6), 128.9 (s, C-9), 
131.6 (d, C-8), 147.2 (s, C-12), 153.8 (s, C-4); m/z (ES) 315.1746 (M  + Na+, 
C17H18O228SiNa requires 315.1756). 
 
(E)-Ethyl-6-(2-(tert-butyldiphenylsilanyloxy)phenyl)-4-methylhex-4-enoate 
244 
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Propionic acid (0.04ml, 0.5mmol) was added dropwise over 2mins, to a stired 
solution of the alcohol 208 (0.78g, 0.3mmol) in triethyl orthoacetate (10ml, 
54.6mmol) at room temperature under a nitrogen atmosphere. The solution was 
heated to 100oC for 5h, then cooled to room temperature and stirred overnight. 
The solution was concentrated in vacuo and then diethyl ether (20ml) and water 
(5ml) were added. The separated aqueous phase was extracted with diethyl ether 
(5 x 10ml) and the combined organic extracts were then washed with saturated 
sodium hydrogen carbonate solution (10ml), dried and concentrated in vacuo. 
The residue was purified by flash column chromatography (5% Et2O, 95% 
petrol) on silica gel, to give the ester 244 (0.89g, 92%) as a colourless oil; 
νmax(sol CHCl3)/cm-1, 2930 (s), 1726 (s), 1452 (m); δH (400MHz, CDCl3), 0.23 
(6H, s, OSi(CH3)2, H-3), 1.01 (9H, s, OSiC(CH3)3, H-1), 1.23 (3H, t, J 7.0Hz, 
OCH2CH3, H-18), 1.70 (3H, app s, C=CCH3, H-13), 2.33-2.46 (4H, m, 
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O=CCH2CH2, H-14,15), 3.31 (2H, d, J 7.0Hz, ArCH2, H-10), 4.10 (2H, q, J 
7.0Hz, OCH2CH3, H-17), 5.36 (1H, tq, J 7.0 and 1.0Hz, C=CH, H-11), 6.78 
(1H, dd, J 8.0 and 1.0Hz, ArH, H-5), 6.87 (1H, ddd, J 7.5, 7.5 and 1.0Hz, ArH, 
H-7), 7.03-7.10 (2H, m, 2 x ArH, H-6,8); δC (100MHz, CDCl3), -4.1 (2C q, C-
3), 14.2 (q, C-18), 16.1 (q, C-13), 18.3 (s, C-2), 25.8 (3C q, C-1), 28.3 (t, C-10), 
33.2 (t, C-15), 34.7 (t, C-14), 60.3 (t, C-17), 118.4 (d, C-5), 121.0 (d, C-7), 
123.4 (d, C-11), 126.6 (d, C-6), 129.5 (d, C-8), 131.8 (s, C-9), 134.4 (s, C-12), 
153.3 (s, C-4), 173.4 (s, C-16); m/z (ES) 385.2150 (M  + Na+, C21H34O328SiNa 
requires 385.2175). 
 
(E)-Ethyl 6-(2-hydroxyphenyl)-4-methylhex-4-enoate 245 
O
O HO 1
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A solution of tetrabutylammonium fluoride (0.21g, 0.7mmol) in tetrahydrofuran 
(0.75ml) was added dropwise over 5mins, to a stirred solution of the TBS ether 
244 (0.20g, 0.6mmol) in tetrahydrofuran (2ml) at room temperature, under a 
nitrogen atmosphere. The mixture was stirred until TLC showed no remaining 
ether (approximately 30mins), and then diethyl ether (5ml) and water (5ml) 
were added. The separated aqueous phase was extracted with diethyl ether (3 x 
10ml) and the combined organic extracts were then washed with brine (10ml), 
dried over sodium sulphate and concentrated in vacuo. The residue was purified 
by flash column chromatography (10% EtOAc, 90% petrol) on silica gel, to give 
the phenol 245 (0.14g, 99%) as an unstable colourless oil was taken through to 
the next step immediately; δH (400MHz, CDCl3), 1.22 (3H, t, J 7.0Hz, 
OCH2CH3, H-15), 1.78 (3H, app s, C=CCH3, H-10), 2.34-2.48 (4H, m, 
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O=CCH2CH2, H-11,12), 3.36 (2H, d, J 7.0Hz, ArCH2, H-7), 4.10 (2H, q, J 
7.0Hz, OCH2CH3, H-14), 4.99 (1H, s, OH), 5.36 (1H, tq, J 7.0 and 1.5Hz, 
C=CH, H-8), 6.79 (1H, dd, J 7.5 and 1.0Hz, ArH, H-5), 6.86 (1H, ddd, J 7.5, 
7.0 and 1.0Hz, ArH, H-4), 7.06-7.13 (2H, m, 2 x ArH, H-2,3). 
 
2-((E)-5-(Ethoxycarbonyl)-3-methylpent-2-enyl)phenyl 
trifluoromethanesulfonate 246 
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Trifluoromethanesulfonic anhydride (0.12ml, 4.7mmol) was added dropwise 
over 5mins, to a stirred solution of the phenol 245 (0.13g, 0.5mmol) in 
dichloromethane (1ml) and pyridine (1ml) at 0oC, under a nitrogen atmosphere. 
The solution was warmed to room temperature overnight and then ethyl acetate 
(5ml) and water (5ml) were added. The separated aqueous phase was extracted 
with ethyl acetate (3 x 10ml) and the combined organic extracts were then 
washed with hydrochloric acid (2M, 5ml), brine (10ml) and saturated copper 
sulphate solution (10ml), dried and concentrated in vacuo. The residue was 
purified by flash column chromatography (5% EtOAc, 95% petrol) on silica gel, 
to give the triflate 246 (0.18g, 92%) as a colourless oil; νmax(sol CHCl3)/cm-1, 
2985 (s), 1727 (s); δH (400MHz, CDCl3), 1.22 (3H, t, J 7.0Hz, OCH2CH3, H-
16), 1.71 (3H, s, C=CCH3, H-11), 2.34-2.47 (4H, m, O=CCH2CH2, H-12,13), 
3.43 (2H, d, J 7.0Hz, ArCH2, H-8), 4.09 (2H, q, J 7.0Hz, OCH2CH3, H-15), 
5.29 (1H, t, J 7.0Hz, C=CH, H-9), 7.21-7.32 (4H, m, 4 x ArH, H-3,4,5,6); δC 
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(100MHz, CDCl3), 14.2 (q, C-16), 16.1 (q, C-11), 28.1 (t, C-8), 33.0 (t, C-13), 
34.5 (t, C-12), 60.3 (t, C-15), 120.2 (q, C-1), 121.0, 121.2 (2 x d, C-3,5), 127.7 
(d, C-9), 128.4 (d, C-4), 130.9 (d, C-6), 134.0 (s, C-7), 136.6 (s, C-10), 147.9 (s, 
C-2), 173.2 (s, C-14); m/z (ES) 403.0803 (M  + Na+, C16H19O532S19F3Na 
requires 403.0803). 
 
(E)-6-(2-Iodophenyl)-4-methylhex-4-enoic acid 247 
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A solution of lithium hydroxide (47mg, 1.1mmol) in water (3ml) was added, in 
one portion, to a stirred solution of the ester 210 (100mg, 0.3mmol) in ethanol 
(2ml) and tetrahydrofuran (8ml) at room temperature. The mixture was stirred at 
room temperature for 12h and then concentrated in vacuo. Diethyl ether (5ml) 
and saturated sodium hydrogen carbonate (5ml) were added and the separated 
organic phase was then extracted with water (3 x 5ml). Hydrochloric acid (2M) 
was added to the combined aqueous extracts until pH 1 (approximately 25ml). 
The acidified aqueous phase was extracted with ethyl acetate (3 x 20ml) and the 
combined organic extracts were then dried over sodium sulphate and 
concentrated in vacuo to leave the acid 247 (80mg, 90%) as a colourless oil, 
which was used in the next step without further purification; νmax(sol 
CHCl3)/cm-1, 2924 (br m), 1710 (s); δH (400MHz, CDCl3), 1.74 (3H, app s, 
C=CCH3, H-10), 2.39 (2H, m, O=CCH2CH2, H-11), 2.51 (2H, m, O=CCH2CH2, 
H-12), 3.42 (2H, d, J 7.0Hz, ArCH2, H-7), 5.33 (1H, tq, J 7.0 and 1.5Hz, C=CH, 
H-8), 6.88 (1H, ddd, J 8.0, 7.0 and 2.0Hz, ArH, H-3), 7.16 (1H, dd, J 7.5 and 
2.0Hz, ArH, H-5), 7.26 (1H, ddd, J 7.5, 7.0 and 1.5Hz, ArH, H-4), 7.81 (1H, dd, 
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J 8.0 and 1.5Hz, ArH, H-2); ); δC (100MHz, CDCl3), 16.5 (q, C-10), 32.6 (t, C-
12), 34.3 (t, C-11), 39.5 (t, C-7), 100.8 (s, C-1), 122.7 (d, C-8), 127.7 (d, C-3), 
128.3 (d, C-4), 129.2 (d, C-5), 135.2 (s, C-9), 139.4 (d, C-2), 143.7 (s, C-6), 
178.7 (s, C-13); m/z (ES) 352.9984 (M  + Na+, C13H15O2127INa requires 
353.0014). 
 
(E)-6-(2-Iodophenyl)-4-methylhex-4-enoyl benzeneselenenate 248 
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Tributylphosphine (125µl, 0.5mmol) was added dropwise over 5mins, to a 
stirred solution of the acid 247 (80mg, 0.3mmol) in dichloromethane (15ml) at -
40oC, under an argon atmosphere. After stirring for 5mins, N-
phenylselenylphthalimide (150mg, 0.5mmol) was added in one portion at -40oC. 
The mixture was stirred at -40oC for 1h then poured onto water (5ml) and 
diluted with dichloromethane (5ml). The separated aqueous phase was extracted 
with dichloromethane (3 x 10ml) and the combined organic extracts were then 
washed with saturated sodium hydrogen carbonate (10ml),dried over sodium 
sulphate and concentrated in vacuo. The residue was purified by flash column 
chromatography (100% petrol) on silica gel, to give the selenyl ester 248 
(53mg, 46%) as a yellow oil; νmax(sol CHCl3)/cm-1, 2925 (m), 1719 (s); δH 
(400MHz, CDCl3), 1.77 (3H, app s, C=CCH3, H-10), 2.47 (2H, t, J 7.0Hz, 
O=CCH2CH2, H-11), 2.88 (2H, t, J 7.0Hz, O=CCH2CH2, H-12), 3.45 (2H, d, J 
7.5Hz, ArCH2, H-7), 5.36 (1H, tq, J 7.5 and 1.0Hz, C=CH, H-8), 6.92 (1H, ddd, 
J 8.0, 7.0 and 1.5Hz, ArH, H-3), 7.19 (1H, dd, J 7.5 and 1.5Hz, ArH, H-5), 7.28 
(1H, ddd, J 7.5, 7.0 and 1.5Hz, ArH, H-4), 7.39 (3H, m, 3 x PhH, H-16,17), 
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7.51 (2H, dd, J 7.5 and 1.0Hz, 2 x PhH, H-15), 7.85 (1H, dd, J 8.0 and 1.5Hz, 
ArH, H-2); δC (100MHz, CDCl3), 16.5 (q, C-10), 34.9 (t, C-11), 39.5 (t, C-7), 
46.0 (t, C-12), 100.8 (s, C-1), 123.2 (d, C-8), 126.4 (s, C-14), 127.8 (d, C-3), 
128.3 (d, C-4), 128.8 (d, C-5), 129.2 (2C d, C-16), 129.3 (d, C-17), 134.7 (s, C-
9), 135.8 (2C d, C-15), 139.4 (d, C-2), 143.7 (s, C-6), 199.7 (s, C-13); m/z (ES) 
492.9539 (M  + Na+, C19H19O127I80SeNa requires 492.9544). 
 
1-Iodo-2-(3-methylbut-2-enyl)benzene 216 
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Tetrahydrofuran (2ml) was added to a flask containing dried (high vacuum at 
80oC for 1h) isopropyltriphenylphosphonium iodide (0.35g, 0.8mmol) at room 
temperature, under an argon atmosphere. n-Butyllithium (2.5M, 0.28ml, 
0.7mmol) was added dropwise over 5mins, to the stirred solution at 0oC, and the 
mixture was then stirred at 0oC for 30mins. A solution of 2-(2-
iodophenyl)acetaldehyde122 212 (0.10g, 0.4mmol) in tetrahydrofuran (2ml) was 
added dropwise over 5mins, at 0oC and the mixture was stirred at 0oC for a 3h 
and then diethyl ether (5ml) and water (5ml) were added. The separated aqueous 
phase was extracted with diethyl ether (5 x 5ml) and the combined organic 
extracts were then washed with brine (10ml), dried and concentrated in vacuo. 
The residue was purified by flash column chromatography (100% petrol) on 
silica gel, to give the olefin 216 (0.10g, 82%) as a colourless oil; νmax(sol 
CHCl3)/cm-1, 2916 (s), 1562 (m); δH (400MHz, CDCl3), 1.76 (3H, s, 
C=C(CH3E)CH3Z, H-11), 1.77 (3H, d, J 1.0Hz, C=C(CH3E)CH3Z, H-10), 3.42 
(2H, d, J 7.0Hz, ArCH2, H-7), 5.27 (1H, tq, J 7.0 and 1.0Hz, (CH3)2C=CH, H-
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8), 6.88 (1H, ddd, J 8.0, 7.5 and 2.0Hz, ArH, H-3), 7.20 (1H, dd, J 7.5 and 
2.0Hz, ArH, H-5), 7.27 (1H, ddd, J 8.0, 7.5 and 1.0Hz, ArH, H-4), 7.82 (1H, dd, 
J 7.5 and 1.0Hz, ArH, H-2); δC (100MHz, CDCl3), 18.2 (q, C-10), 25.8 (q, C-
11), 39.7 (t, C-7), 100.8 (s, C-1), 121.7 (d, C-8), 127.6 (d, C-3), 128.3 (d, C-4), 
129.3 (d, C-5), 133.6 (s, C-9), 139.4 (d, C-2), 144.3 (s, C-6); m/z (EI) 272.0069 
(C11H13127I requires 272.0062). 
 
3-(2-Iodobenzyl)-2,2-dimethyloxirane 217 
I
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A solution of 3-chloroperbenzoic acid (75% in H2O, 100mg, 0.4mmol) in 
dichloromethane (2ml) was added dropwise over 5mins, to a stirred solution of 
the olefin 216 (100mg, 0.4mmol) in dichloromethane (2ml) at 0oC, under a 
nitrogen atmosphere. The mixture was stirred at room temperature for 24h and 
then saturated sodium hydrogen carbonate (5ml) was added. The separated 
aqueous phase was extracted with dichloromethane (3 x 5ml) and the combined 
organic extracts were then washed with brine (10ml), dried over sodium 
sulphate and concentrated in vacuo. The residue was purified by flash column 
chromatography (100% petrol) on silica gel, to give the epoxide 217 (89mg, 
84%) as a colourless oil; νmax(sol CHCl3)/cm-1, 2965 (s); δH (400MHz, CDCl3), 
1.36 (3H, s, C=C(CH3E)CH3Z, H-11), 1.42 (3H, s, C=C(CH3E)CH3Z, H-10), 
2.92-3.05 (3H, m, ArCH2CH, H-7,8), 6.94 (1H, ddd, J 8.0, 7.0 and 2.0Hz, ArH, 
H-3), 7.28-7.34 (2H, m, 2 x ArH, H-4,5), 7.85 (1H, dd, J 8.0 and 1.0Hz, ArH, 
H-2); δC (100MHz, CDCl3), 19.1 (q, C-10), 24.8 (q, C-11), 40.0 (t, C-7), 58.7 
(s, C-9), 63.4 (d, C-8), 100.8 (s, C-1), 128.3, 128.5 (2 x d, C-3,4), 129.6 (d, C-
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5), 139.5 (d, C-2), 141.4 (s, C-6); m/z (ES) 310.9891 (M  + Na+, C11H13O127INa 
requires 310.9909). 
 
(±)-1-(2-Iodophenyl)-3-methylbut-3-en-2-ol 211 
I
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Aluminium triisopropoxide (75mg, 0.4mmol) was added in one portion, to a 
stirred solution of epoxide 217 (100mg, 0.3mmol) in toluene (2ml) at room 
temperature, under a nitrogen atmosphere. The mixture was heated to reflux for 
12h, then cooled to room temperature and diethyl ether (5ml) was added. The 
mixture was poured onto hydrochloric acid (2M, 5ml) and the separated 
aqueous phase was then extracted with diethyl ether (3 x 5ml). The combined 
organic extracts were washed with saturated sodium hydrogen carbonate (10ml), 
then dried over sodium sulphate and concentrated in vacuo. The residue was 
purified by flash column chromatography (5% EtOAc, 95% petrol) on silica gel, 
to give the alcohol 211 (83mg, 83%) as a colourless oil; νmax(sol CHCl3)/cm-1, 
3604 (s), 3468 (br w), 2958 (s), 1651 (m); δH (400MHz, CDCl3), 1.57 (1H, d, J 
9.0Hz, OH), 1.86 (3H, s, C=CCH3, H-10), 2.84 (1H, dd, J 14.0 and 9.0Hz, 
ArCHaHb, H-7a), 3.06 (1H, dd, J 14.0 and 4.0Hz, ArCHaHb, H-7b), 4.36 (1H, 
app br d, J 9.0Hz, HOCH, H-8), 4.88 (1H, app t, J 1.5Hz, C=CHEHZ, H-11E), 
5.03 (1H, app t, J 1.5Hz, C=CHEHZ, H-11Z), 6.92 (1H, ddd, J 8.0, 7.0 and 
2.0Hz, ArH, H-3), 7.22-7.32 (2H, m, 2 x ArH, H-4,5), 7.84 (1H, dd, J 8.0 and 
1.0Hz, ArH, H-2); δC (100MHz, CDCl3), 18.3 (q, C-10), 46.7 (t, C-7), 74.8 (d, 
C-8), 101.0 (s, C-1), 111.2 (t, C-11), 128.2, 128.4 (2 x d, C-3,4), 131.1 (d, C-5), 
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139.7 (d, C-2), 141.2 (s, C-6), 146.9 (s, C-9); m/z (ES) 310.9892 (M  + Na+, 
C11H13O127INa requires 310.9909). 
 
(E)-Ethyl 6-(2-iodophenyl)-4-methylhex-4-enoate 210 
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Propionic acid (0.1ml, 1.3mmol) was added dropwise over 2mins, to a stirred 
solution of the alcohol 211 (2.6g, 9.0mmol) in triethyl orthoacetate (35ml, 
185.0mmol) at room temperature under a nitrogen atmosphere. The solution was 
heated to 100oC under Dean-Stark conditions for 4 days, then cooled to room 
temperature and concentrated in vacuo. Diethyl ether (20ml) and water (20ml) 
were added, and the separated aqueous phase was then extracted with diethyl 
ether (3 x 20ml). The combined organic extracts were washed with saturated 
sodium hydrogen carbonate solution (20ml), then dried and concentrated in 
vacuo. The residue was purified by flash column chromatography (2% EtOAc, 
98% petrol) on silica gel, to give the ester 210 (2.9g, 91%) as a colourless oil; 
νmax(sol CHCl3)/cm-1, 2984 (m), 1727 (s), 1562 (m); δH (400MHz, CDCl3), 1.23 
(3H, t, J 7.0Hz, OCH2CH3, H-15), 1.74 (3H, app s, C=CCH3, H-10), 2.34-2.41 
(2H, m, O=CCH2CH2, H-11), 2.42-2.48 (2H, m, O=CCH2CH2, H-12), 3.41 (2H, 
d, J 7.0Hz, ArCH2, H-7), 4.10 (2H, q, J 7.0Hz, OCH2CH3, H-14), 5.30 (1H, tq, 
J 7.0 and 1.0Hz, C=CH, H-8), 6.88 (1H, ddd, J 8.0, 7.5 and 2.0Hz, ArH, H-3), 
7.16 (1H, dd, J 7.5 and 2.0Hz, ArH, H-5), 7.26 (1H, ddd, J 8.0, 7.5 and 1.5Hz, 
ArH, H-4), 7.81 (1H, dd, J 7.5 and 1.5Hz, ArH, H-2); δC (100MHz, CDCl3), 
14.2 (q, C-15), 16.4 (q, C-10), 33.1 (t, C-12), 34.6 (t, C-11), 39.5 (t, C-7), 60.3 
(t, C-14), 100.7 (s, C-1), 122.4 (d, C-8), 127.7 (d, C-3), 128.3 (d, C-4), 129.1 (d, 
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C-5), 135.5 (s, C-9), 138.3 (d, C-2), 143.8 (s, C-6), 173.3 (s, C-13); m/z (ES) 
359.0499 (M  + H+, C15H20O2127I requires 359.0508). 
 
(4E)-Methyl-6-(2-((E)-3-hydroxy((tert-butyl)dimethylsilane)prop-1-
enyl)phenyl)-4-methylhex-4-enoate 200 and (±)-methyl-4-(2-((E)-3-
hydroxy((tert-butyl)dimethylsilane)prop-1-enyl)phenyl)-4-methylhex-5-enoate 
201 
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n-Butyllithium (2.5M, 14.5ml, 36.3mmol) was added dropwise over 30mins, to 
a stirred solution of (2-bromocinnamyloxy)(tert-butyl)dimethylsilane 199 
(11.2g, 34.3mmol) and copper iodide (6.8g, 34.2mmol) in tetrahydrofuran 
(100ml) at -78oC, under an argon atmosphere. The mixture was stirred at -78oC 
for 2h, then warmed to -35oC, and stirred at -35oC for 45mins. The mixture was 
cooled to -45oC and then a solution of (E)-methyl 6-bromo-4-methylhex-4-
enoate 198 (6.2g, 28.1mmol) in tetrahydrofuran (20ml) was added, via canula, 
over 30mins. The mixture was allowed to warm slowly to room temperature 
over 15h, and then diethyl ether (100ml) and saturated ammonium chloride 
(50ml) were added. The separated aqueous phase was extracted with diethyl 
ether (3 x 20ml) and the combined organic extracts were then washed with brine 
(50ml), dried over sodium sulphate and concentrated in vacuo. The residue was 
purified by flash column chromatography (5% EtOAc, 95% petrol) on silica gel, 
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to give the esters 200/201 (10.0g, 95%) as an inseparable 8:5 mixture of olefin 
isomers, as a colourless oil; νmax(sol CHCl3)/cm-1, 3010 (s), 2956 (s), 3502 (br 
w), 1731 (s), 1599 (w); m/z (ES) 411.2331 (M  + Na+, C23H36O3SiNa requires 
411.2326); NMR data for trisubstituted olefin 200: δH (400MHz, CDCl3), 0.12 
(6H, s, OSi(CH3)2, H-3), 0.94 (9H, s, SiC(CH3)3, H-1), 1.73 (3H, app s, 
C=CCH3, H-16), 2.34 (2H, t, J 7.0Hz, O=CCH2CH2, H-17), 2.44 (2H, t, J 
7.0Hz, O=CCH2CH2, H-18), 3.38 (2H, d, J 7.0Hz, ArCH2, H-13), 3.63 (3H, s, 
OCH3, H-20), 4.36 (2H, dd, J 3.5 and 1.5Hz, OCH2, H-4), 5.29 (1H, tq, J 7.0 
and 1.0Hz, H3CC=CH, H-14), 6.15 (1H, dt, J 15.5 and 3.5Hz, ArCH=CH, H-5), 
6.82 (1H, dt, J 15.5 and 1.5Hz, ArCH, H-6), 7.14-7.32 (3H, m, 3 x ArH, H-
9,10,11), 7.38 (1H, dd, J 7.0 and 1.5 Hz, ArH, H-8); δC (100MHz, CDCl3), -5.1 
(2C q, C-3), 16.2 (q, C-16), 18.4 (s, C-2), 25.9 (3C q, C-1), 31.8 (t, C-18), 34.6 
(t, C-17), 34.6 (t, C-13), 51.5 (q, C-20), 64.0 (t, C-4), 123.6 (d, C-14), 126.5 (d, 
C-5), 127.2 (d, C-9), 127.4 (d, C-8), 127.8 (d, C-10), 129.4 (d, C-11), 130.8 (d, 
C-6), 134.3, 136.0 (2 x s, C-7,12), 138.5 (s, C-15), 173.8 (s, C-19); NMR data 
for monosubstituted olefin 201: δH (400MHz, CDCl3), 0.10 (6H, s, OSi(CH3)2, 
H-3), 0.94 (9H, s, SiC(CH3)3, H-1), 1.43 (3H, s, C=CCH3, H-13), 2.34 (2H, t, J 
7.0Hz, O=CCH2CH2, H-17), 2.43 (2H, t, J 7.0Hz, O=CCH2CH2, H-18), 3.60 
(3H, s, OCH3, H-20), 4.31 (2H, dd, J 4.5 and 1.5Hz, OCH2, H-4), 4.97 (1H, dd, 
J 17.0 and 1.0Hz, HC=CHEHZ, H-16E), 5.09 (1H, dd, J 10.5 and 1.0Hz, 
HC=CHEHZ, H-16Z), 5.94 (1H, dt, J 15.5 and 4.5Hz, ArCH=CH, H-5), 6.07 
(1H, dd, J 17.0 and 10.5Hz, H2C=CH, H-15), 6.84 (1H, dt, J 15.5 and 1.5Hz, 
ArCH, H-6), 7.09-7.25 (3H, m, 3 x ArH, H-9,10,11), 7.44 (1H, dd, J 6.0 and 
2.0Hz, ArH, H-8); δC (100MHz, CDCl3), -5.2 (2C q, C-3), 18.4 (s, C-2), 25.9 
(3C q, C-1), 26.8 (q, C-14), 29.7 (t, C-18), 32.9 (t, C-17), 44.5 (s, C-13), 51.5 
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(q, C-20), 63.8 (t, C-4), 112.4 (t, C-16), 126.6 (d, C-5), 126.8 (d, C-9), 127.5 (d, 
C-8), 127.9 (d, C-10), 129.4 (d, C-11), 131.2 (d, C-6), 138.1 (s, C-7), 142.0 (s, 
C-12), 146.7 (d, C-15), 174.3 (s, C-19). 
 
(4E)-Ethyl-6-(2-((E)-3-hydroxyprop-1-enyl)phenyl)-4-methylhex-4-enoate 226 
O
O
9
14
12
13
1
18
HO
4
   226 
A solution of the aryl iodide 210 (2.50g, 7.0mmol) (or the aryl triflate 246) and 
(E)-3-(tributylstannyl)prop-2-en-1-ol 225117 (2.60g, 7.5mmol) in N-
dimethylformamide (20ml) was added dropwise over 1min, to flame-dried 
lithium chloride (0.58g, 13.5mmol) and lithium iodide (1.80g, 13.0mmol) in a 
Schlenk flask at room temperature, under an argon atmosphere. The mixture 
was degassed and bis-triphenylphosphinepalladium dichloride (0.24g, 0.3mmol) 
was added in one portion, and the mixture was then degassed again. The 
mixture was heated to 80oC for 16h, and then cooled to room temperature and 
poured onto water (50ml) and ethyl acetate (50ml). The separated aqueous 
phase was extracted with ethyl acetate (3 x 100ml) and the combined organic 
extracts were then washed with water (3 x 20ml), hydrochloric acid (2M, 10ml) 
and brine (50ml), dried over sodium sulphate and concentrated in vacuo to leave 
a residue which consisted of a 6:1 mixture of Z:E olefin isomers of the alkene. 
Data for Z-isomer: δH (400MHz, CDCl3), 1.20 (3H, t, J 7.0Hz, OCH2CH3, H-
18), 1.73 (3H, app s, C=CCH3, H-13), 2.37 (2H, t, J 7.0Hz, O=CCH2CH2, H-
14), 2.43 (2H, t, J 7.0Hz, O=CCH2CH2, H-15), 3.36 (2H, d, J 7.5Hz, ArCH2, H-
10), 4.09 (2H, q, J 7.0Hz, OCH2CH3, H-17), 4.27 (2H, dd, J 6.5 and 1.5Hz, 
154 
HOCH2, H-1), 5.39 (1H, tq, J 7.5 and 1.0Hz, C=CH, H-11), 5.94 (1H, dt, J 11.5 
and 6.5Hz, ArCH=CH, H-2), 6.65 (1H, dt, J 11.5 and 1.5Hz, ArCH=CH, H-3), 
7.07 (1H, dd, J 6.0 and 2.0Hz, ArH, H-8), 7.12-7.20 (2H, m, 2 x ArH, H-6,7), 
7.46 (1H, dd, J 6.5 and 1.5Hz, ArH, H-5); 
The mixture was dissolved in benzene (50ml), and approximately 10 grains of 
iodine on silica (iodine adsorbed onto chromatographic silica with 
dichloromethane) were added. The mixture was left for 12h in direct sunlight, 
then saturated sodium thiosulphate (50ml) was added and the organic phase was 
separated and concentrated in vacuo. The residue was purified by flash column 
chromatography (40% Et2O, 60% petrol) on silica gel, to give the E-alcohol 226 
(1.25g, 60%) (58% from aryl triflate 246) as a colourless oil; νmax(sol 
CHCl3)/cm-1, 3611 (w), 3502 (br w), 3011 (m), 1725 (s), 1601 (w); δH 
(400MHz, CDCl3), 1.15 (3H, t, J 7.0Hz, OCH2CH3, H-18), 1.76 (3H, app s, 
C=CCH3, H-13), 2.34 (2H, t, J 7.0Hz, O=CCH2CH2, H-14), 2.43 (2H, t, J 
7.0Hz, O=CCH2CH2, H-15), 3.38 (2H, d, J 7.0Hz, ArCH2, H-10), 4.04 (2H, q, J 
7.0Hz, OCH2CH3, H-17), 4.32 (2H, dd, J 5.5 and 1.0Hz, HOCH2, H-1), 5.24 
(1H, tq, J 7.0 and 1.0Hz, C=CH, H-11), 6.25 (1H, dt, J 15.5 and 5.5Hz, 
ArCH=CH, H-2), 6.79 (1H, dt, J 15.5 and 1.0Hz, ArCH=CH, H-3), 7.13 (1H, 
dd, J 6.0 and 2.0Hz, ArH, H-8), 7.15-7.20 (2H, m, 2 x ArH, H-6,7), 7.46 (1H, 
dd, J 6.5 and 1.5Hz, ArH, H-5); δC (100MHz, CDCl3), 14.1 (q, C-18), 16.2 (q, 
C-13), 32.3 (t, C-10), 33.0 (t, C-15), 34.5 (t, C-14), 60.4 (t, C-17), 63.9 (t, C-1), 
123.9 (d, C-11), 125.9 (d, C-2), 126.3 (d, C-6), 127.7 (d, C-5), 128.5 (d, C-7), 
129.3 (d, C-8), 130.1 (d, C-3), 133.9, 135.6 (2 x s, C-4,9), 138.7 (s, C-12), 
173.4 (s, C-16); m/z (ES) 311.1619 (M  + Na+, C18H24O3Na requires 311.1618). 
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(E)-Ethyl-6-(2-(2-(hydroxymethyl)cyclopropyl)phenyl)-4-methylhex-4-enoate 
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Diethylzinc (1.0M in hexanes, 520µl, 0.5mmol) was added dropwise over 20 
min, to a stirred solution of the olefin 226 (100mg, 0.3mmol) and 
diiodomethane (84µl, 1.0mmol) in  dichloromethane (10ml) at room 
temperature, under an argon atmosphere. The mixture was stirred at room 
temperature for 4h and then more diethylzinc (1.0M in hexanes, 520µl, 
0.5mmol) and diiodomethane (84µl, 1.0mmol) were added dropwise, over 
20mins. The mixture was stirred at room temperature for 14h and then ethyl 
acetate (50ml) and water (50ml) were added. The separated aqueous phase was 
extracted with ethyl acetate (3 x 20ml), and the combined organic extracts were 
then washed with brine (10ml), dried over sodium sulphate and concentrated in 
vacuo. The residue was purified by flash column chromatography (30% Et2O, 
70% petrol) on silica gel, to give the cyclopropane 227 (86mg, 82%) as a 
colourless oil; νmax(sol CHCl3)/cm-1, 3613 (w), 3520 (br w), 3009 (m), 1726 (s), 
1602 (w); δH (400MHz, CDCl3), 0.87-0.94 (2H, m, ArCHCH2, H-3), 1.19 (3H, 
t, J 7.0Hz, OCH2CH3, H-19), 1.38-1.45 (1H, m, HOCH2CH, H-2), 1.75 (3H, d, J 
1.0Hz, C=CCH3, H-14), 1.84 (1H, app dt, J 9.0 and 5.0Hz, ArCH, H-4), 2.10 
(1H, app br s, OH), 2.37 (2H, t, J 7.0Hz, O=CCH2CH2, H-15), 2.44 (2H, t, J 
7.0Hz, O=CCH2CH2, H-16), 3.47 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-11a), 
3.53 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-11b), 3.66 (2H, d, J 6.5Hz, 
HOCH2, H-1), 4.07 (2H, q, J 7.0Hz, OCH2CH3, H-18), 5.34 (1H, app tq, J 7.0 
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and 1.0Hz, C=CH, H-12), 6.99 (1H, dd, J 6.0 and 2.0Hz, ArH, H-6), 7.10-7.15 
(3H, m, 3 x ArH, H-7,8,9); δC (100MHz, CDCl3), 12.0 (t, C-3), 14.2 (q, C-19), 
16.2 (q, C-14), 19.0 (d, C-4), 23.4 (d, C-2), 31.8 (t, C-11), 33.1 (t, C-16), 34.7 
(t, C-15),  60.4 (t, C-18), 66.6 (t, C-1), 123.9 (d, C-12), 125.8, 126.1, 126.2 (3 x 
d, C-7,8,9), 128.6 (d, C-6), 134.3 (s, C-10), 139.6 (s, C-13), 140.7 (s, C-5), 
173.5 (s, C-17); m/z (ES) 325.1784 (M  + Na+, C19H26O3Na requires 325.1774). 
 
(E)-Ethyl 6-(2-(2-formylcyclopropyl)phenyl)-4-methylhex-4-enoate 228 
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2-Iodoxybenzoic acid (2.75g, 9.8mmol) was added portionwise, to a stirred 
solution of the alcohol 227 (1.85g, 6.1mmol) in dimethylsulfoxide (25ml) at 
room temperature, under an argon atmosphere. The solution was stirred at room 
temperature for 12h and then water (25ml) was added. The mixture was filtered 
through celite using diethyl ether (50ml), and the separated aqueous phase was 
then extracted with diethyl ether (3 x 20ml). The combined organic extracts 
were washed with brine (30ml), then dried over sodium sulphate and 
concentrated in vacuo. The residue was purified by flash column 
chromatography (20% EtOAc, 80% petrol) on silica gel, to give the aldehyde 
228 (1.31g, 70%) as a colourless oil; νmax(sol CHCl3)/cm-1, 3011 (m), 1715 (br 
s), 1603 (w); δH (400MHz, CDCl3), 1.21 (3H, t, J 7.0Hz, OCH2CH3, H-19), 
1.52-1.58 (1H, m, ArCHCHaHb, H-3a), 1.67-1.70 (1H, m, ArCHCHaHb, H-3b), 
1.71 (3H, app s, C=CCH3, H-14), 2.05 (1H, ddd, J 9.0, 7.0 and 5.0Hz, ArCH, H-
4), 2.35 (2H, t, J 7.0Hz, O=CCH2CH2, H-15), 2.43 (2H, t, J 7.0Hz, 
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O=CCH2CH2, H-16), 2.62-2.70 (1H, m, O=CHCH, H-2), 3.42 (2H, d, J 7.0Hz, 
ArCH2, H-11), 4.09 (2H, q, J 7.0Hz, OCH2CH3, H-18), 5.28 (1H, tq, J 7.0 and 
1.0Hz, C=CH, H-12), 7.00 (1H, dd, J 7.5 and 1.5Hz, ArH, H-6), 7.12-7.23 (3H, 
m, 3 x ArH, H-7,8,9), 9.34 (1H, d, J 5.0Hz, O=CH, H-1); δC (100MHz, CDCl3), 
14.1 (q, C-19), 15.0 (t, C-3), 16.2 (q, C-14), 24.3 (d, C-4), 31.6 (t, C-11), 32.3 
(d, C-2), 33.0 (t, C-16), 34.5 (t, C-15),  60.2 (t, C-18), 122.9 (d, C-12), 125.9, 
126.2, 127.1 (3 x d, C-7,8,9), 128.8 (d, C-6), 134.9 (s, C-10), 136.3 (s, C-13), 
140.9 (s, C-5), 173.2 (s, C-17), 199.9 (s, C-1); m/z (ES) 323.1617 (M  + Na+, 
C19H24O3Na requires 323.1618). 
 
(E)-Ethyl 4-methyl-6-(2-(2-vinylcyclopropyl)phenyl)hex-4-enoate 209 
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Tetrahydrofuran (40ml) was added to freshly dried (100oC, 1mmHg, 5h) 
methyltriphenylphosphonium bromide (4.3g, 12.0mmol) at room temperature, 
under an argon atmosphere. A solution of sodium hexamethyldisilazane (1.0M) 
in THF (5.6ml, 5.6mmol) was added dropwise over 15 min to the stirred 
solution at -78oC. The mixture was stirred at -78oC for 15 min and then a 
solution of the aldehyde 228 (1.4g, 4.7mmol) in tetrahydrofuran (20ml) was 
added dropwise, via canula, over 15 min. The mixture was stirred at -78oC for a 
further 2h and then allowed to warm to room temperature over 12h. Diethyl 
ether (50ml) and water (50ml) were added, and the separated aqueous phase was 
then extracted with diethyl ether (3 x 20ml). The combined organic extracts 
were dried over sodium sulphate and then concentrated in vacuo. The residue 
158 
was purified by flash column chromatography (5% EtOAc, 95% petrol) on silica 
gel, to give the alkene 209 (1.3g, 93%) as a colourless oil; νmax(sol CHCl3)/cm-1, 
3011 (s), 1727 (s), 1634 (m), 1602 (w); δH (400MHz, CDCl3), 1.05 (1H, app dt, 
J 8.5 and 5.0Hz, ArCHCHaHb, H-4a), 1.22 (3H, t, J 7.0Hz, OCH2CH3, H-20), 
1.24-1.27 (1H, m, ArCHCHaHb, H-4b), 1.54-1.59 (1H, m, H2C=CHCH, H-3), 
1.72 (3H, app s, C=CCH3, H-15), 1.96 (1H, ddd, J 8.5, 5.5 and 5.0Hz, ArCH, H-
5), 2.36 (2H, t, J 7.0Hz, O=CCH2CH2, H-16), 2.43 (2H, t, J 7.0Hz, 
O=CCH2CH2, H-17), 3.43 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12a), 3.49 
(1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12b), 4.10 (2H, q, J 7.0Hz, OCH2CH3, 
H-19), 4.96 (1H, dd, J 10.0 and 1.5Hz, HC=CHEHZ, H-1Z), 5.13 (1H, dd, J 17.0 
and 1.5Hz, HC=CHEHZ, H-1E), 5.34 (1H, app tq, J 7.0 and 1.5Hz, C=CH, H-
13), 5.58 (1H, ddd, J 17.0, 10.0 and 8.5Hz, H2C=CH, H-2), 6.99 (1H, dd, J 6.0 
and 2.0Hz, ArH, H-7), 7.12-7.15 (3H, m, 3 x ArH, H-8,9,10); δC (100MHz, 
CDCl3), 14.2 (q, C-20), 14.6 (t, C-17), 16.2 (q, C-15), 23.0 (d, C-5), 25.7 (d, C-
3), 31.6 (t, C-17), 33.2 (t, C-16), 34.7 (t, C-12), 60.3 (t, C-19), 112.4 (t, C-1), 
123.6 (d, C-13), 125.7, 126.0, 126.1 (3 x d, C-8,9,10), 128.4 (d, C-7), 134.4 (s, 
C-11), 139.5 (s, C-14), 140.9 (s, C-6), 141.0 (d, C-2), 173.4 (s, C-18); m/z (ES) 
321.1817 (M  + Na+, C20H26O2Na requires 321.1825). 
 
(E)-4-Methyl-6-(2-(2-vinylcyclopropyl)phenyl)hex-4-enoic acid 229 
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A solution of lithium hydroxide (40mg, 1.7mmol) in water (2ml) was added 
dropwise over 2min, to a stirred solution of the ester 209 (150mg, 0.5mmol) in 
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acetonitrile (4ml) at room temperature. The mixture was stirred at room 
temperature for 24h, then diethyl ether (1ml) was added and the separated 
organic phase was extracted with water (2 x 5ml) and sodium hydroxide (2M, 
5ml). Hydrochloric acid (2M) was added to the combined aqueous extracts until 
pH 1 (approximately 10ml). The acidified aqueous phase was extracted with 
ethyl acetate (3 x 10ml), and the combined organic extracts were dried over 
sodium sulphate and concentrated in vacuo, to leave the carboxylic acid 229 
(135mg, 96%) as a colourless oil which was used in the next step without 
further purification; νmax(sol CHCl3)/cm-1, 3059 (s), 2929 (s), 1709 (w), 1600 
(m); δH (400MHz, CDCl3), 1.05 (1H, app dt, J 8.5 and 5.0Hz, ArCHCHaHb, H-
4a), 1.25 (1H, ddd, J 8.5, 6.0 and 5.0Hz, ArCHCHaHb, H-4b), 1.53-1.61 (1H, m, 
H2C=CHCH, H-3), 1.73 (3H, app s, C=CCH3, H-15), 1.96 (1H, ddd, J 8.5, 5.5 
and 5.0Hz, ArCH, H-5), 2.37 (2H, t, J 7.0Hz, O=CCH2CH2, H-16), 2.49 (2H, t, 
J 7.0Hz, O=CCH2CH2, H-17), 3.44 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-
12a), 3.49 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12b), 4.96 (1H, dd, J 10.0 and 
1.5Hz, HC=CHEHZ, H-1Z), 5.13 (1H, dd, J 17.0 and 1.5Hz, HC=CHEHZ, H-1E), 
5.37 (1H, app tq, J 7.0 and 1.5Hz, C=CH, H-13), 5.57 (1H, ddd, J 17.0, 10.0 
and 8.5Hz, H2C=CH, H-2), 6.99 (1H, dd, J 6.0 and 2.0Hz, ArH, H-7), 7.12-7.15 
(3H, m, 3 x ArH, H-8,9,10); δC (100MHz, CDCl3), 14.6 (t, C-4), 16.2 (q, C-15), 
23.0 (d, C-5), 25.7 (d, C-3), 31.7 (t, C-17), 32.7 (t, C-16), 34.3 (t, C-12), 112.5 
(t, C-1), 123.8 (d, C-13), 125.7, 126.0, 126.1 (3 x d, C-8,9,10), 128.5 (d, C-7), 
134.0 (s, C-11), 139.5 (s, C-14), 140.8 (s, C-6), 141.1 (d, C-2), 179.0 (s, C-18); 
m/z (ES) 271.1693 (M  + H+, C18H23O2 requires 271.1693). 
 
(E)-Phenyl-4-methyl-6-(2-(2-vinylcyclopropyl)phenyl)hex-4-eneselenoate 193 
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N-Phenylselenylphthalimide (200mg, 0.5mmol) was added, in one portion, to a 
stirred solution of the carboxylic acid 229 (110mg, 0.4mmol) and 
tributylphosphine (0.27ml, 1.2mmol) in benzene (1ml) at room temperature, 
under an argon atmosphere. The mixture was stirred at room temperature for 
24h, then poured onto silica and purified by flash column chromatography 
(100% petrol) on silica gel to give the selenyl ester 193 (90mg, 55%) as a pale 
yellow oil; νmax(sol CHCl3)/cm-1, 2924 (m), 1717 (s), 1634 (m); δH (400MHz, 
CDCl3), 1.05 (1H, app dt, J 8.5 and 5.0Hz, ArCHCHaHb, H-4a), 1.26 (1H, ddd, J 
8.5, 6.0 and 5.0Hz, ArCHCHaHb, H-4b), 1.54-1.60 (1H, m, H2C=CHCH, H-3), 
1.73 (3H, app s, C=CCH3, H-15), 1.96 (1H, ddd, J 8.5, 6.0 and 5.0Hz, ArCH, H-
5), 2.43 (2H, t, J 7.5Hz, O=CCH2CH2, H-16), 2.84 (2H, t, J 7.5Hz, 
O=CCH2CH2, H-17), 3.44 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12a), 3.50 
(1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12b), 4.97 (1H, dd, J 10.0 and 1.5Hz, 
HC=CHEHZ, H-1Z), 5.14 (1H, dd, J 17.0 and 1.5Hz, HC=CHEHZ, H-1E), 5.38 
(1H, app tq, J 7.0 and 1.5Hz, C=CH, H-13), 5.58 (1H, ddd, J 17.0, 10.0 and 
8.5Hz, H2C=CH, H-2), 7.00 (1H, dd, J 6.0 and 2.0Hz, ArH, H-7), 7.13-7.16 
(3H, m, 3 x ArH, H-8,9,10), 7.34-7.41 (3H, m, 3 x ArH, H-20,22), 7.46-7.51 
(2H, m, 2 x ArH, H-21); δC (100MHz, CDCl3), 14.6 (t, C-4), 16.3 (q, C-15), 
23.0 (d, C-5), 25.8 (d, C-3), 31.7 (t, C-16), 34.9 (t, C-12), 46.1 (t, C-17), 112.5 
(t, C-1), 124.4 (d, C-13), 125.7, 126.0, 126.1 (3 x d, C-8,9,10), 126.4 (s, C-19), 
128.5 (d, C-7), 128.8 (d, C-22), 129.3 (2C d, C-21), 133.5 (s, C-11), 135.8 (2C 
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d, C-20), 139.5 (s, C-14), 140.7 (s, C-6), 141.1 (d, C-2), 199.8 (s, C-18); m/z 
(ES) 433.1031 (M  + Na+, C24H26O80SeNa requires 433.1041). 
 
1-((E)-3-Methylpent-2-enyl)-2-(2-vinylcyclopropyl)benzene 230, 3-(2-((E)-3-
methylpent-2-enyl)phenyl)-5-vinyl-1,2-dioxolane 242, (E)-4-methyl -6-(2-(2-
vinylcyclopropyl)phenyl)hex-4-enal 231, (6E,12E)-8,9,14,15-tetra hydro-7-
methyl-5H-benzo[13]annulen-10(11H)-one 232, 1,2,4a,5,6,6a,11, 11a-
octahydro-11b-methyl-4H-benzo[a]fluoren-3(11bH)-one 194 and (E)-Se-
phenyl-4-methyl-6-(2-(5-vinyl-1,2-dioxolan-3-yl)phenyl)hex-4-eneselenoate 
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A solution of tri-n-butyltin hydride (92l, 0.34mmol) and 1,1'-
azobis(cyclohexanecarbonitrile) (2mg, 0.01mmol) in degassed benzene (20ml), 
was added dropwise over 8h via syringe pump, to a stirred solution of the 
selenyl ester 193 (110mg, 0.26mmol) and 1,1'-azobis(cyclohexanecarbonitrile) 
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(2mg, 0.01mmol) in degassed benzene (200ml), at 80oC under an argon 
atmosphere. The mixture was heated under reflux for a further 12h, then 
allowed to cool to room temperature and concentrated in vacuo. The residue 
was purified by flash column chromatography on silica (0–25% Et2O, 100-75% 
petrol) to give: i) the vinylcyclopropane hydrocarbon 230 (<1mg, 1%) (eluted 
first) as a colourless oil; δH (400MHz, CDCl3), 1.01 (3H, t, J 7.5Hz, CH2CH3, 
H-17), 1.05 (1H, app dt, J 8.5 and 5.0Hz, ArCHCHaHb, H-4a), 1.24-1.32 (1H, m, 
ArCHCHaHb, H-4b), 1.50-1.61 (1H, m, H2C=CHCH, H-3), 1.71 (3H, app s, 
C=CCH3, H-15), 1.99 (1H, ddd, J 8.5, 6.0 and 5.0Hz, ArCH, H-5), 2.04 (2H, q, 
J 7.5Hz, CH2CH3, H-16), 3.44 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12a), 
3.49 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12b), 4.95 (1H, dd, J 10.0 and 
1.5Hz, HC=CHEHZ, H-1Z), 5.13 (1H, dd, J 17.0 and 1.5Hz, HC=CHEHZ, H-1E), 
5.29 (1H, app tq, J 7.0 and 1.5Hz, C=CH, H-13), 5.58 (1H, ddd, J 17.0, 10.0 
and 8.5Hz, H2C=CH, H-2), 6.98 (1H, dd, J 6.0 and 1.5Hz, ArH, H-7), 7.11-7.18 
(3H, m, 3 x ArH, H-8,9,10); upon standing in air, for 5mins, the 
vinylcyclopropane 230 became oxidised leading to the dioxolane 242 (<1mg, 
1%), as a yellow oil; δH (400MHz, CDCl3), 1.03 (3H, t, J 7.5Hz, CH2CH3, H-
17), 1.75 (3H, app s, C=CCH3, H-15), 2.06 (2H, q, J 7.5Hz, CH2CH3, H-16), 
2.39 (1H, app dt, J 12.0 and 7.5Hz, ArCHCHaHb, H-4a), 3.23 (1H, app dt, J 12.0 
and 7.5Hz, ArCHCHaHb, H-4b), 3.35 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-
12a), 3.41 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12b), 4.89 (1H, app dt, J 7.5 
and 7.0Hz, H2C=CHCH, H-3), 5.21 (1H, app tq, J 7.0 and 1.5Hz, C=CH, H-13), 
5.30 (1H, dd, J 10.0 and 1.5Hz, HC=CHEHZ, H-1Z), 5.41 (1H, dd, J 17.0 and 
1.5Hz, HC=CHEHZ, H-1E), 5.55 (1H, app t, J 7.5Hz, ArCH, H-5), 5.93 (1H, 
ddd, J 17.0, 10.0 and 7.0Hz, H2C=CH, H-2), 7.19 (1H, dd, J 6.0 and 1.5Hz, 
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ArH, H-7), 7.25-7.31 (3H, m, 3 x ArH, H-8,9,10); ii) the saturated aldehyde 231 
(3mg, 4%) (eluted second) as a yellow oil; νmax(sol CHCl3)/cm-1, 2928 (s), 1720 
(s), 1634 (m), 1605 (m); δH (400MHz, CDCl3), 1.05 (1H, app dt, J 8.5 and 
5.0Hz, ArCHCHaHb, H-4a), 1.24-1.28 (1H, m, ArCHCHaHb, H-4b), 1.52-1.63 
(1H, m, H2C=CHCH, H-3), 1.73 (3H, d, J 1.0Hz, C=CCH3, H-15), 1.95 (1H, 
ddd, J 8.5, 6.0 and 5.0Hz, ArCH, H-5), 2.38 (2H, t, J 7.5Hz, O=CCH2CH2, H-
16), 2.56 (2H, td, J 7.5 and 2.0Hz, O=CCH2CH2, H-17), 3.45 (1H, dd, J 16.0 
and 7.0Hz, ArCHaHb, H-12a), 3.49 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12b), 
4.96 (1H, dd, J 10.0 and 1.5Hz, HC=CHEHZ, H-1Z), 5.13 (1H, dd, J 17.0 and 
1.5Hz, HC=CHEHZ, H-1E), 5.35 (1H, tq, J 7.0 and 1.0Hz, C=CH, H-13), 5.58 
(1H, ddd, J 17.0, 10.0 and 8.5Hz, H2C=CH, H-2), 7.00 (1H, dd, J 6.0 and 
2.0Hz, ArH, H-7), 7.11-7.17 (3H, m, 3 x ArH, H-8,9,10), 9.77 (1H, t, J 2.0Hz, 
O=CH, H-18); m/z (ES) 277.1565 (M  + Na+, C18H22ONa requires 277.1568); 
recovered starting selenyl ester 193 (5mg, 5%); iii) the macrocyclic dienone 232 
(15mg, 22%) (eluted third) as a colourless oil; νmax(sol CHCl3)/cm-1, 2920 (s), 
1710 (s), 1605 (w); δH (400MHz, CDCl3), 1.72 (3H, d, J 1.5Hz, HC=CCH3, H-
15), 2.33 (2H, app dd, J 6.0 and 4.5Hz, O=CCH2CH2, H-16), 2.48 (2H, app dtd, 
J 7.5, 5.5 and 1.0Hz, ArCH2CH2, H-4), 2.51 (1H, app d, J 12.0Hz, 
O=CCHaHbCH2, H-17a), 2.52 (1H, app td, J 4.5 and 1.0Hz, O=CCHaHbCH2, H-
17b), 2.69 (1H, app d, J 5.5Hz, ArCHaCHbCH2, H-5a), 2.70 (1H, app dd, J 6.0 
and 5.5Hz, ArCHaCHbCH2, H-5b), 2.91 (2H, app dd, J 7.0 and 1.0Hz, O=CCH2, 
H-1), 3.27 (2H, app d, J 7.0Hz, ArCH2CH=C, H-12), 5.05 (1H, app tq, J 7.0 and 
1.5Hz, ArCH2CH=C, H-13), 5.26 (1H, app dtt, J 15.5, 7.5 and 1.0Hz, 
O=CCH2CH=CH, H-3), 5.47 (1H, app dtt, J 15.5, 7.0 and 1.0Hz, 
O=CCH2CH=CH, H-2), 7.07-7.12 (2H, m, 2 x ArH, H-7,8), 7.17 (1H, ddd, J 
164 
7.5, 7.0 and 2.0Hz, ArH, H-9), 7.24 (1H, dd, J 7.5 and 1.0Hz, ArH, H-10); δC 
(100MHz, CDCl3), 17.1 (q, C-15), 31.0 (t, C-12), 32.3 (t, C-16), 32.7 (t, C-5), 
33.7 (t, C-4), 40.1 (t, C-17), 45.1 (t, C-1), 121.2 (d, C-13), 125.0 (d, C-2), 
126.0, 126.3 (2 x d, C-8,9), 128.7 (d, C-7), 130.2 (d, C-10), 131.9 (s, C-11), 
134.6 (d, C-3), 139.0 (s, C-14), 139.8 (s, C-6), 207.9 (s, C-18); m/z (ES) 
277.1575 (M  + Na+, C18H22ONa requires 277.1568); iv) a 1:1 mixture of 
angular methyl epimers of the tetracyclic ketone 194 (15mg, 22%) (eluted 
fourth) as a crystalline solid m.p 128-129oC (Ethanol); νmax(sol CHCl3)/cm-1, 
2928 (s), 1704 (s); The epimers were separated by reverse phase preparative 
HPLC (MeCN:H2O) and showed the following data: trans, anti, trans isomer 
194a (present together with ~20% of other epimer impurity) δH (400MHz, 
CDCl3), 1.13 (3H, s, CH3, H-18), 1.36 (1H, dddd, J 12.5, 12.0, 12.0 and 4.5Hz, 
ArCHCHaxHeq, H-7ax), 1.43-1.53 (1H, m, O=CCH2CHCHaHb, H-6a), 1.51-1.60 
(1H, m, O=CH2CHaxHeq, H-1ax), 1.56-1.62 (1H, m, O=CCH2CHCHaHb, H-6b), 
1.60-1.68 (1H, m, O=CCH2CH, H-4), 1.67 (1H, ddd, J 12.5, 12.0 and 7.0, 
ArCHCH, H-9), 1.96 (1H, ddd, J 13.0, 6.5 and 2.0Hz, O=CCH2CHaxHeq, H-1eq), 
2.21 (1H, ddd, J 14.5, 4.0 and 2.0Hz, O=CCHaxHeqCH, H-4eq), 2.31 (1H, dd, J 
14.5 and 13.5Hz, O=CCHaxHeqCH, H-4ax), 2.34-2.42 (2H, 2 x m, 
O=CCHaxHeqCH2, H-2eq + ArCHCHaxHeq, H-7eq), 2.49 (1H, ddd, J 15.0, 13.5 
and 6.5Hz, O=CCHaxHeqCH2, H-2eq), 2.65 (1H, dd, J 14.0 and 12.0Hz, 
ArCHaxHeq, H-11ax), 2.73 (1H, dd, J 14.0 and 7.0Hz, ArCHaxHeq, H-11eq), 2.93 
(1H, ddd, J 12.5, 12.0 and 3.5Hz, ArCH, H-8), 7.12-7.17 (3H, m, 3 x ArH, H-
14,15,16), 7.23 (1H, dd, J 7.0 and 2.0Hz, ArH, H-13); δC (100MHz, CDCl3), 
11.6 (q, C-18), 28.8 (t, C-7), 29.5 (t, C-6), 31.3 (t, C-11), 35.6 (s, C-10), 38.0 (t, 
C-2), 38.4 (t, C-1), 44.0 (d, C-8), 44.3 (t, C-4), 46.6 (d, C-5), 60.7 (d, C-9), 
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122.0 (d, C-16), 124.6 (d, C-13), 126.2 (2 x d, C-14,15), 143.0 (s, C-12), 146.6 
(s, C-17), 211.4 (s, C-3); cis, syn, trans isomer 194b δH (400MHz, CDCl3), 1.33 
(1H, dddd, J 14.5, 13.0, 12.0 and 3.5Hz, ArCHCHaxHeq, H-7ax), 1.37 (3H, s, 
CH3, H-18), 1.45 (1H, dddd, J 14.0, 13.0, 12.5 and 3.5Hz, O=CCH2CHCHaxHeq, 
H-6ax), 1.66-1.72 (1H, m, O=CCH2CHaxHeq, H-1eq), 1.68-1.74 (1H, m, 
O=CCH2CHCHaxHeq, H-6eq), 1.81 (1H, ddd, J 12.5, 12.0 and 6.5Hz, ArCHCH, 
H-9), 1.81-1.89 (1H, m, ArCH2CH, H-5), 2.10 (1H, ddd, J 14.5, 2.5 and 2.0Hz, 
O=CCHaHbCH, H-4a), 2.17 (1H, ddd, J 14.0, 13.5 and 5.0Hz, O=CCH2CHaxHeq, 
H-1ax), 2.29-2.36 (1H, m, O=CCHaxHeqCH2, H-2eq), 2.32-2.38 (1H, m, 
ArCHCHaxHeq, H-7eq), 2.53 (1H, dddd, J 14.5, 14.0, 7.0 and 0.5Hz, 
O=CCHaxHeqCH2, H-2ax), 2.56 (1H, dd, J 14.0 and 12.5Hz, ArCHaxHeq, H-11ax), 
2.81 (1H, dd, J 14.0 and 6.5Hz, ArCHaxHeq, H-11eq), 2.82 (1H, dd, J 14.5 and 
12.0Hz, ArCH, H-8), 2.87 (1H, ddd, J 14.5, 6.5 and 0.5Hz, O=CCHaHbCH, H-
4b), 7.11-7.18 (3H, m, 3 x ArH, H-14,15,16), 7.23 (1H, dd, J 7.0 and 2.0Hz, 
ArH, H-13); δC (100MHz, CDCl3), 24.8 (q, C-18), 27.1 (t, C-1), 29.2 (t, C-7), 
30.2 (t, C-6), 31.7 (t, C-11), 35.1 (s, C-10), 37.5 (t, C-2), 43.2 (d, C-8), 44.2 (t, 
C-4), 46.2 (d, C-5), 59.8 (d, C-9), 122.0 (d, C-16), 124.5 (d, C-13), 126.1 (2 x d, 
C-14,15), 143.0 (s, C-12), 146.6 (s, C-17), 212.1 (s, C-3); m/z (ES) 277.1570 
(M  + Na+, C18H22ONa requires 277.1568); a small amount of starting phenyl 
seleno ester 193 (5%) was also recovered, together with the corresponding 
dioxolane 233 (10mg, 8%) (eluted last) as a colourless oil; δH (400MHz, 
CDCl3), 1.74 (3H, d, J 0.5Hz, HC=CCH3, H-15), 2.36 (1H, app dt, J 12.0 and 
7.0Hz, ArCHCHaHb, H-4a), 2.42 (2H, t, J 7.5Hz, O=CCH2CH2, H-16), 2.83 
(2H, t, J 7.5Hz, O=CCH2CH2, H-17), 3.18 (1H, app dt, J 12.0 and 7.5Hz, 
ArCHCHaHb, H-4b), 3.34 (1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12a), 3.39 
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(1H, dd, J 16.0 and 7.0Hz, ArCHaHb, H-12b), 4.85 (1H, app dtt, J 7.5, 7.0 and 
1.0Hz, H2C=CHCH, H-3), 5.27 (1H, app dt, J 10.0 and 1.0Hz, HC=CHEHZ, H-
1Z), 5.28 (1H, app tq, J 7.0 and 0.5Hz, C=CH, H-13), 5.38 (1H, app dt, J 17.0 
and 1.0Hz, HC=CHEHZ, H-1E), 5.49 (1H, app t, J 7.5Hz, ArCH, H-5), 5.89 (1H, 
ddd, J 17.0, 10.0 and 7.5Hz, H2C=CH, H-2), 7.14 (1H, dd, J 7.5 and 1.5Hz, 
ArH, H-7), 7.33-7.40 (3H, m, 3 x ArH, H-8,9,10), 7.44-7.47 (3H, m, 3 x ArH, 
H-20,22), 7.57 (2H, dd, J 7.5 and 7.0Hz, 2 x ArH, H-21); δC (100MHz, CDCl3), 
16.3 (q, C-15), 31.5 (t, C-16), 34.8 (t, C-12), 45.9 (t, C-17), 48.8 (t, C-4), 79.6 
(d, C-5), 82.3 (d, C-3), 119.0 (t, C-1), 124.2 (d, C-13), 125.7, 126.7, 128.1, 
128.9 (4 x d, C-7,8,9,10), 126.4 (s, C-19), 129.3 (2C d, C-21), 129.4 (d, C-22), 
134.0 (s, C-11), 135.0 (d, C-2), 135.7 (2C d, C-20), 136.7 (s, C-14), 138.4 (s, C-
6), 199.7 (s, C-18); m/z (ES) 465.0956 (M  + Na+, C24H26O380SeNa requires 
465.0945). 
 
 
 
 
 
 
 
 
 
 
 
 
167 
 
 
 
 
 
 
 
 
 
References 
 
 
 
 
 
 
 
168 
                                                                                                                                       
1  D. J. Newman, G. M. Cragg, K. M. Snader, J. Nat. Prod., 2003, 66, 1022-
1037. 
2  J. J. Brocks, G. A. Logan, R. Buick, R. E. Summons, Science, 1999, 285, 
1033-1036. 
3  T. R. Cupps, A. S. Fauci, Immunol. Rev., 1982, 65, 133-155. 
4  a) D. Hartley, H. Smith, J. Chem. Soc., 1964, 4492-4495; b) C. H. Kuo, D. 
Taub, N. L. Wendler, J. Org. Chem., 1968, 33, 3126-3132 and refs. cited 
therein. 
5  N. Ikekawa, Med. Res. Rev., 1987, 7, 333-366. 
6  P. M. Dewick, Medicinal Natural Products: A Biosynthetic Approach, 
2005, John Wiley and Sons Ltd. 
7  R. B. Woodward, K. Bloch, J. Am. Chem. Soc. 1953, 75, 2023-2024. 
8  I. Abe, Nat. Prod. Rep., 2007, 24, 1311-1331. 
9  L. F. Fieser, M. Fieser, Steroids, 1959, Reinhold Publishing Corp. 
10  G. Popjak, W. S. Agnew, Mol. Cell. Biochem., 1979, 2, 97-116. 
11  T. T. Chen, K. Bloch, J. Am. Chem. Soc., 1955, 77, 6085-6086. 
12  E. J. Corey, H. Cheng, C. H. Baker, S. P. T. Matsuda, D. Li, X. Song, J. 
Am. Chem. Soc., 1997, 119, 1289-1296. 
13  D. J. Reinert, G. Balliano, G. E. Schulz, Chem. Biol., 2004, 11, 121-126. 
14  R. Thoma, T. Schulz-Gasch, B. D’Arcy, Hennig, M. Stihle, A. Ruf, Nature, 
2004, 432, 118-122. 
15  R. A. Yoder, J. N. Johnston, Chem. Rev., 2005, 12, 4730-4756. 
16  K. U. Wendt, G. E. Schulz, E. J. Corey, D. R. Liu, Angew. Chem. Int. Ed., 
2000, 39, 2812-2832. 
17  K. U. Wendt, Angew. Chem. Int. Ed., 2005, 44, 3966-3971. 
169 
                                                                                                                                       
18  C. Djerassi, Science, 1989, 245, 356-361. 
19  J. R. Hanson, Nat. Prod. Rep., 2001, 18, 282-290.  
20  W. E. Bachmann, W. Cole, A. L. Wilds, J. Am. Chem. Soc., 1939, 61, 974-
975. 
21  G. Anner, K. Miescher, Helv. Chim. Acta., 1948, 31, 2173-2183. 
22  Z. G. Hajos, D. R. Parrish, J. Org. Chem., 1974, 39, 1615-1621. 
23  W. S. Johnson, M. B. Gravestock, B. E. McCarry, J. Am. Chem. Soc., 1971, 
93, 4332-4334. 
24  G. Stork, A. W. Burgstahler, J. Am. Chem. Soc., 1955, 77, 5068-5077. 
25  C. Heinemann, M. Demuth, J. Am. Chem. Soc., 1999, 121, 4894-4895. 
26  W. S. Johnson, W. R. Bartlett, B. A. Czekis, A. Gautier, C. H. Lee, R. 
Lemoine, E. J. Leopold, G. R. Leudtke, K. J. Bancroft, J. Org. Chem., 1999, 
64, 9587-9595. 
27  L. F. Tietze, T. Nobel, M. Specha, J. Am. Chem. Soc., 1998, 120, 8971-
8977. 
28  Y. Zhang, G. Z. Wu, G. Agnel, E. I. Negishi, J. Am. Chem. Soc., 1990, 112, 
8590-8592. 
29  D. Hildebrandt, G. Dyker, J. Org. Chem., 2006, 71, 6728-6733. 
30  O. Diels, K. Alder, Liebigs. Ann., 1928, 460, 98-122. 
31  R. B. Woodward, F. Sondheimer, D. Taud, K. Heusler, W. M. McLamore, 
J. Am. Chem. Soc., 1952, 72, 4223-4251.  
32  P. Deslongchamps, Pure Appl. Chem., 1992, 64, 1831-1847. 
33  M. Couturier, P. Deslongchamps, Synlett, 1996, 11, 1140-1142. 
34  R. L. Funk, K. P. C. Vollhardt, J. Am. Chem. Soc., 1979, 101, 215-217. 
35  H. Nemoto, K. Fukumoto, Tetrahedron, 1998, 54, 5425-5464.  
170 
                                                                                                                                       
36  K. P. C. Vollhardt, Pure Appl. Chem., 1985, 57, 1819-1826. 
37  K. C. Nicolaou, D. J. Edwards, P. G. Bulger, Angew. Chem. Int. Ed., 2006, 
45, 7134-7186. 
38  M. Gomberg, J. Am. Chem. Soc., 1900, 22, 757-771.  
39  M. Newcomb, Tetrahedron, 1993, 49, 1151-1176. 
40  D. P. Curran, Synlett, 1991, 63-72. 
41  a) C. P. Jasperse, D. P. Curran, T. L. Fevig, Chem. Rev., 1991, 91, 1237-
1286; b) B. Giese, Radicals in Organic Chemistry: Formation of Carbon-
Carbon Bonds, 1986, Pergamon Press; c) W. B. Motherwell, D. Crich, Free 
Radical Chain Reactions in Organic Synthesis, 1992, Academic Press; d) 
D. P. Curran, N. A. Porter, B. Giese, Stereochemistry of Radical Reactions, 
1996, VCH Ltd. 
42  a) R. Hirschmann, C. S. Snoddy, N. I. Wendler, J. Am. Chem. Soc., 1952, 
74, 2693-2694; b) W. Lawrie, W. Hamilton, J. McLean, J. Meney, J. Chem. 
Soc. Perkin Trans. 1, 1978, 471-479. 
43  T. Teruya, S. Nakagawa, T. Koyama, H. Arimoto, M. Kita, D. Uemura, 
Tetrahedron, 2004, 60, 6989-6993. 
44  K. Saito, Bull. Chem. Soc. Japan, 1940, 15, 22-27. 
45  O. Krayer, R. B. Arora, E. Meilman, J. Pharmacol. Exp. Ther., 1955, 113, 
446-459. 
46  O. Krayer, J. Pharmacol. Exp. Ther., 1949, 96, 422-437. 
47  K. Fukuma, Jap. J. Pharmacol., 1956, 5, 102-114. 
48  R. F. Keeler, Lipids, 1978, 13, 708-715. 
49  F. von Gizycki, G. Kotitschke, Arch. Pharm., 1951, 284, 129. 
171 
                                                                                                                                       
50  O. Nalbandov, R. T. Yamamoto, G. S. Fraenkel, Agric. Food Chem., 1964, 
12, 55-59. 
51  M. J. Begley, L. Crombie, P. J. Ham, D. A. Whiting, J. Chem. Soc., Perkin 
Trans. 1, 1976, 304-308, and refs. cited therein. 
52  R. B. Bates, D. J. Eckert, J. Am. Chem.. Soc., 1972, 94, 8258-8260. 
53  S. P. Green, D. A. Whiting, J. Chem. Soc., Perkin Trans. 1, 1996, 1027-
1034, and refs. cited therein. 
54  H. K. Gill, R. W. Smith, D. A. Whiting, J. Chem. Commun., 1986, 1457-
1458. 
55  R. B. Bates, S. R. J. Morehead, J. Chem. Soc. Chem. Commun., 1974, 125-
126. 
56  B. M. Stoltz, T. Kano, E. J. Corey, J. Am. Chem. Soc., 2000, 122, 9044-
9045. 
57  M. Ge, B. M. Stoltz, E. J. Corey, J. Org. Lett., 2000, 2, 1927-1929. 
58  S. Handa, P. S. Nair, G. Pattenden, Helv. Chim. Acta, 2000, 83, 2629-2643. 
59  A. Batsanov, L. Chen, G. B. Gill, G. Pattenden, J. Chem. Soc. Perkin Trans. 
1, 1996, 45-55. 
60  N. A. Porter, B. Lacher, V. H. T. Chang, D. R. Magnin, J. Am. Chem. Soc., 
1989, 111, 8309-8310. 
61  N. A. Porter, D. R. Magnin, B. T. Wright, J. Am. Chem. Soc., 1986, 108, 
2787-2788. 
62  N. A. Porter, V. H. T. Chang, D. R. Magnin, B. T. Wright, J. Am. Chem. 
Soc., 1988, 110, 3554-3560. 
63  N. J. G. Cox, G. Pattenden, Tetrahedron Lett., 1989, 30, 621-624. 
172 
                                                                                                                                       
64  J. E. Baldwin, R. M. Adlington, M. B. Mitchell, J. Robertson, J. Chem. 
Soc., Chem. Commun., 1990, 22, 1574-1575. 
65  N. A. Porter, B. Lacher, V. H. Chang, D. R. Magnin, J. Am. Chem. Soc., 
1989, 111, 8309-8310. 
66  N. A. Porter, V. H. T. Chang, D. R. Magnin, B. T. Wright, J. Am. Chem. 
Soc., 1988, 110, 3554-3560. 
67  A. J. McCarroll, J. C. Walton, Angew. Chem. Int. Ed., 2001, 40, 2224-2248. 
68  G. Pattenden, M. J. Begley, A. J. Smithies, D. S. Walter, Tetrahedron Lett., 
1994, 35, 2417-2420. 
69  S. Handa, G. Pattenden, Contemp. Org. Synth., 1997, 4, 196-215. 
70  G. Pattenden, D. A. Stoker, N. M. Thomson, Org. Biomol. Chem., 2007, 5, 
1776-1778. 
71  G. Pattenden, M. A. Gonzalez, S. McCulloch, A. Walter, S. J. Woodhead, 
Proc. Natl. Acad. Sci., 2004, 101, 12024-12029. 
72  G. Pattenden, L. K. Reddy, A. Walter, Tetrahedron Lett., 2004, 45, 4027-
4030. 
73  U. Jahn, D. P. Curran, Tetrahedron Lett., 1995, 36, 8921-8924. 
74  a) V. Grignard, C. R. Acad. Sci., 1900, 1322-1324, b) J. F. Garst, M. P. 
Soriaga, Coord. Chem. Rev., 2004, 248, 623-652. 
75  H. Finkelstein, Ber., 1910, 43, 1528-1532. 
76  J. B. Baudin, G. Hareau, S. A. Julia, R. Lorne, O. Ruel, Tetrahedron Lett., 
1991, 32, 1175-1178. 
77  J. B. Baudin, G. Hareau, S. A. Julia, R. Lorne, O. Ruel, Bull. Soc. Chim. 
Fr., 1993, 130, 856-878. 
78  R. F. Nystrom, W. G. Weldon, J. Am. Chem. Soc., 1948, 70, 3738-3740. 
173 
                                                                                                                                       
79  O. Mitsunobu, M. Yamada, T. Mukaiyama, Bull. Chem. Soc. Jpn., 1967, 40, 
935-939. 
80  W. R. Bowman, J. M. D. Storey, Chem. Soc. Rev., 2007, 36, 1803-1822. 
81  W. R. Bowman, E. Mann, J. Parr, J. Chem. Soc. Perkin Trans. 1, 2000, 
2991-2999. 
82  D. Crich, J. T. Hwang, J. Org. Chem., 1998, 63, 2765-2770. 
83  A. L. J. Beckwith, V. W. Bowry, W. R. Bowman, E. Mann, J. Parr, J. M. D. 
Storey, Angew. Chem. Int. Ed., 2004, 43, 95-98.  
84  W. R. Bowman, E. Mann, J. Parr,. J. Chem. Soc. Perkin Trans. 1, 2000, 
2991-2999. 
85  E. Bonfand, L. Forslund, W. B. Motherwell, S. Vasquez, Synlett, 2000, 475-
478. 
86  D. C. Harrowven, B. J. Sutton, S. Coulton, Tetrahedron, 2002, 58, 3387-
3400. 
87  P. S. Engel, W. X. Wu, J. Am. Chem.. Soc., 1989, 111, 1830-1835. 
88  J. P. Kutney, J. Cable, W. A. F. Gladstone, H. W. Hanssen, G. V. Nair, E. J. 
Torupka, W. D. C. Warnock, Can. J. Chem., 1975, 53, 1796-1817. 
89  a) W. S. Johnson, H. A. P. deJongh, C. E. Coverdale, J. W. Scott, U. 
Burckhardt, J. Am. Chem. Soc., 1967, 89, 4523-4524; b) W. S. Johnson, J. 
M. Cox, D. W. Graham, H. W. Whitlock, J. Am. Chem. Soc., 1967, 89, 
4524-4526. 
90  D. W. Stoutamire, Ph.D Dissertation, University of Wisconsin, 1957. 
91  C. Chatgilaloglu, D. Crich, M. Komatsu, I. Ryu, Chem. Rev., 1999, 99, 
1991-2069. 
92  D. L. Boger, R. J. Mathvink, J. Org. Chem., 1989, 54, 1779-1781.  
174 
                                                                                                                                       
93  G. Pattenden, P. Wiedenau, Tetrahedron Lett., 1997, 38, 3647-3650. 
94  J. K. Stille, Angew. Chem., 1986, 98, 504-519. 
95  a) M. Rubin, M. Rubina, V. Gevorgyan, Chem. Rev., 2007, 107, 3117-3179; 
b) H. N. C. Wong, M. Y. Hon, C. W. Tse, Y. C. Yip, J. Tanko, T. Hudlicky, 
Chem. Rev. 1989, 89, 165-198. 
96  A. B. Charette, A. Giroux, J. Org. Chem., 1996, 61, 8718-8719. 
97  E. Piers, M. Jean, P. S. Marrs, Tetrahedron Lett., 1987, 28, 5075-5078. 
98  J. Furukawa, N. Kawabata, J. Nishimura, Tetrahedron Lett., 1966, 3353-
3354. 
99  M. Frigerio, M. Santagostino, S. Sputore, J. Org. Chem., 1999, 64, 4537-
4538. 
100  G. Wittig, W. Haag, Chem. Ber., 1958, 88, 1654-1666. 
101  G. D. Allred, L. S. Liebeskind, J. Am. Chem. Soc., 1996, 118, 2748-2749. 
102  O. Diels, K. Alder, Ber., 1929, 62B, 2081-2087. 
103  A. Barbero, F. J. Pulido, Synthesis, 2004, 3, 401-404. 
104  M. D. Bercich, R. C. Cambie, P. S. Rutledge, Aust. J. Chem, 1999, 52, 303-
316. 
105  P. A. Plé, A. Hamon, G. Jones, Tetrahedron, 1997, 53, 3395-3400. 
106  L. Canonica, B. Rindone, E. Santaniello, C. Scolastico, Tetrahedron, 1972, 
28, 4395-4404. 
107  R. E. Ireland, R. H. Mueller, J. Am. Chem. Soc., 1972, 94, 5897-5898. 
108  M. A. Bramble, C. C. Flowers, M. Tross, K. Y. Tsang, Tetrahedron, 2006, 
62, 5883-5896. 
109  W. S. Johnson, L. Werthemann, W. R. Bartlett, T. J. Brocksom, T. T. Li, D. 
J. Faulkner, M. R. Petersen, J. Am. Chem. Soc., 1970, 92, 741-743. 
175 
                                                                                                                                       
110  R. Pedrosa, C. Andres, J. M. Iglesias, J. Org. Chem, 2001, 66, 243-250. 
111  M. Nahmany, A. Melman, Tetrahedron, 2005, 61, 7481-7488. 
112  B. K. Bhattacharyya, A. K. Bose, A. Chatterjee, B. P. Sen, J. Indian Chem. 
Soc., 1964, 41, 479-495. 
113  K. S. Feldman, R. E. Simpson, J. Am. Chem. Soc., 1989, 111, 4878-4886.  
114  W. C. Still, M. Kahn, A. Mitra, J. Org. Chem., 1978, 43, 2923-2925. 
115  L. Fieser, M. Fieser, Reagents for Organic Synthesis, Volume 1, 1967, 
Wiley. 
116  M. Frigerio, M. Santagostino, S. Sputore, J. Org. Chem. 1999, 64, 4537-
4538. 
117  H. Takamitsu, S. Kergo, H. Doi, M. Wakoo, M. Suzuki, Org. Biomol. 
Chem., 2006, 4, 410-415. 
118  A. B. Charette, H. Juteau, H. Lebel, C. Molinaro, J. Am. Chem. Soc., 1998, 
120, 11943-11952. 
119  G. S. Sheppard, J. Wang, M. Kawai, S. D. Fidanze, N. Y. BaMaung, S. A. 
Erickson, D. M. Barnes, J. S. Tedrow, L. Kolaczkowski, A. Vasudevan, D. 
C. Park, G. T. Wang, W. J. Sanders, R. A. Mantei,  F. Palazzo, L. Tucker-
Garcia, P. Lou, Q. Zhang, C. H. Park, K. H. Kim, A. Petros, E. Olejniczak, 
D. Nettesheim, P. Hajduk, J. Henkin, R. Lesniewski, S. K. Davidsen, R. L. 
Bell, J. Med. Chem., 2006, 49, 3832-3849. 
120  J. M. Schomeker, S. Bhettacharjee, J. Yan, B. Borham, J. Am. Chem. Soc., 
2007, 129, 1996-2003. 
121  S. C. Pelley, S. Govender, M. A. Fernandes, H. G. Schmalz, C.B. de Konig, 
J. Org. Chem., 2007, 72, 2857-2864. 
176 
                                                                                                                                       
122  A. Padwa, H. Lipka, S. H. Walterson, S. S. Murphree, J. Org. Chem., 
2003, 68, 6238-6250. 
